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Regulated intracellular protein degradation is critical for cellular viability. In many organisms, 
degradation controls cell-cycle progression, executes responses to stress-inducing environmental 
changes, and enables the rapid depletion of unwanted or deleterious proteins. In bacteria, most 
processive protein degradation is carried out by a family of AAA+ compartmentalized proteases. 
These molecular machines convert the chemical energy of ATP binding and hydrolysis into 
mechanical work, forcefully unfolding their substrates as a prelude to proteolysis. 
 
The AAA+ ClpXP protease, recognizes short peptide tags (degrons) in substrate proteins either 
directly or with the aid of dedicated specificity factors (adaptors). The prior identification and 
detailed biochemical characterization of an efficient ClpXP degron (the ssrA tag) and cognate 
adaptor (SspB) serve as powerful tools and enable the mechanistic studies presented here.  
 
In Chapter 2, I describe a collaborative investigation of substrate denaturation and degradation 
by ClpXP with single-molecule resolution. Detailed kinetic analysis of these experiments 
revealed homogenous protease activity across the population of enzymes with comparable levels 
of microscopic and macroscopic ClpXP activity. These experiments required the development of 
methods to attach ClpXP to surfaces and stabilize the multimeric enzyme at sub-nanomolar 
concentrations, advances that should be applicable to future single-molecule studies of complex 
protein machines. 
 
Subsequent chapters describe the development of molecular tools that harness our understanding 
of targeted proteolysis and enable small-molecule control of degradation. By engineering 
synthetic substrates, adaptors and proteases, I directly test models previously proposed to explain 
adaptor function and identify the minimal requirements for adaptor-mediated substrate delivery. 
Many different configurations of protease and adaptor domains lead to efficient, predictable 
substrate degradation and demonstrate the highly modular nature of this system. These tools 
allow for facile, small-molecule controlled protein degradation in vivo and should be valuable in 
basic research and biotechnology. I also describe a family of synthetic insulated promoters that 
allow predictable, context-independent levels of protein synthesis. 
 
Thesis Supervisor: Robert T. Sauer 
Title: Salvador E. Luria Professor of Biology 
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A cell’s ability to maintain proper steady-state protein levels is vital for survival. In some 
instances, the ratio of one protein to another is critical, whereas in other cases, the absolute 
concentration is important. Enzymatic activity, for example, is a function of both the cellular 
concentration of the enzyme and its specific activity. Indeed, cells control total activity both 
through the regulation of steady-state enzyme concentrations as well as by dynamically 
modulating enzyme specific activity using post-translational modifications, inhibitors, and 
activators. Descriptions of such post-translational regulation can be found elsewhere (Cohen, 
2002; Mann and Jensen, 2003). This chapter will instead focus on how intracellular protein 
concentrations are controlled both naturally and experimentally. In particular, I will emphasize 
known mechanisms of bacterial proteolysis and how such systems can be utilized to control 
protein degradation in basic research and biotechnology. 
A protein’s steady-state concentration is a function of both its rate of production and its rate of 
degradation. Briefly, cellular RNA polymerase transcribes mRNA from the genome. Balance 
between mRNA production and the combined effects of degradation by RNAses and dilution via 
growth results in a steady-state pool of mRNA that serves as a template for protein synthesis. 
New protein molecules, synthesized via translation of mRNA, are eventually degraded or diluted 
through cell growth and division. This entire process can be modeled using ordinary differential 
equations as shown in Equations 1.1-1.2. Under steady-state conditions, i.e. when the time-
dependent changes in mRNA and protein concentrations are zero, the intracellular concentration 
of a given protein can be expressed as a function of its basic rate constants for transcription, 
mRNA degradation, growth rate, translation, and protein degradation (see Equation 1.3). 





= 𝑘𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡𝑖𝑜𝑛 −  𝑘𝑚𝑅𝑁𝐴𝐷𝑒𝑔 + 𝑘𝑔𝑟𝑜𝑤𝑡 ℎ  𝑚𝑅𝑁𝐴 = 0 (1.1) 
  𝑚𝑅𝑁𝐴 =
𝑘𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡𝑖𝑜𝑛








= 𝑘𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛  𝑚𝑅𝑁𝐴 −  𝑘𝑝𝑟𝑜𝑡𝑒𝑖𝑛𝐷𝑒𝑔 + 𝑘𝑔𝑟𝑜𝑤𝑡 ℎ  𝑝𝑟𝑜𝑡𝑒𝑖𝑛 = 0 (1.2) 
  𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
𝑘𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛  𝑚𝑅𝑁𝐴 









𝑘𝑚𝑅𝑁𝐴𝐷𝑒𝑔 + 𝑘𝑔𝑟𝑜𝑤𝑡 ℎ





Each rate in this process (transcription, mRNA degradation, translation and protein degradation) 
has been carefully tuned by the process of evolution. For example, the rates of transcription and 
translation are strongly dependent on sequence elements located in the promoter of the gene and 
ribosome binding site of the mRNA (Pribnow, 1975; Shine and Dalgarno, 1975). To regulate the 
rates of mRNA degradation, cellular RNAses have coevolved with mRNA coding sequences 
selecting for the presence or absence of cleavage sites (Kuwano et al., 1977). Proteins and 
proteases have evolved under similar selective pressure, incorporating protease recognition sites 
in proteins that must be rapidly degraded (Neher et al., 2006; Chien et al., 2007). Lastly, a 
protein’s thermodynamic stability often correlates with its susceptibility to proteolysis (Parsell 
and Sauer, 1989), and thus thermodynamic stability may be under selective pressure not only as 
a determinant of protein folding but also for its role in protein degradation. In E. coli, such 
selective evolution has given rise to a range of intracellular protein concentrations spanning four 
orders of magnitude (Lu et al., 2007). 
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Cells must also dynamically regulate protein levels in response to changing environmental 
conditions. Powerful techniques exist to directly measure a cell’s genome-wide transcriptional 
response to environmental perturbations, allowing for identification of the proteins whose 
transcription is regulated in response to such environmental perturbations (DeRisi et al., 1997; 
Causton et al., 2001). The bacterial lac operon, for example, is exquisitely sensitive to the 
presence of lactose. In the absence of this sugar, a transcriptional repressor, LacI, forms a tight 
complex with the lac operator thereby blocking transcription of the downstream genes, lacZ, 
lacY, and lacA. When lactose is imported into the cell, it binds to the repressor, and induces a 
conformational change that results in dissociation of LacI from the promoter. This process allows 
RNA polymerase to transcribe the genes required for the lactose metabolism (Wilson et al., 
2007). In Chapter 5, I demonstrate that targeted degradation of LacI can also be used to induce 
transcription of the lac operon. 
In addition to regulation of protein-production, evidence has steadily accumulated that protein 
degradation also plays a critical role in the cellular response to changing environments. In 1942, 
Rudolf Scheonheimer observed degradation and recycling of human proteins using 
15
N labeled 
amino acids (Ciechanover, 2005). Since then, controlled protein degradation was found to play a 
critical role many processes including cell-cycle progression, the response to stress-inducing 
environmental changes, inhibition of viral infection, and the maintenance of protein homeostasis 
through the removal of unwanted or deleterious proteins (Murray et al., 1989; Jenal and Fuchs, 
1998; Dougan et al., 2002; Neher et al., 2003; Sakuma et al., 2007; Abdelmohsen et al., 2009). 
In each of these instances, protein degradation is used in concert with additional regulatory 
mechanisms to efficiently control intracellular protein concentrations.  
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Our understanding of the biological mechanisms that control protein concentrations has also led 
to the development of experimental methods to change protein levels artificially by altering the 
rates of protein production or degradation. Such targeted approaches often complement classical 
“forward-genetics” (i.e. generating random mutations, screening for a phenotype, and eventually 
mapping the mutation responsible for the phenotype) in the study of biological systems. For 
genes with a proposed function, targeted techniques provide a means to test specific models in an 
organismal context. For genes of unknown activity, comparing the phenotypes of an 
experimentally altered strain and its parent strain may illuminate function. 
Techniques to experimentally control protein levels have also been applied in biological 
engineering. Applications include the engineering of synthetic genetic circuits and metabolic 
pathways (Elowitz and Leibler, 2000; Gardner et al., 2000; Martin et al., 2003; Kobayashi et al., 
2004; Ro et al., 2006; Atsumi and Liao, 2008). In each case, optimization of steady-state protein 
concentrations was critical for successful implementation and was achieved using a combination 
of techniques to tune steady-state protein concentrations. 
Techniques for genomic perturbations 
Numerous overexpression techniques can be used to increase intracellular protein concentrations  
(Lloyd, 2003; Kitagawa et al., 2005; Sopko et al., 2006; Campbell and Brown, 2008). Here, I 
will focus on the variety of protein knockdown techniques currently available for use in 
eukaryotic and prokaryotic organisms. Each technique offers different compromises between 
ease of application, specificity for a given target, efficiency, ability to control the knockdown in 
a conditional manner, and the speed of the temporal response. 
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For nonessential targets in genetically tractable organisms, the genetic locus can be directly 
perturbed (Baba et al., 2006). In bacteria for example, transiently expressed phage proteins 
facilitate homologous recombination between linear dsDNA and the chromosome. This 
approach, termed recombineering, allows for more efficient bacterial genetic manipulation than 
is possible using endogenous recA-mediated recombination (Court et al., 2002). Recombineering 
makes use of a targeting construct containing the desired alteration (mutation, insertion or 
deletion) fused to a selectable marker and surrounded by short (~40 bp) overhangs homologous 
to the region of interest. After induction of the phage recombination factors, the linearized 
targeting cassette is electroporated into cells and recombination incorporates the entire construct 
into the genome, replacing the targeted loci between the homologous regions. Cells are then 
plated on selective media to identify recombinants (Figure 1.1A,B).  
If a cassette containing both a selectable and conditionally counter-selectable marker is first 
introduced at a locus of interest, it is possible to perform a second round of recombineering, 
which simultaneously introduces a genetic perturbation and removes the initial cassette (Lee et 
al., 2001b). This technique allows for the “scarless” manipulation of the genome as illustrated in 
Figure 1.1C. In the Methods section of Chapter 5, I describe this technique and the novel use of 
the marker mPheS to perform the counter-selectable recombineering step. Because the phage 
recombination machinery facilitates homologous recombination so readily, robust methods have 
been developed to closely control phage protein expression and thus avoid genomic instability 
(Yu et al., 2000; Datta et al., 2006). 
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Figure 1.1. Schematic of homologous recombination-based techniques for genomic 
manipulation. Rectangles represent dsDNA and ovals represent bacterial chromosomes. 
Black and green squares are regions of DNA with a minimum of 40 base pairs of 
sequence homology. Recombination events are represented by black arrows. (A) Gene 
deletions are obtained by fusing a selectable marker (an antibiotic resistance cassette for 
example) to overhangs homologous to sequences residing 5´ and 3´ of the gene target. 
(B) By fusing a mutated variant of the targeted sequence to a selectable marker, 
mutations, insertions, and deletions can be easily isolated. (C) Using sequential rounds of 
phage-mediated recombination, one can generate “scarless” mutations. First, a cassette 
bearing both a selectable and conditionally counter-selectable marker is recombined into 
the genome without disturbing the gene target. Next, this entire cassette is replaced with a 
desired insertion. After recombination, cells are plated on selective media such that those 
retaining the counter-selectable marker are killed. Only clones that have successfully 
undergone this second round of recombination survive. 
The utility of this technique is derived from its specificity (a single nucleotide can be mutated in 
the context of an entire genome) and its general applicability (mutations can target virtually any 
genetically encoded function). For essential genes, however, this direct manipulation can result 
in a lethal phenotype which generally precludes further characterization or utilization (Knight 
and Shokat, 2007). Even for nonessential genes, investigating the mutant phenotypes on short-
time scales is challenging, as the isolation of mutated strains generally requires multiple days and 
many cell generations. During this time, compensatory pathways may be up-regulated or 
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suppressor mutations may arise, thereby masking the direct effect of the perturbation (Gerdes et 
al., 2003). 
Conditional knockdown techniques 
To overcome limitations associated with gene replacement or mutation, conditional knockdown 
techniques have been developed. Some approaches (such as introducing a regulated promoter, a 
temperature-sensitive mutation, or a degradation tag) rely on the availability of techniques to 
manipulate the target organism’s genome (Gossen and Bujard, 1992; Couso et al., 1993; Furth et 
al., 1994; Varadarajan et al., 1996; McGinness et al., 2006; Griffith and Grossman, 2008). Other 
methods, including RNA interference and chemical inhibitors can often be used in organisms 
without developed techniques for genetic manipulation. Importantly, however, all of these 
techniques give researchers temporal control over initiation of the perturbation. 
The use of a regulated promoter is a straightforward method to control transcription of a target 
gene artificially. A number of different systems have been developed. In each, a gene’s native 
promoter is replaced with a transcription-factor regulated promoter whose activity can be 
controlled by a small molecule, temperature, or light (Sussman and Jacob, 1962; Mieschendahl 
and Muller-Hill, 1985; Furth et al., 1994; Strickland et al., 2008; Moglich et al., 2009). 
Tetracycline-controlled systems derived from the bacterial TetR repressor are particularly well 
developed for use in eukaryotic cells (Bertram and Hillen, 2008). In some variants, addition of a 
small molecule down-regulates transcription; in others, the small molecule leads to 
transcriptional activation (Gossen and Bujard, 1992; Gossen et al., 1995). Similar systems have 
been developed for use in bacteria. For example, synthetic promoters derived from the lactose 
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operon have been used to control gene expression using the lactose analog, IPTG. As described 
above, addition of the inducer upregulates transcription by freeing the promoter of the LacI 
repressor (Jensen et al., 1993).  
Despite many reports of success using synthetic, regulated promoters, implementation can be 
difficult for several reasons. When the native promoter is replaced, researchers must often try 
many variants of the synthetic promoter to identify a sequence that recapitulates wild-type rates 
of transcription in the absence of the inducer. Moreover, proteins whose native transcription is 
dynamic (e.g., cell-cycle regulated genes) are extremely difficult to study using these synthetic 
promoters, as recreating the complex temporal profile of wild-type transcription is virtually 
impossible. Lastly, because polycistronic genes are common in bacteria, it can be challenging to 
specifically perturb one gene in a multi-protein operon. To overcome this, the gene of interest 
must be knocked out and then reintroduced at another locus. In some cases, the gene can be 
introduced with its native promoter on a plasmid bearing a temperature-sensitive origin of 
replication. Cells grown under permissive conditions produce the gene product of interest. Upon 
shifting to the restrictive temperature, plasmid replication is inhibited, resulting in plasmid 
dilution and eventual loss (Jasin and Schimmel, 1984; Pyne and Bognar, 1992; Silo-Suh et al., 
2009). 
As an alternative to controlling transcription, translation can be perturbed using RNA 
interference (RNAi) and antisense RNA. Unlike the techniques described above, these 
approaches allow for use of native transcriptional control elements. RNAi occurs when mRNA is 
specifically targeted for degradation either by injecting or controlling the endogenous 
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transcription of short RNA sequences that are complementary to the mRNA of interest. Using 
Watson-Crick base pairing, these short interfering RNAs (siRNAs) hybridize to the mRNA of 
interest, resulting in an RNA duplex. In protozoa and higher eukaryotes, a conserved response to 
such duplex RNA is initiated which results in cleavage and degradation of the targeted mRNA 
(Sharp, 2001; McManus and Sharp, 2002; Dorsett and Tuschl, 2004). As such, translation is 
precluded, effectively “knocking down” production of the gene product of interest. 
Less commonly, translational inhibition techniques have been applied in bacterial species (Ji et 
al., 2001; Croxen et al., 2007; Gillaspie et al., 2009). Production of short RNAs, which 
specifically bind to the mRNA translation initiation region and occlude binding of the 30S 
ribosome to the message, can be used to effectively block translation (Waters and Storz, 2009). 
Further, because the mRNA is not actively translated, it is more susceptible to degradation, 
thereby enhancing the silencing effect. 
The efficacy of the transcriptional- and translational-repression techniques described above is 
strongly dependent on the cell’s ability to degrade pre-existing protein products. For stable 
proteins with long half-lives, simply terminating production is not sufficient to give rise to a 
knockout phenotype. The pre-existing molecules will continue to function despite the 
termination of synthesis. Thus, several generations may be required for the protein to be diluted 
to a concentration that prevents function. This fact precludes observing phenotypes on time-
scales shorter than the half-life of the protein. In response to these limitations, techniques to 
directly target the pre-existing protein products have been developed.  
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Directly targeting pre-existing molecules 
For some proteins, mutations can be isolated that greatly decrease the level of activity at one 
temperature (called a restrictive temperature) but show minimal effect at a different temperature 
(termed the permissive temperature) (Chakshusmathi et al., 2004). In some instances, the 
temperature shift causes global protein unfolding, often resulting in the display of protease 
recognition sites and eventual degradation. For other mutations, the temperature shift impedes 
catalysis but not folding (Bolhuis et al., 1999). These mutants are reversibly inactivated, 
recovering activity upon a shift back to the permissive temperature. Still other mutants are only 
deficient for folding or macromolecular assembly at restrictive temperatures but, if first 
assembled at the permissive temperature, are completely functional after the temperature shift 
(Sadler and Novick, 1965; Smith et al., 1980). In such cases, dilution of pre-existing molecules 
by sustained cell growth and division at the restrictive temperature eventually leads to a loss-of-
function phenotype. 
Historically, temperature-sensitive mutants (ts-mutants) were isolated by randomly mutagenizing 
an entire genome, screening for temperature-sensitive phenotypes, and mapping the mutations to 
a particular gene (Edgar and Lielausis, 1964; Hartwell, 1967). To isolate a ts-mutant for a 
particular gene, one can instead mutagenize the isolated locus and assay for temperature-
dependent function. The ability to perform such an activity assay requires some understanding of 
the gene product and is thus inapplicable to the study of genes of unknown function. Even when 
appropriate assays are available, screening the enormous number of possible mutants can be 
overwhelming. To expedite this search, computational methods have been developed to help 
predict ts-mutants from primary sequence (Varadarajan et al., 1996; Chakshusmathi et al., 2004).  
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Once a ts-mutant has been identified and characterized, the strain bearing the mutation can be 
generated and grown at permissive temperatures. After shifting cells to the restrictive 
temperature, one can directly measure the phenotype associated with the loss of activity from the 
ts-mutant. In many cases, however, the global changes concomitant with a temperature shift can 
complicate interpretation.  In yeast, for example, a temperature shift from 25 °C to 37 °C results 
in the altered expression of 854 genes, half of which have unknown function (Causton et al., 
2001). Further complicating experimental design and interpretation, mutations that phenocopy a 
wild-type strain at the permissive temperature and a null strain at the restrictive temperature are 
rare. Despite these shortcomings, successful analysis of ts-mutants has guided the understanding 
of essential gene function in a variety of organisms (Edgar and Lielausis, 1964; Eidlic and 
Neidhardt, 1965; Hartwell, 1967). 
Pharmacology, the use of small molecules to perturb biological function, offers another approach 
to target pre-existing proteins directly. A large variety of natural and synthetic molecules have 
been identified that are potent (i.e., efficacious at low concentrations), specific (i.e., alter the 
activity of only one protein in the context of a complete proteome), and cell-permeable. 
However, for many proteins, the identification of small-molecule inhibitors and activators is not 
trivial. Moreover, conclusively ruling out “off-target” effects is a substantial challenge, as such 
compounds often act on an entire class of similar proteins (Knight and Shokat, 2007). 
In response to these limitations, Shokat and colleagues have developed a technique that targets a 
particular kinase by mutating the active site to allow binding of a complementary inhibitor. 
Cellular kinases that lack this mutation exclude inhibitor binding, providing genetically encoded 
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specificity as well as pharmacological temporal control (Bishop et al., 1998).  Unfortunately, this 
“bump-hole” strategy requires substantial engineering and is currently limited to isolated 
members of the kinase superfamily. 
Harnessing the power of directed proteolysis could circumvent some of the aforementioned 
problems. Various controlled degradation systems have been developed for use in both 
prokaryotes and eukaryotes. Although the details differ, these systems share several common 
properties. In most cases, the endogenous protein coding sequence is modified by fusing a 
degradation tag (“degron”) to either the N- or C-terminus of the targeted protein. Ideally, under 
permissive conditions, this tag neither perturbs the natural function of the protein nor targets it 
for degradation. Under restrictive conditions, the tag should be recognized by intracellular 
proteases, leading to degradation. In the following section, I discuss our current understanding of 
energy-dependent proteolysis and provide examples of how these systems have been utilized to 
degrade target substrates. 
Energy-dependent proteases 
The majority of intracellular proteolysis in eukaryotes and prokaryotes is carried out by a group 
of energy-dependent proteases of the AAA
+
 family (Hanson and Whiteheart, 2005). These 
enzymes form ring oligomers composed of an unfoldase domain (the AAA+ domain) and a 
protease domain (Sauer et al., 2004). The bacterial Lon and FtsH proteases encode the unfoldase 
and protease domains as a single polypeptide chain. In contrast, the bacterial ClpXP, ClpAP, 
HslUV proteases and the eukaryotic 26S proteasome utilize separate proteins for each function 
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(Gottesman, 1996; Okuno et al., 2006; Murata et al., 2009). In the latter group, subunits of the 
unfoldase and protease assemble to form the proteolytic complex. 
ClpXP, one of the best characterized energy-dependent proteases, consists of a tetradecameric 
compartmentalized protease, ClpP, which is capped by a hexameric unfoldase, ClpX (Sauer et 
al., 2004). As shown in Figure 1.2, the cylindrical protease has an axial channel that runs from 
the top of ClpX to the sequestered active-site residues of ClpP. This pore is small relative to the 
size of a folded protein, and thus only denatured polypeptides are allowed access to the 
sequestered proteolytic sites. In this regard, ClpX acts as a gatekeeper, selecting which cellular 
proteins will be targeted for cleavage by the active sites of ClpP. 
 
Figure 1.2. Schematic representation of a compartmentalized protease. ClpXP, a 
representative compartmentalized protease, is composed of the ClpP14 peptidase shown in 
red, and the two ClpX6 unfoldases, shown in blue. The axial pore that runs the length of 
the complex is too narrow for folded substrates to enter the degradation chamber. Native 
proteins are first unfolded in an ATP-dependent reaction by ClpX. After translocation to 
the degradation chamber, substrates are hydrolyzed to short peptides (~10 amino acids) 
by the active sites of ClpP (yellow). Critically, these active sites are sequestered from 
solution and thus only act on substrates that have been unfolded and translocated by 
ClpX. 
 Davis | 25 
 
In some instances, such as the ubiquitin-proteasome system, substrate selection by the proteases 
can be a complicated process, involving many accessory factors and post-translational 
modification of the substrate (Hershko and Ciechanover, 1998). In other instances, such as the 
ssrA-tagging system in bacteria, substrates are targeted for degradation through the simple co-
translational addition of a short, C-terminal peptide degradation tag (Keiler et al., 1996). 
Detailed biochemical studies have shown that ClpX binds to such exposed degradation tags 
using a set of loops that line the pore of the unfoldase (Farrell et al., 2007; Martin et al., 2008a). 
ATP binding and hydrolysis are used to drive conformational changes of these loops, resulting in 
engagement and translocation of the bound substrate down through the pore (Kenniston et al., 
2004; Martin et al., 2008a; Glynn et al., 2009). This translocation is thought to pull the folded 
substrate against the body of ClpX, and thus apply an unfolding force. Successful substrate 
denaturation results from a combination of the applied pulling force and stochastic changes in 
local protein stability (Kenniston et al., 2003). For example, if thermally-induced fraying of 
nearby substrate secondary structure coincides with a pulling event, then complete unfolding of 
the substrate is more probable. Once globally denatured, the substrate is rapidly translocated, 
precluding refolding. Interestingly, for some substrates, the process of denaturation is rate-
limiting for overall proteolysis, indicating that the probability of a pulling event resulting in 
denaturation is low. For substrates that are readily unfolded,  translocation into the lumen of 
ClpP is the rate-limiting step, indicating that the probability of an unfolding event is relatively 
high (Kenniston et al., 2004). The process of substrate binding, engagement, denaturation, 
translocation, and eventual proteolysis is depicted in Figure 1.3. 
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Figure 1.3. ClpXP-mediated protein degradation cycle. Pore loops (orange) extending 
from ClpX (blue) bind to the substrate’s exposed degradation tag (green). Successive 
rounds of ATP hydrolysis drive conformational change in ClpX, which eventually result 
in substrate unfolding. The denatured polypeptide is translocated to the sequestered active 
sites (yellow) of ClpP (red) and cleaved. For ease of representation, only one ClpX 
hexamer per ClpP 14-mer is shown. Substrate denaturation and translocation can require 
hundreds of rounds of ATP hydrolysis by multiple subunits, a limited number is shown 
for simplicity. 
Although the details of substrate recognition differ for each AAA+ protease (ClpXP, ClpAP, 
HslUV, Lon, FtsH, and the 26S proteasome), all are thought to unfold, translocate and degrade 
substrate using a mechanism similar to that described for ClpX (Kim et al., 2000; Lee et al., 
2001a; Reid et al., 2001; Liu et al., 2006). Indeed, biochemical studies have directly 
demonstrated energy-dependent substrate unfolding and translocation by ClpAP, Lon and HslUV 
(Weber-Ban et al., 1999; Kwon et al., 2004; Burton et al., 2005; Gur and Sauer, 2009). Further, 
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like ClpX, each member of this class has been shown to form ring oligomers composed of 
AAA+ domains which cap compartmentalized proteases (Kopp et al., 1986; Lowe et al., 1995; 
Bochtler et al., 1997; Groll et al., 1997; Wang et al., 1997; Grimaud et al., 1998; Sousa et al., 
2000; Glynn et al., 2009). Lastly, ClpX loops known to be critical for substrate translocation are 
conserved throughout this class of enzymes and, in the cases of HslUV and ClpAP, have been 
shown to mediate substrate translocation (Siddiqui et al., 2004; Hinnerwisch et al., 2005; Park et 
al., 2005; Martin et al., 2008b). 
Interestingly, ClpX translocates polypeptides with almost no significant sequence specificity, 
implying that initial substrate binding and engagement are the critical steps in regulating the 
potentially destructive activity of ClpXP (Barkow et al., 2009). Consistent with this hypothesis, 
accessory specificity factors (also known as adaptor proteins) have been isolated that affect 
substrate selection by ClpXP (Levchenko et al., 2000; Zhou et al., 2001). 
The simplest mechanism to explain adaptor function is for the adaptor to simultaneously bind to 
the substrate and the protease, thereby increasing the substrate’s effective concentration (Baker 
and Sauer, 2006). Much biochemical evidence has accumulated that the E. coli adaptor, SspB, 
delivers ssrA-tagged substrates using this “tethering” mechanism (Levchenko et al., 2000). In a 
series of detailed in vitro experiments, Wah et al. demonstrated that limited treatment of SspB 
with the endoprotease subtilisin resulted in production of a stably folded N-terminal domain 
(residues 1-117). The C-terminal tail (residues 118-165), by contrast, was protease sensitive and 
appeared to be highly flexible (Wah et al., 2003). The isolated N-terminal domain of SspB was 
competent for adaptor dimerization, and bound to ssrA tags as well as full-length SspB. This 
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domain, however, was not capable of delivering ssrA-tagged substrates to ClpXP and actually 
inhibited their degradation. Direct binding studies combined with gel-filtration experiments 
showed that the C-terminal tail of SspB bound to ClpX and facilitated formation of a ternary 
complex consisting of SspB, the ssrA-tagged substrate, and ClpX. Critically, this work also 
demonstrated that the substrate binding domain and tail of SspB must be physically linked for 
adaptor function, as addition of the individual components failed to deliver substrates for 
degradation. These observations led to the tethering model shown in Figure 1.4A. Crystal 
structures have been solved of the ssrA tag bound to the substrate-binding domain of SspB and 
of the C-terminal SspB tail in complex with an isolated N-terminal domain of ClpX (Levchenko 
et al., 2003; Song and Eck, 2003; Park et al., 2007). Taken together, these studies conclusively 
demonstrate that tethering is necessary for substrate delivery by SspB. 
As predicted by the concentration-dependent tethering mechanism described above, ssrA-tagged 
substrates are degraded in absence of SspB, but the KM for degradation is substantially decreased 
by addition of the adaptor (Levchenko et al., 2000). Moreover, mutations in the terminal three 
amino acids of ssrA tag (illustrated in Figure 1.4B) have been identified that do not affect 
adaptor binding but vastly decrease ClpX’s affinity for the tag (Flynn et al., 2001; McGinness et 
al., 2006). Substrate delivery by SspB can compensate for this decreased protease affinity, 
thereby facilitating robust degradation (McGinness et al., 2006; Griffith and Grossman, 2008). 
The controlled degradation systems described in Chapters 3 and 5 rely on these adaptor-
dependent degradation tags (Davis et al., 2009). 
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Figure 1.4. Adaptor-mediated delivery of an ssrA-tagged substrate. (A) The ssrA tag 
of the substrate binds to the N-terminal domain of SspB while the adaptor’s flexible C-
terminal tails simultaneously tether the substrate-adaptor complex to ClpX. Once 
tethered, substrate is engaged by ClpX, eventually leading to unfolding and proteolysis. 
(B) Biochemical studies have elucidated distinct, non-overlapping SspB and ClpX 
binding sites on the ssrA tag that allow protease and adaptor to simultaneously bind to the 
tag, albeit with slightly diminished affinity (Flynn et al., 2001; Bolon et al., 2004). 
Insertion of a short linker between the binding sites relieves this inhibition resulting in a 
more efficiently degraded “extended tag” (Hersch et al., 2004; McGinness et al., 2006). 
Mutations in the C-terminal residues of the ssrA tag have been identified which decrease 
affinity for ClpX without affecting affinity for SspB. Degradation of substrates bearing 
these “adapter-dependent tags” is strongly dependent on adaptor-mediate tethering to 
ClpX (McGinness et al., 2006; Davis et al., 2009). 
In tethering models, the exact geometry of the delivery complex can greatly affect the efficiency 
of substrate delivery and thus it is not necessarily true that any molecule that tethers a substrate 
to a protease will act as an adaptor (McGinness et al., 2007). Indeed, more complicated models 
for adaptor function have been proposed. For example, Thibault et al. proposed that SspB 
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function is mediated, in part, by its ability to direct large conformational changes in the N-
terminal domain of ClpX (Thibault et al., 2006). I have demonstrated, however, that the ClpX N-
terminal domain is dispensable for SspB-mediated substrate delivery and can be replaced by 
synthetic tethering domains (Chapter 3). The fact that substrate delivery is as efficient with these 
synthetic constructs as with the natural adaptor argues against the aforementioned 
conformational-change model. Furthermore, by analyzing degradation using synthetic adaptors, 
proteases and substrates, the work in Chapter 3 demonstrates that in many instances tethering-
alone is both necessary and sufficient for SspB-mediated substrate delivery. Indeed, substrates 
bearing multiple ClpX-binding motifs can “auto-tether”, thereby mimicking SspB-mediated 
delivery and degradation. 
For some adaptors, tethering alone is not sufficient for function. Recently, ClpS mutants have 
been identified that simultaneously bind N-end rule substrates and the ClpAP protease but fail to 
facilitate degradation (Hou et al., 2008). This result indicates that more complicated interactions 
between this adaptor and protease are required to ensure substrate delivery. Still other adaptors 
are required for the oligomerization and assembly of active ClpC protease, demonstrating the 
wide range of biochemical activities performed by this class of regulatory proteins (Kirstein et 
al., 2006). 
Controlled protein degradation systems 
Controllable degradation systems using AAA+ proteases and their substrate targeting machinery 
have been developed. In eukaryotes, it is known that aberrantly folded proteins are recognized 
and, through the action of a series of protein ligases, are modified by the covalently addition of 
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multiple ubiquitin molecules (Haas et al., 1982; Hershko and Ciechanover, 1998). The fused 
polyubiquitin chain then acts like an adaptor, targeting the substrate to the proteasome where it is 
unfolded and eventually hydrolyzed to short peptides (Thrower et al., 2000; Goldberg, 2003; 
Prakash et al., 2004). A protein of interest can be experimentally targeted for degradation by 
fusing it to another protein that is conditionally misfolded. In one example of this technique, a 
misfolded mutant of the FKBP12 protein is fused to a target protein. Shield, an analog of the 
small-molecule rapamycin, binds to FKBP12 and stabilizes the folded protein, effectively 
blocking degradation. After removal of Shield, FKBP12 is destabilized, eventually leading to 
degradation of the entire fusion construct (Banaszynski et al., 2006). Although not directly 
demonstrated by the authors, this degradation may occur as a result of substrate ubiquitination 
and subsequent targeting to the proteasome. Unfortunately, this technique is not particularly 
rapid, requiring many hours for dissociation and sufficient dilution of Shield. 
In prokaryotes, proteins with an N-terminal Phe, Leu, Trp or Tyr residue are degraded by ClpAP 
(Tobias et al., 1991; Erbse et al., 2006; Wang et al., 2007; Schmidt et al., 2009). Target proteins 
can be expressed with an N-terminal domain bearing an endoprotease recognition site, which 
reveals one of these N-terminal residues following cleavage. As a proof of principle, the Sumo 
domain has been appended to target proteins in a way that allows induction and cleavage by the 
cognate Ulp1 protease, generating an exposed N-end rule residue that targets the protein for 
ClpAP degradation (Wang et al., 2007). 
Other controlled degradation systems in bacteria rely on the production of adaptors that aid in 
protease recognition of suitably tagged substrates. In these systems, the adaptor gene is knocked 
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out of the chromosome and resides on a vector plasmid under the control of an inducible 
promoter (McGinness et al., 2006). Specific proteins are targeted for degradation through the C-
terminal fusion of an adaptor-dependent degradation tag (Griffith and Grossman, 2008). To 
deplete the cell of the target proteins, one simply induces production of the adaptor. 
Controlled degradation systems directly target pre-existing molecules, providing an improved 
temporal response relative to transcriptional and translational knockdowns. Because they require 
a genetically-encoded degradation tag these methods are also highly specific. Unlike chemical 
inhibitors or ts-mutations, targeted degradation should, in principle, be directly applicable to 
most intracellular proteins without extensive screening and optimization. In Chapter 5, I describe 
a controlled degradation system, using SspB and ClpXP, that employs the small-molecule 
rapamycin to control degradation. Because rapamycin diffuses into cells and shows no off-target 
effects in bacteria, this approach promises to be generally applicable in a variety of prokaryotic 
systems. 
Research Approach 
In subsequent chapters, I describe a series of experiments that improve our understanding of 
bacterial energy-dependent proteases and harness the power of these enzymes for controlled 
intracellular degradation. Chapter 2 details the collaborative development of a single-molecule 
assay to probe the kinetics of ClpXP-mediated substrate denaturation and degradation 
(Supplemental experiments can be found in Appendix A). This work, the first inspection of 
ClpXP activity at the single-molecule level, provides additional evidence that degradation of 
ssrA-tagged substrates is processive, proceeding from the C- to N-terminus. Further, our detailed 
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comparison of degradation kinetics, either of single molecules or in bulk solution, indicates 
similar overall levels of microscopic and macroscopic ClpXP activity, with no indication of non-
uniform enzyme activity. During the development of this assay, we identified suitable methods 
to attach ClpXP to surfaces, to stabilize the hexameric form of the enzyme at extremely low 
concentrations, and to pre-engage substrates in a way that allows synchronous degradation. 
These technical advances promise to be valuable in future single-molecule studies of ClpXP. 
Building on this work, we generated a FRET-based assay to probe conformational changes in 
ClpXP with single-molecule resolution. The development and preliminary results of this assay 
are detailed in Appendix B. Results include a novel method to site-specifically attach fluorescent 
probes to individual ClpX subunits in the context of a hexamer. Using these fluorescently labeled 
molecules, we can directly observe nucleotide-dependent conformational changes either in bulk 
solution or at the single-molecule level. 
As described above, the minimal biochemical activities sufficient for adaptor function had not 
been defined. In Chapter 3, I describe experiments that further test the “tethering” model. I 
generated synthetic adaptors, proteases, and substrates that interact through non-natural protein 
interfaces and performed degradation assays using these components. Consistent with the 
“tethering” model, these results show that specific contacts between the SspB adaptor and the 
ClpXP protease are dispensable for substrate delivery. Moreover, I demonstrate that tethering 
alone is both necessary and sufficient for synthetic adaptor function. Importantly, tethering in 
these constructs can be controlled using a small molecule, providing a means to regulate protein 
degradation with great specificity and temporal control. To facilitate the expression of these 
degradation components in vivo, I designed and characterized a library of σ70-dependent 
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constitutive bacterial promoters. A detailed analysis of these promoters is presented in Chapter 4. 
Appendix C describes the collaborative development of a method to measure relative promoter 
activity. 
Chapter 5 details the use of a small-molecule-controlled degradation system in vivo. Specifically, 
I demonstrate rapamycin-dependent degradation of multiple substrates in E. coli using the 
endogenous ClpXP protease, and a synthetic adaptor. I extend this system by engineering a 
synthetic adaptor-tag pair, which can be utilized in E. coli in the presence of wild-type SspB. Use 
of this system simply requires appending a short degradation tag to a protein of interest, 
transforming cells with a plasmid driving constitutive production of the synthetic adaptor, and 
addition of rapamycin. 
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Abstract 
ClpXP is an ATP-fueled molecular machine that unfolds and degrades target proteins. ClpX, an 
AAA+ enzyme, recognizes specific proteins, and then uses cycles of ATP hydrolysis to denature 
any native structure and to translocate the unfolded polypeptide into ClpP for degradation. Here, 
we develop and apply single-molecule fluorescence assays to probe the kinetics of protein 
denaturation and degradation by ClpXP. These assays employ a single-chain variant of the ClpX 
hexamer, linked via a single biotin to a streptavidin-coated surface, and fusion substrates with an 
N-terminal fluorophore and a C-terminal GFP-titin-ssrA module. In the presence of adenosine 5′-
[γ-thio]triphosphate (ATPγS), ClpXP degrades the titin-ssrA portion of these substrates but stalls 
when it encounters GFP. Exchange into ATP then allows synchronous resumption of 
denaturation and degradation of GFP and any downstream domains. GFP unfolding can be 
monitored directly, because intrinsic fluorescence is quenched by denaturation. The time 
required for complete degradation coincides with loss of the substrate fluorophore from the 
protease complex. Fitting single-molecule data for a set of related substrates provides time 
constants for ClpX unfolding, translocation, and a terminal step that may involve product release. 
Comparison of these single-molecule results with kinetics measured in bulk solution indicates 
similar levels of microscopic and macroscopic ClpXP activity. These results support a stochastic 
engagement/unfolding mechanism that ultimately results in highly processive degradation and 





Abbreviations: GFP, green fluorescent protein; CFP, cyan fluorescent protein; PEG, 
polyethylene glycol; TIRF, total internal reflection fluorescence. 
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Introduction 
Molecular machines of the AAA+ (ATPases associated with diverse cellular activities) enzyme 
superfamily play crucial roles in cellular processes ranging from protein degradation and DNA 
replication to membrane fusion and the movement of motor proteins along microtubule tracks 
(Ogura and Wilkinson, 2001; Hanson and Whiteheart, 2005). AAA+ proteases degrade proteins 
that are damaged, remove proteins that are no longer needed by the cell, and function in 
regulatory circuits that require proteolysis of specific target proteins. In bacteria, such as 
Escherichia coli, intracellular proteolysis is carried out by multiple ATP-dependent proteases, 
including ClpXP, ClpAP, HslUV, Lon, and FtsH (Gottesman, 2003). In the ClpXP machine, for 
example, the AAA+ ClpX component engages protein substrates, unfolds them, and ultimately 
translocates the denatured polypeptide into an internal chamber of the associated ClpP peptidase 
for irreversible proteolysis (Sauer et al., 2004). Thus, the overall process of ClpXP degradation 
involves the operation and coordination of enzymatic machinery for substrate recognition, 
denaturation, translocation, and degradation. 
ClpX functions as an asymmetric ring of six subunits, with the sites for ATP binding and 
hydrolysis located at subunit interfaces (Kim and Kim, 2003; Glynn et al., 2009). ClpP is also 
active as a multimer, in which two stacked heptameric rings enclose a degradation chamber 
containing 14 active sites for peptide-bond cleavage (Wang et al., 1997). A hexameric ClpX ring 
and a heptameric ClpP ring stack coaxially, creating a central channel that allows translocation 
of unfolded substrates through the ClpX pore and into the ClpP peptidase chamber (Ortega et al., 
2000). ClpX recognizes specific substrates by binding to exposed peptide sequences. For 
example, appending the ssrA tag (AANDENYALAA) to the C terminus of a protein makes it a 
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substrate for ClpXP degradation (Gottesman et al., 1998). The ssrA tag initially binds in the axial 
pore of ClpX (Siddiqui et al., 2004; Martin et al., 2008b). Changes in ClpX conformation, 
powered by ATP binding and hydrolysis, are then postulated to initiate tag translocation through 
the pore. Because native proteins are larger than the ClpX pore, continued translocation 
eventually pulls on the attached protein and results in an unfolding force. For very stable protein 
domains, hundreds of cycles of ATP hydrolysis can be required on average before unfolding is 
successful, although single mutations that destabilize the substrate can reduce this value almost 
50-fold (Kenniston et al., 2003). Moreover, a hyperstable substrate can dissociate from the 
enzyme after an unsuccessful denaturation attempt (Kenniston et al., 2005). Thus, any structural 
perturbations caused by the transient strain of attempted unfolding would almost certainly relax 
before that substrate was rebound by another enzyme. These facts suggest that successful 
unfolding results from a combination of the applied pulling force and stochastic changes in 
protein stability. For example, fluctuations in the distribution of thermal energy in the protein 
could result in occasional fraying of secondary structure or in partial unfolding that then allows a 
single ClpX pulling event to cooperatively denature the entire protein domain (Kenniston et al., 
2003). It is also possible that all ClpXP enzymes in bulk solution hydrolyze ATP but only a 
small fraction is active in denaturation. By this model, rare encounters between “active” ClpXP 
and substrate could lead to efficient denaturation in a single turnover, whereas the vast majority 
of substrate-enzyme interactions would not. In this case, average properties calculated assuming 
that all ClpXP enzymes in bulk solution are equally active could be very different from the actual 
properties of individual enzymes. 
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Since the first detection of single fluorophores at cryogenic temperatures (Moerner and Kador, 
1989), single-molecule fluorescence has become a powerful technique for exploring the 
nanoscale behavior of individual molecules. For example, such studies have revealed important 
information regarding mechanoenzyme motility, unassisted and chaperone-mediated protein 
folding, and enzyme dynamics (Lu et al., 1998; Deniz et al., 2000; Yildiz et al., 2003; Ueno et 
al., 2004). Here, we develop and apply a single-molecule fluorescence assay to probe the kinetics 
of ClpXP-mediated substrate denaturation and degradation. Our results provide important 
support for mechanistic conclusions based on ensemble experiments and set the stage for more 
detailed single-molecule studies of ClpXP function. 




We had to overcome several problems during assay development. For example, wild-type E. coli 
ClpX bound nonspecifically and nonfunctionally to surfaces, apparently because hexamers 
dissociated and the isolated subunits were prone to denaturation. In addition, some methods of 
surface attachment precluded ClpX binding to ClpP. Eventually, we used a single-chain ClpX 
pseudohexamer lacking the N-domain (Martin et al., 2005), which is not needed to degrade ssrA-
tagged substrates (Singh et al., 2001) but seemed to contribute to surface inactivation. This 
single-chain variant (ClpX
SC
) was cloned with a sequence that allowed enzyme-mediated 
covalent attachment of one biotin molecule to each pseudohexamer. The biotinylated ClpX
SC
 
enzyme was as active as wild-type ClpX in ClpP-mediated degradation of a GFP-ssrA substrate 
(Figure A.S1, Appendix A). 
Three substrates were used for single-molecule studies (Figure 2.1A). Each had an N-terminal 
cysteine, which we modified with a Cy3 fluorophore, and a common GFP-titin
V15P
-ssrA unit, 
consisting of a GFP domain, the I27 domain of titin bearing the destabilizing V15P mutation, 
and a C-terminal ssrA tag (Kenniston et al., 2003; Martin et al., 2008a). In the presence of Mg
2+
 
and adenosine 5′-[γ-thio]triphosphate (ATPγS), an ATP analog which ClpX hydrolyzes slowly, 
ClpXP degrades the titin
V15P
-ssrA portion of these substrates but stalls when it reaches the GFP 
domain Figure 2.1B; (Martin et al., 2008a). These stalled complexes are stable after chelation of 
Mg
2+
 by excess EDTA, which prevents nucleoside-triphosphate hydrolysis, and after replacing 
ATPS/EDTA with ATP/EDTA (Figure A.S2, Appendix A). Subsequent addition of ATP/Mg2+ 
then initiates ATP hydrolysis and degradation of the GFP domain and downstream portions of 
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the substrate (Martin et al., 2008a). Substrates were incubated with biotinylated ClpX
SC
, ClpP, 
and ATPS/Mg2+ to form stalled complexes, which were then introduced into a flow cell, 
immobilized on a glass slide coated with a mixture of covalently attached PEG and PEG-biotin-
streptavidin (Joo et al., 2006), and quantified by objective-side TIRF imaging (Figure 2.1C). We 
included an oxygen scavenging system (Yildiz et al., 2003) and minimized the intensity and/or 
duration of laser excitation to reduce photobleaching. The Cy3 dye served as a marker for stalled 
complexes and remained bound to the surface-attached enzyme until completion of degradation. 
 
Figure 2.1. Substrates and methods used for single-molecule assays of ClpXP 
degradation. (A) Substrates contained an N-terminal Cy3 fluorophore, a GFP domain, a 
titin-I27 domain with the V15P mutation, and a C-terminal ssrA tag. (B) In the presence 
of ATPS, ClpXP degrades the titinV15P-ssrA portion of substrates but stalls because it 
cannot denature GFP (Martin et al., 2008a). Exchange into ATP then permits GFP 
denaturation and completion of degradation. (C) For single-molecule experiments, pre-
engaged complexes of substrates, biotinylated ClpX
SC
, and ClpP were formed in the 
presence of ATPS, tethered to a PEG-coated glass surface via PEG-biotin-streptavidin, 
and visualized by TIRF microscopy. Degradation reactions were initiated by exchange of 
ATP for ATPS. 
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Initial controls were performed by using the Cy3-GFP-titin
V15P
-ssrA substrate. Under standard 
conditions with biotinylated ClpX
SC
, ClpP, and ATPS/Mg2+, we observed 99.8 ± 7.2 fluorescent 
spots per field of view (Figure 2.2A). Several experiments established that most spots 
corresponded to complexes of the substrate and the immobilized protease. (i) When biotinylated 
ClpX
SC
 was omitted (Figure 2.2B) or nonbiotinylated ClpX
SC
 was used, 9 ± 2 spots were 
observed. (ii) When ATPS (Figure 2.2C) or Mg2+ was omitted from the preincubation, 13 ± 3 
spots were observed. (iii) When Cy3-labeled substrate was omitted, no more than two spots were 
observed. (iv) In the continual presence of ATPS/Mg2+, Cy3-labeled substrate photobleached in 
an exponential process with a time constant of 330 s (Figure A.S3A, Appendix A), similar to the 
photobleaching times of Cy3-labeled molecules bound to control surfaces. (v) When buffer with 
Mg
2+
 but no ATPS nucleotide was flowed over the surface, most spots disappeared with a time 
constant of ≈14 s (Figure A.S3B, Appendix A), consistent with studies showing that nucleotide 
is required for ClpX to maintain an active grip on the substrate (Martin et al., 2008b). 
 
Figure 2.2. Single-molecule TIRF images of the Cy3-GFP-titin
V15P
-ssrA substrate 
bound to a glass surface coated with PEG and PEG-biotin-streptavidin. (A) 
Approximately 100 fluorescent spots were detected after preincubation of the substrate (1 
µM) with biotinylated ClpX
SC
 (0.31 µM), ClpP (1 µM), ATPS (2 mM), and Mg2+ (10 
mM), and the mixture was flowed over the surface. Far fewer spots were detected when 
biotinylated ClpX
SC
 (B) or ATPS (C) was omitted from the preincubation mix. 
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Single-molecule degradation/denaturation 
After exchanging ATP for ATPS in the absence of Mg2+, we excited the Cy3 dye, focused, and 
selected a field of view containing immobilized complexes of ClpX
SC





 was then injected into the flow cell to initiate 
unfolding and degradation. Images were acquired at intervals (typically 3-5 s), and a custom 
software algorithm was used to quantify the lifetime of each spot. These data were combined for 
a large number of spots (1,122 spots) observed in 11 independent experiments and are presented 
as a probability density distribution of spot lifetimes (Figure 2.3A) or as fractional spot 
populations as a function of time (Figure 2.3B). As discussed below, these data can be corrected 
for photobleaching and related to the time required by the immobilized protease to unfold, 
translocate, and degrade substrates. 
 
Figure 2.3. Single-molecule degradation. (A) Distribution of spot lifetimes for the Cy3-
GFP-titin
V15P
-ssrA substrate. (B) Kinetic profiles of single-molecule ClpXP degradation 
were constructed by summing the number of Cy3 spots in TIRF images taken at 3- to 9- s 
intervals after initiating degradation at ≈18 °C by addition of ATP/Mg2+ and normalizing 
to the initial value. The total number of initial spots was 1,122 for the Cy3-GFP-titin
V15P
-
ssrA substrate, 974 for the Cy3-CFP-GFP-titin
V15P
-ssrA substrate, and 419 for the Cy3-
titin-GFP-titin
V15P
-ssrA substrate. The solid lines are fits to reaction models described in 
Kinetic Modeling. 
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After addition of ATP/Mg
2+
 (1/10 mM), the population of the preengaged Cy3-GFP-titin
V15P
-
ssrA substrate decreased to half the initial value in ≈60 s (Figure 2.3B). Several results indicated 
that the majority of this population decrease represents active ClpXP degradation. First, spot loss 
was faster with ATP/Mg
2+
 than with ATPS/Mg2+ (50% loss in 231 s). In the latter experiment, 
degradation does not occur, and spots are only lost via photobleaching. Second, as expected from 
solution experiments (Martin et al., 2008a), spot loss slowed when a lower concentration of ATP 
(0.1 mM) was used (50% loss in 90 s; Figure A.S4A, Appendix A) or when a mixture of 
ATP/ATPS (1/0.25 mM) was used (50% loss in 155 s; Figure A.S4B, Appendix A). 
We used substrates with additional domains to confirm that the loss of Cy3 fluorescence 
correlated with the time required for complete ClpXP degradation. For example, single-molecule 
ClpXP degradation of both Cy3-CFP-GFP-titin
V15P
-ssrA (50% loss in 80 s) and Cy3-titin-GFP-
titin
V15P
-ssrA (50% loss in 279 s)
1
 proceeded more slowly than degradation of Cy3-GFP-
titin
V15P
-ssrA (Figure 2.3B). The relative rates of single-molecule ClpXP degradation of all three 
substrates were consistent with solution studies (Kenniston et al., 2003; Martin et al., 2008a), in 
which GFP and CFP domains are degraded at similar rates, but titin is degraded ≈4-fold more 
slowly because of its exceptional mechanical stability. These results are also consistent with 
studies that show that degradation of ssrA-tagged substrates proceeds processively from the C to 
the N terminus (Lee et al., 2001; Kenniston et al., 2005), and thus the Cy3 dye is lost only when 
degradation is complete. 
                                                 
1
 For this substrate, a 9 s interval between images was used and the photobleaching time constant was 1330 s. 
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The processive model predicts that GFP denaturation should be an early event in overall 
degradation (Figure 2.1B). To test this hypothesis, we monitored loss of fluorescent GFP spots 
after initiating ClpXP denaturation of preengaged GFP-titin
V15P
-ssrA. As expected, GFP spots 
were lost at a faster rate than Cy3 spots (Figure 2.4A), indicating that denaturation of the GFP 
domain occurs earlier than release of the Cy3 fluorophore during ClpXP degradation. Fitting of 
the GFP data, including a correction for photobleaching, gave a time constant of 19 s for 
denaturation of this domain. 
Kinetic modeling 
We globally fit the degradation data for Cy3-GFP-titin
V15P
-ssrA (called S1) and Cy3-CFP-GFP-
titin
V15P
-ssrA (called S2) to kinetic models with individual steps for unfolding (unf) and 
translocation (trans) of each domain (see Materials and Methods). Solution studies indicate that 
ClpXP unfolds and translocates GFP and CFP at similar rates (Martin et al., 2008a), and thus we 
used the same time constants for both domains. A model including just these kinetic steps 
predicts that S2 should take twice as long to degrade as S1 and fit the data poorly. Indeed, S2 
was only degraded ≈1.5-fold more slowly than S1 in our experiments, suggesting that an extra 
slow step contributes to both reactions. Fitting to the following reactions, which include a time 
constant (term) for an unspecified terminal step, resulted in good simultaneous fits to both data 
sets (Figure 2.3B). 
       unf         trans         term 
S1        I1        I2        degraded 
 
       unf         trans             unf         trans         term 
S2        I1        I2       I3       I4       degraded 
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When unfolding was constrained to the experimental value (unf = 19 s), the fitted time constants 
were trans = 6.2 s and term = 29.6 s, yielding time constants for overall degradation of 54.8 s for 
S1 and 80 s for S2 (Table A.S1, Appendix A). 
We also fit the data for Cy3-titin-GFP-titin
V15P
-ssrA degradation by using the unf and trans 
values determined for GFP, assuming that trans for the titin domain was half the GFP value 
because it has half as many amino acids, allowing unf for titin to vary, and using the term value 
obtained above. This procedure gave a good fit of the experimental data (Figure 2.3B) with a 
time constant of 347 s for titin unfolding (Table A.S1, Appendix A), indicating that ClpXP 
unfolding of the titin domain proceeds almost 20-fold more slowly than unfolding of the GFP or 
CFP domains. 
Substrate unfolding and translocation in solution 
The single-molecule experiments were performed at ≈18 °C, a temperature where ClpXP activity 
is not typically assayed. To allow comparisons, we performed a set of bulk experiments in 
solution at 18 °C. Because some experiments required initial ClpXP binding and degradation of 
the titin
V15P
-ssrA portion of substrates, we unfolded the titin
V15P
 domain by carboxymethylation 
(titin
CM
) to preclude the need for unfolding (Kenniston et al., 2003). First, we determined KM 
(1.9 µM) and Vmax (0.62 min
-1
) for degradation of GFP-titin
CM
-ssrA by biotinylated ClpX
SC
 and 
ClpP. The corresponding time constant for steady-state degradation (97 s) was longer than for 
single-molecule degradation but includes the times required for binding, engagement, and 
translocation of titin
CM
 as well as for denaturation and translocation of GFP. 
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-ClpP and initiated degradation by stopped-flow addition of ATP/Mg
++
 (Martin 
et al., 2008a). In this experiment, the loss of native GFP fluorescence, which accompanied ClpX-
mediated unfolding, showed a minor burst phase (amplitude 19%;  = 0.87 s) and a major 
unfolding phase (amplitude 81%;  = 25 s) (Figure 2.4B). Importantly, the kinetics of GFP 
unfolding in this solution experiment were similar to the kinetics estimated from the single-
molecule data ( = 19 s). Given the lack of precise temperature control and low time resolution in 
the single-molecule experiments, the differences between these values are probably not 
significant. 
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Figure 2.4. Substrate denaturation assayed by single-molecule or solution 
experiments. (A) Single-molecule ClpXP denaturation of the pre-engaged Cy3-GFP-
titin
V15P
-ssrA substrate. Circles represent a kinetic profile constructed by summing the 
number of GFP spots in TIRF images taken at 7 s intervals after addition of ATP/Mg
2+
 
and normalizing to the initial value (251 spots). The solid-line is a double exponential fit 
(y = 0.9•exp(-t/17.3) + 0.1•exp(-t/197)). After correcting the time constant for the 
dominant phase to account for a photobleaching contribution, the time constant for GFP 
denaturation was 19 s. The squares show the Cy3 degradation data for the same substrate. 





and ClpP were generated in the presence of ATPS/Mg2+, purified, and GFP denaturation 
at 18 °C was initiated by addition of ATP/Mg
2+
 in a stopped flow instrument and 
monitored by changes in GFP fluorescence (Martin et al., 2008a). The solid-line is a 
double exponential fit of the data (y = 0.19•exp(-t/0.87) + 0.81•exp(-t/25)). The fast 
phase may represent diminished fluorescence caused by ClpX extraction of the C-
terminal -strand of GFP (see ref. 21). (C) Solution denaturation of the CFP-GFP-titinCM-
ssrA substrate. At time 0, the substrate (0.5 µM) was mixed with ClpX
SC
 (1 µM), ClpP (2 
µM), the SspB adaptor (0.75 µM), and an ATP regeneration system at 18 °C. Changes in 
GFP fluorescence or CFP fluorescence were monitored in separate experiments. The 
solid lines are fits to the model described in Substrate Unfolding and Translocation in 
Solution. 
 
Finally, we monitored loss of GFP or CFP fluorescence under single-turnover conditions with 
ClpXP in 2-fold excess over CFP-GFP-titin
CM
-ssrA (Figure 2.4C). In these experiments, ClpXP 
must bind, engage, and translocate the unfolded titin
CM
-ssrA portion of the substrate and then 
denature/translocate the GFP domain followed by the CFP domain. Fitting the GFP data gave a 
time constant of 10 s for binding/engagement/translocation of titin
CM
-ssrA and a time constant of 
25 s for GFP denaturation, the same value determined above using the preengaged substrate 
(Figure 2.4C). The CFP data fit well to a model with time constants of 10 s for titin
CM
-ssrA 
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binding/engagement/translocation, 20 s for GFP unfolding, 6 s for translocation of unfolded GFP, 
and 20 s for CFP unfolding (Figure 2.4C). The difference in the GFP unfolding value for the two 
fits is probably caused by poor fitting of the initial rise in fluorescence that occurs in the CFP 
trace because of the loss of FRET that occurs upon GFP denaturation (Figure 2.4C). 
Nevertheless, the kinetic constants obtained from these solution experiments were very similar to 
the values obtained by fitting the single-molecule data. 
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Discussion 
In our experiments, individual complexes of surface-attached ClpXP enzymes with preengaged 
substrates containing a Cy3 fluorophore are detected by TIRF microscopy. Under appropriate 
experimental conditions, these complexes remain fluorescent until the Cy3 dye is removed by the 
final steps of the degradation reaction or is photobleached. The photobleaching rate can be 
independently determined, allowing pooled population data to be fitted to determine apparent 
rates of single-molecule degradation. Multiple experiments indicate that these rates reflect 
degradation of the complete substrate. First, single-molecule degradation times increased as 
additional domains were added to the substrate and as these extra domains became more difficult 
to denature. Second, ClpXP degraded the same substrate more slowly when lower concentrations 
of ATP or mixtures of ATP/ATPS were used, as expected from solution studies (Martin et al., 
2008a). Third, monitoring GFP instead of Cy3 fluorescence during degradation of GFP-titin
V15P
-
ssrA resulted in faster rates. This result is expected because GFP fluorescence is immediately 
quenched upon ClpX-mediated denaturation, whereas loss of Cy3 requires additional kinetic 
steps, including translocation of the unfolded GFP polypeptide, proteolysis by ClpP, and product 
release. These combined results also provide strong support for a model in which ClpXP 
degradation of ssrA-tagged substrates proceeds processively from the C terminus to the N 
terminus (Lee et al., 2001; Kenniston et al., 2005; Martin et al., 2008a). 
In our single-molecule experiments, most ClpXP enzymes that engaged the substrate in the 
presence of ATPS were then able to denature GFP and to complete the degradation reaction 
when ATP was added. For example, when we monitored single-molecule GFP denaturation, 90% 
of the fluorescence loss occurred by the denaturation pathway with 10% following a 
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photobleaching-only pathway. This ratio is almost exactly that predicted from control 
experiments, in which ≈10% of the Cy3-GFP-titinV15P-ssrA substrate appeared to be bound 
nonspecifically to the surface. Moreover, single-molecule experiments and single-turnover 
solution experiments gave similar time constants for GFP denaturation and, in both cases, the 
data were fit reasonably well by a single exponential process. These results would not be 
expected if the individual enzymes in the preparations used for these studies displayed a broad 
range of denaturation activities, although there could be a population of completely inactive 
enzymes. Lower estimates of the percentage of active ClpXP enzymes (58-75%) were obtained 
by fitting the single-molecule degradation data. Because the overall time of laser irradiation was 
longer in the degradation experiments, some enzyme inactivation may occur during the 
experiment, potentially as a consequence of oxidative damage. 
Intriguingly, good fits to our single-molecule degradation data required a step in addition to 
substrate denaturation and translocation. In principle, this step could correspond to slow ClpP 
cleavage of some polypeptide sequences, to slow product release of the Cy3-labeled peptide 
from ClpP, or if the final step of translocation is slow because the substrate is no longer engaged 
efficiently by the translocation machinery. Solution studies have shown that steady-state rates of 
ClpXP degradation at substrate saturation (Vmax) are slower than those predicted from single-
turnover measurements of substrate denaturation and translocation (Martin et al., 2008a). Thus, 
the additional kinetic step suggested by our single-molecule experiments may also slow the 
steady-state rate of ClpXP substrate degradation in solution. It is also possible that inactive 
enzymes in our ClpXP preparations reduce the average activity and lead to an underestimate of 
Vmax, which is calculated with the assumption that all enzymes are active. We note, however, that 
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ClpXP degraded carboxymethylated GFP-titin
V15P
-ssrA at a steady-state maximal rate that 
corresponds to a time constant of 97 s for solution degradation. The time constant for single-
molecule ClpXP degradation of the GFP portion of this substrate was 55 s. The ratio of these 
values suggests that at least 57% of the ClpXP enzymes in solution are active. However, this 
value is likely to be higher because the solution reaction includes additional steps of substrate 
binding and translocation of the unfolded titin portion of the substrate compared to the single-
molecule reaction. Importantly, these results are inconsistent with models in which the solution 
activity of ClpXP is mediated by a small fraction of active enzymes. 
Understanding the operating principles and detailed mechanisms of complex macromolecular 
machines, like ClpXP, will ultimately require a combination of structural, biochemical, and 
biophysical approaches. Here, we have developed methods that allow a single-chain variant of 
ClpX to be tethered to a surface, to bind ClpP, and to carry out denaturation and degradation of 
specific substrate proteins. Importantly, the summed single-molecule activities of our surface-
tethered ClpXP enzymes recapitulate those of a population of free enzymes in bulk single-
turnover experiments. It should be straightforward to extend these methods to allow single-
molecule measurements of the forces exerted during protein denaturation and/or translocation by 
ClpXP, to measure detailed rates and step sizes for polypeptide translocation by ClpXP, to 
perform multiple-color experiments, and to introduce FRET probes that will allow real-time 
assays of the repetitive ATP-fueled conformational changes that drive the mechanical operations 
of the ClpXP machine. 
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Materials and Methods 
Protein expression and purification 
Detailed methods for the expression and purification of enzymes and substrates are provided in 
Appendix A (A.S1 text). Prior to labeling substrates with Cy3 maleimide (GE Healthcare), DTT 
was removed by exchange into 25 mM Hepes (pH 7.2), 50 mM KCl, 1 mM EDTA, 10% glycerol. 
An aliquot of Cy3 maleimide (2 µL of a freshly prepared 3 mM solution in dimethyl formamide) 
was then added to 100 µL of the substrate solution (typically 1-5 µM) and the mixture was 
incubated overnight at room temperature. Unreacted Cy3 dye was removed by chromatography 
by using three sequential desalting columns. Controls showed that Cy3 labeling was reduced to 6% 
when substrates lacked a cysteine at the N terminus (Figure A.S5, Appendix A). 
Flow cells 
Flow cells (30 x 5 mm) had a volume of approximately 15 µL and were made from double-sided 
sticky tape gaskets sandwiched between a predrilled glass slide and an etched-glass coverslip 
coated with a mixture of 99% PEG (molecular weight 5,000) and 1% biotin-PEG (Laysan Bio) to 
minimize nonspecific binding. The holes in the drilled slide were attached to flexible tubing to 
allow rapid buffer exchange, while minimizing motion of the sample. The flow chamber and 
tubing were sealed with epoxy. Preengaged substrate-enzyme complexes were formed by 
incubating substrates (1 µM) with single-chain ClpX
SC
 (0. 31 µM), ClpP-H6 (1 µM), and ATPγS 
(2 mM) for 45 min in PD buffer [25 mM Hepes (pH 7.6) , 100 mM KCl, 10 mM MgCl2, 10% 
glycerol (vol/vol), 0.1% Tween (vol/vol)] at 30 °C (Singh et al., 2001). After treating the flow 
cell with 20 µl of 0.01 mg/mL streptavidin, preengaged substrate-ClpXP complexes were diluted 
≈30-fold, introduced into the flow cell, and incubated for 20 min at room temperature to allow 
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binding of biotinylated ClpX
SC
 to the streptavidin-biotin-PEG surface. In all subsequent washes, 
ClpP-H6 (800 nM) was included to ensure maintenance of the ClpX
SC
-ClpP complex. After the 
binding step, the flow cell was washed with 2 mM ATPγS and 50 mM EDTA to chelate Mg2+ 
and prevent further hydrolysis. The chamber was then washed with PD buffer (without Mg2+) 
plus 6 mM EDTA and 1 mM ATP. After identifying a suitable region of the surface for analysis, 
the shutters were closed and the stage was moved slightly to a nearby field of view. The shutters 
were reopened to acquire the first image and 100 µL of PD buffer plus ATP was flowed into the 
cell to initiate the reaction (final ATP/Mg
2+
 concentration normally 1/10 mM). An oxygen 
scavenging system consisting of 0.8% D(+)-glucose, 165 units/mL glucose oxidase, 2,170 
units/mL catalase and 0.1% 2-mercaptoethanol was added in this final buffer to minimize 
photobleaching (Yildiz et al., 2003). 
Single-molecule fluorescence 
Single-molecule assays were performed by using a heavily modified inverted microscope 
outfitted with objective-side total internal reflection fluorescence capabilities (Brau et al., 2006; 
Tarsa et al., 2007). To minimize photobleaching, the excitation laser (532 nm for Cy3; 488 nm 
for GFP) was modulated with an acousto-optic modulator and also rapidly toggled with an 
electronic shutter to extend ﬂuorophore longevity and synchronize image acquisition. The 
custom TIRF system included a 1.45 N.A. 100X objective and a dichroic mirror. Images were 
acquired by using an EMCCD camera, which was triggered externally to collect during the 300-
ms on-time of the excitation laser, with an average power of 50 µW at the specimen plane. A 
series of 100 images was taken at 3- to 9-s intervals for degradation experiments; 21 images were 
taken at 7 s intervals for the denaturation experiment. The excitation zone was typically 300 µm
2
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and an average of 99.8 ± 7.2 spots were observed. Images were analyzed to determine the 
longevity of each fluorescent spot by using custom MATLAB software. Figure A.S6 (Appendix 
A) shows typical kinetic traces for Cy3 spots, in which fluorescence was lost in a single step. 
Blinking was observed for some GFP spots (see Figure A.S7, Appendix A), but the software 
counted only events in which fluorescence was permanently lost as degradation or 
photobleaching. 
Solution assays 
Solution unfolding or single-turnover degradation of substrates by ClpX
SC
-ClpP was measured at 
18 °C by using methods previously described (Martin et al., 2008a). Assays were performed in 
PD-1 buffer (25 mM Hepes (pH 7.6), 5 mM MgCl2, 10% glycerol, and 200 mM KCl) by using a 
creatine-phosphate based ATP-regeneration system. GFP fluorescence (excitation 467 nm; 
emission 511) or CFP fluorescence (excitation 433 nm; emission 475 nm) were used to monitor 
unfolding. The GFP-titin
V15P
-ssrA substrate was preengaged using ATPS, and the enzyme-
substrate complex was exchanged into a buffer with ATP but no Mg
2+
 as described (Martin et al., 
2008a). GFP unfolding was initiated by mixing one volume of the preengaged enzyme-substrate 
complex with an equal volume of 2X ATP buffer (8 mM ATP, 32 mM creatine phosphate, and 
0.64 mg/ml creatine kinase in PD buffer) and the reaction was monitored by fluorescence by 
using an Applied Photophysics DX.17MV stopped-flow fluorimeter equipped with a 495-nm 
cutoff emission filter. 
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Kinetic fitting 
Fitting of experimental data to kinetic models was performed by an iterative nonlinear least-
squares algorithm implemented in IGOR PRO 4.07 (WaveMetrics). The probabilities for each 
kinetic state were derived by solving rate equations with the Laplace transform. In these models 
(see Appendix A text for more detail), each state either moved on to next state (e.g., from 
domain unfolding to translocation) or photobleached. The model also included a substrate 
subpopulation that only lost fluorescence by the photobleaching pathway. The sum of all 
probabilities except for the final nonfluorescent states corresponds to the expected fractional spot 
population at any given time. The experimental fractional spot populations for degradation of the 
S1 and S2 substrates were globally fitted to these models, after fixing the unfolding time 
constant of GFP (19 s) and the photobleaching time constant of Cy3 (330 s) based on 
independent measurements. 
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Abstract 
Facile control of targeted intracellular protein degradation has many potential uses in basic 
science and biotechnology. One promising approach to this goal is to redesign adaptor proteins, 
which can regulate proteolytic specificity by tethering substrates to energy-dependent AAA+ 
proteases. Using the ClpXP protease, we have probed the minimal biochemical functions 
required for adaptor function by designing and characterizing variant substrates, adaptors, and 
ClpX enzymes. We find that substrate tethering mediated by heterologous interaction domains 
and a small bridging molecule mimics substrate delivery by the wild-type system. These results 
show that simple tethering is sufficient for synthetic adaptor function. In our engineered system, 
tethering and proteolysis depend on the presence of the macrolide rapamycin, providing a 
foundation for engineering highly specific degradation of target proteins in cells. Importantly, 














-nitrilotriacetic acid; CV, column volume; GFP, green fluorescent 
protein; DHFR, dihydrofolate reductase 
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Introduction 
Targeted proteolytic degradation plays important roles in protein-quality control and in 
regulating cellular circuitry in organisms ranging from bacteria to humans (Gottesman, 2003; 
Sauer et al., 2004; Baker and Sauer, 2006; Bukau et al., 2006). In some instances, substrates are 
recognized directly by a protease enzyme via a degradation tag (Figure 3.1-top) (Gottesman et 
al., 1998; Neher et al., 2003). In other cases, adaptor proteins or multiple types of substrate 
sequences are also required to ensure efficient degradation (Figure 3.1-middle, 3.1-bottom) 
(Flynn et al., 2004; McGinness et al., 2006). 
 
Figure 3.1. The ClpX component of the ClpXP protease recognizes some substrates via a 
degradation tag, denatures the substrate, and then translocates the unfolded protein into 
ClpP for degradation (top). Adaptor-assisted binding of a substrate to ClpXP (middle). 
Self-tethering of a substrate to ClpXP (bottom). 
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Experimentally induced degradation can be used as a tool to probe the role of specific proteins in 
cellular processes. For example, a protein that is normally stable can be modified to make its 
degradation conditionally dependent on the presence of an adaptor, allowing studies of the 
consequences of depletion after induction of adaptor synthesis (McGinness et al., 2006; Griffith 
and Grossman, 2008). Such systems complement methods, such as RNAi, that rely upon 
repressing biosynthesis of the target protein but offer significant advantages when rapid 
depletion of otherwise long-lived proteins is the goal (Fire et al., 1998; Janse et al., 2004; 
Banaszynski et al., 2006). We are interested in engineering synthetic adaptor systems to control 
targeted intracellular degradation.  
ClpXP is a AAA+ protease present in bacteria and mitochondria that consists of two 
components, ClpX and ClpP. Hexamers of ClpX recognize degradation tags in specific substrate 
proteins, unfold them in a reaction that requires ATP hydrolysis, and then use additional cycles 
of ATP hydrolysis to translocate the unfolded polypeptide into an interior chamber of ClpP, 
where proteolysis takes place (Figure 3.1-top). The simplest way in which an adaptor could 
stimulate degradation is by tethering a specific substrate to a protease, thereby increasing its 
effective concentration and facilitating proteolysis (Figure 3.1-middle); (Baker and Sauer, 2006). 
The SspB adaptor, for example, appears to function by this mechanism. SspB enhances ClpXP 
degradation of certain substrates, including N-RseA and proteins bearing the ssrA-degradation 
tag (Levchenko et al., 2000; Flynn et al., 2004; Sauer et al., 2004). ClpXP degrades these 
substrates in the absence of SspB, but KM for degradation is substantially lower when this 
adaptor is present. Two features of SspB are consistent with a tethering mechanism. It has a 
substrate-binding domain with a groove that binds a portion of the ssrA tag or a sequence in N-
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RseA, and it contains a flexible C-terminal extension terminating with a peptide motif (XB) that 
binds to the N-terminal domain of ClpX (Dougan et al., 2003; Levchenko et al., 2003; Song and 
Eck, 2003; Wah et al., 2003; Levchenko et al., 2005; Park et al., 2007). Mutations that prevent 
SspB binding to ClpX or block substrate binding to SspB eliminate stimulation of degradation 
(Levchenko et al., 2000; Bolon et al., 2004; Park et al., 2007). 
It has not been rigorously established, however, that tethering per se is sufficient for the activity 
of any adaptor. Based on biochemical experiments, for instance, Thibault et al. proposed that the 
adaptor activity
 
of SspB is mediated, in part, by its ability to direct the movement
 
of the N-
terminal domains of ClpX, and thereby to regulate the delivery of tagged substrates to ClpXP 
(Thibault et al., 2006). For some adaptors, tethering of the substrate to the protease is not 
sufficient for degradation. For example, the ClpS adaptor tethers N-end-rule substrates to the 
AAA+ ClpAP protease (Dougan et al., 2002; Erbse et al., 2006; Wang et al., 2007), but some 
ClpS mutants mediate efficient substrate tethering to ClpAP without facilitating degradation 
(Hou et al., 2008). In such cases, more complicated transactions between the adaptor and the 
protease appear to be needed to ensure that the substrate is properly delivered to the protease. 
Moreover, in some instances, adaptors play roles in substrate delivery but are also required for 
assembly of the active protease (Kirstein et al., 2006). 
The studies reported here were motivated by two major goals. First, we wished to test if a 
completely synthetic adaptor system could be used to regulate substrate degradation. Second, we 
sought to design a proteolysis system that could be controlled by the presence or absence of a 
small molecule. To define the minimal biochemical properties required for adaptor-protein 
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function, we engineered and characterized synthetic variants of adaptors, substrates, and the 
ClpXP protease. We reasoned that if specialized interactions between SspB and the N-terminal 
domain of ClpX were a requisite part of substrate delivery, then replacing either component 
would preclude efficient degradation. By contrast, we found that rapid degradation of an 
otherwise poor substrate was possible in the absence of SspB and the N-domain as long as 
substrate-enzyme tethering was maintained by other interaction domains. These results show that 
tethering alone is sufficient for synthetic-adaptor function. We were also able to control 
degradation in vitro and in vivo using systems in which a small molecule, rapamycin, drives 
assembly of tethered proteolytic complexes. Thus, targeted degradation can be engineered to 
depend, in a conditional fashion, on the presence of a small molecule. In principle, degradation 
under small-molecule control has many of the advantages of chemical genetics (Walsh and 
Chang, 2006), but should be even simpler and more widely applicable as a method of functional 
inhibition. In addition, controlling degradation in this fashion is possible even when biosynthesis 
of new macromolecules is precluded. 
 




LB1 buffer (pH 7.6) contained 20 mM Hepes, 400 mM NaCl, 100 mM KCl, 20 mM imidazole, 
10% glycerol, and 10 mM 2-mercaptoethanol. LB2 buffer (pH 8.0) contained 100 mM NaH2PO4, 
10 mM Tris-HCl, 6 M GuHCl, and 10 mM imidazole. EB1 buffer (pH 7.6) contained 20 mM 
Hepes, 400 mM NaCl, 100 mM KCl, 200 mM imidazole, 10% glycerol, 10 mM 2-mercapto-
ethanol. QB1 buffer (pH 7.0) contained 50 mM NaPO4 and 100 mM NaCl. GF1 buffer (pH 7.6) 
contained 50 mM Tris-HCl, 1 mM dithiothreitol, 300 mM NaCl, 0.1 mM EDTA, and 10% 
glycerol. PD-1 buffer (pH 7.6) contained 25 mM Hepes KOH, 5 mM MgCl2, 10% glycerol, and 
200 mM KCl. YEG media contained 0.5% yeast extract, 1% NaCl, and  0.4% glucose. 1.5xYT 
broth (pH 7.0) contained 1.3 % tryptone, 0.75 % yeast extract, and 0.75 % NaCl. 
Plasmids and strains 
XB-tail-Arc-DAS+4 was cloned into a pET24d vector and consisted of the following sequences 
from the N- to the C-terminus: (M)GDDRGGRPA LRVVK (XB motif underlined); residues 
113-154 of Escherichia coli SspB; a H6 tag; phage P22 Arc repressor; the st11 sequence 
H6KNQHD; and a DAS+4 tag (AANDENYSENYADAS). Arc-DAS+4 lacks the XB-tail 
sequence but is otherwise identical to XB-tail-Arc-DAS+4. Arc-ssrA is identical to Arc-DAS+4 





]3 were cloned in pACYC vectors and consisted of the N-terminal human FKBP12 
protein, followed by residues 139-165 of E. coli SspB, a H6 tag, and either by E. coli ClpX
ΔN
 
(residues 61-424) or the covalently linked [ClpX
ΔN
]3 trimer (Martin et al., 2005). For studies in 
vivo, FKBP-linker-[ClpX
ΔN
]3 was placed under control of a constitutive promoter and ribosome-
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binding site (Bba_J23101 and Bba_B0032 respectively, obtained from the Registry of Standard 
Biological Parts) and expressed from a plasmid bearing a ColE1 origin of replication. The gene 
for SspB
core
-FRB was generated in a pET vector by fusing the coding sequence for residues 1-
113 of E. coli SspB to the FRB domain of rat mTOR (residues 2015-2114) with a connecting 
linker sequence of H6RGS. Plasmids encoding λO-DHFRII-FRB and λO-titin-I27-FRB were 
generated by replacing the SspB
core
/H6 cassette in the SspB
core
-FRB construct with a fragment 
encoding (M)TNTAKILNFGRS-(DHFRII/titin-I27)-GGSEH6GS. Standard techniques were 
used to replace the λO tag in λO-titin-I27-FRB with the sequence MD6. The GFP-DAS+4, titin-
I27-DAS+4 substrates were expressed from pET vectors with N-terminal H6ID2LG tags for ease 
of purification. All growth and degradation experiments in vivo were performed in E. coli strain 
X90 [F'lacI
qlac' pro'/ara Δ(lac-pro) nalA argE(am) rifRthi-1 clpX–, recA–]. 
Protein expression and purification 
E. coli ClpP was expressed and purified as described previously (Kim et al., 2000). Unless noted, 
all other proteins were over-expressed from IPTG-inducible promoters in E. coli strain BLR 
(BL21 recA
–
 λ(DE3)). Briefly, cells were grown to OD600 0.7 at 37 °C in 1-2 liters of 1.5xYT 
broth, the cells were chilled to 18 °C, and expression was induced with 1 mM IPTG. Cells were 
harvested 4 h after induction, resuspended in LB1 buffer (15 mL/liter of culture), and frozen at -
80 °C until purification. To aid lysis, cells were subjected to two rounds of freezing and thawing 
before the addition of 1 mM PMSF, 0.1 mg/mL lysozyme, and 250 Units benzonase nuclease. 
After a 30-min incubation at 4 °C, lysates were centrifuged at 8000 rpm in a Sorvall SA600 rotor 
for 40 min, and the supernatant was decanted and saved. 
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For purification of ClpX and its variants, the lysate supernatant was incubated with 1 mL Ni
2+
-
NTA resin equilibrated with LB1 buffer for 5 min. After two bulk washes with 30 column 
volumes (CV) of lysis buffer, the slurry was poured into a column, washed with a 20 CVs of 
LB1 buffer, and the protein was eluted with EB1 buffer (8 x 0.5 CV elutions). Fractions were 
pooled based on Bradford assays, concentrated using Amicon Ultracel 10k filters, and 
chromatographed on a Superdex S200 gel-filtration column equilibrated in GF1 buffer. Fractions 
were analyzed by SDS-PAGE, concentrated, and stored frozen in GF1 buffer at -80 °C. 
The GFP-DAS+4, titin-I27-DAS+4, and λO-DHFRII-FRB proteins were purified by Ni2+-NTA 
chromatography as described above, and stored frozen in EB1 buffer at -80 °C. XB-tail-Arc-
DAS+4 was lysed in denaturing buffer LB2. After centrifugation as described above, the soluble 
fraction was applied to a Ni
2+
-NTA column, washed with 10 CVs of LB2, 20 CVs of LB1 and 
eluted as described above. Fractions were pooled based on Bradford analysis, exchanged into 
QB1 buffer using a spin column, and loaded onto an Amersham 5/50 GL MonoQ column 
equilibrated in QB1 buffer. The column was washed with five CVs of QB1 buffer and a 10 mL 
gradient from 0.1 M to 1 M NaCl in QB1 buffer was applied. Appropriate fractions were 
concentrated, pooled, and stored frozen at -80 °C. For each protein, MALDI-TOF mass 
spectrometry indicated that the full-length protein without truncations had been purified. 
Biochemical assays 
Assays were performed in PD-1 buffer at 30 °C using a NADH-coupled colorimetric assay and a 
plate reader for ATPase assays (Norby, 1988) or an ATP-regeneration system using creatine 
phosphate for degradation assays (Martin et al., 2008). Degradation assays of XB-tail-Arc-
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DAS+4 (10 µM) by 0.3 µM ClpX6 and 0.9 µM ClpP14 were quenched by boiling in SDS and 
monitored by SDS-PAGE. GFP degradation was monitored by loss of fluorescence (excitation 
467 nm; emission 511 nm). Degradation of titin-I27-DAS+4 was monitored by release of 
radioactive peptides soluble in trichloroacetic acid (Gottesman et al., 1998). Log-phase growth 
rates at 30 °C in YEG media were measured using a plate reader to monitor OD600; the plasmid 
expressing FKBP-linker-[ClpX
ΔN
]3 was maintained using ampicillin (100 µg/mL), and the 
plasmid expressing λO-DHFRII-FRB was maintained using tetracycline (10 µg/mL). 
Degradation assays in vivo were performed by centrifuging 1 mL of 0.7 OD600 cultures, 
resuspending the pellet in 8 M urea, normalizing each sample by total protein content using a 
Bradford assay, running SDS-PAGE, transferring by electro-blotting to a PVDF membrane, and 
probing using a polyclonal anti-DHFRII antibody (a gift from Dr. Elizabeth Howell, U. 
Tennessee, Knoxville, TN). 
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Results 
Tethering-dependent degradation with no adaptor 
SspB uses one part of its structure to bind a substrate and another part (the XB peptide) to bind to 
the N-domain of ClpX (Dougan et al., 2003; Levchenko et al., 2003; Song and Eck, 2003; Wah 
et al., 2003; Wojtyra et al., 2003; Park et al., 2007). For a substrate that normally requires 
delivery by SspB, we reasoned that the need for the substrate-binding portion of this adaptor 
might be obviated by fusing the XB peptide and the flexible tail of SspB directly to a substrate. 
In principle, this design would allow the protein to tether itself to the N-domain of ClpX. 
Efficient ClpXP degradation of such a “substrate” would support a passive tethering model, 
whereas poor degradation would suggest that the core substrate-binding domain of SspB plays a 
more active role in delivery. 
We constructed and purified a protein consisting of the XB peptide of SspB, the flexible tail of 
SspB, the Arc repressor protein, and the DAS+4 degradation tag, arranged from the N- to the C-
terminus (XB-tail-Arc-DAS+4) The DAS+4 tag (AANDENSENYADAS) is a variant of the ssrA 
tag that binds SspB normally but binds ClpX with dramatically reduced affinity (McGinness et 
al., 2006). Proteins containing the DAS+4 tag are degraded in-efficiently by ClpXP, except at 
very high substrate concentrations or in the presence of SspB. In degradation assays monitored 
by SDS-PAGE, ClpXP degraded a 33-fold excess of the XB-tail-Arc-DAS+4 protein to near 
completion over the course of 60 min (Figure 3.2A). By contrast, an otherwise identical variant 
lacking the XB peptide and tail (Arc-DAS+4) was degraded much more slowly under identical 
conditions (Figure 3.2B). 
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Two additional control experiments confirmed that degradation of XB-tail-Arc-DAS+4 
depended on tethering of the XB region of the substrate to the N-terminal domain of ClpX. First, 
ClpX
ΔN
, a truncated enzyme lacking the N-domain, failed to support ClpP degradation of XB-
tail-Arc-DAS+4 (Figure 3.2C) but degraded a tethering-independent substrate (Arc-ssrA) rapidly 
(Figure 3.2D). Second, addition of free XB peptide substantially slowed degradation of XB-tail-
Arc-DAS+4 by wild-type ClpXP (Figure 3.2E) but had no effect on degradation of Arc-ssrA 
(Figure 3.2F).  
 
Figure 3.2. SDS-PAGE assays of protein degradation by the ClpXP or ClpX
ΔN
/ClpP 
proteases (300 nM ClpX or ClpX
ΔN
; 900 nM ClpP). The XB-tail-Arc-DAS+4 substrate 
(10 µM) required auto-tethering to the N-terminal domain of ClpX for efficient 
degradation. Hence, this substrate was not degraded if the N-domain of ClpX was deleted 
or if excess XB peptide was present in the proteolysis reaction. Degradation of the Arc-
ssrA substrate (10 µM) did not require the ClpX N-domain and was not inhibited by XB 
peptide. 
 
Taken together, these results suggest that the role of SspB in enhancing substrate degradation is 
largely one of tethering the substrate to the N-terminal domain of ClpX and increasing its local 
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concentration. If interactions between SspB and the N-domain are essential for facilitating 
degradation, then these contacts must be limited to the flexible tail and XB peptide, which 
comprise the C-terminal 41 residues of SspB. 
Artificial tethering supports substrate delivery 
Do contacts between the XB peptide and the N-domain of ClpX serve functions other than 
simple tethering? To address this question, we designed a new binding interface that involved 
neither the N-domain of ClpX nor the XB peptide. First, we constructed a ClpX variant 
containing the human FKBP12 protein at the N-terminus, a linker region, and ClpX
ΔN
 at the C-
terminus (FKBP-linker-ClpX
ΔN
; Figure 3.3A). Second, we fused a SspB variant containing the 
substrate-binding core domain but lacking the flexible tail and XB motif to the N-terminus of the 
FRB domain from rat mTor (SspB
core
-FRB). The FKBP12 protein and the FRB domain bind to 
each other with high affinity only in the presence of the small molecule rapamycin (Choi et al., 
1996). Thus, adaptor-mediated tethering in this system is predicted to be rapamycin dependent. 
The FKBP-linker-ClpX
ΔN
 enzyme displayed rates of ATP hydrolysis that increased non-linearly 
at low protein concentrations (Figure 3.3B). Because N-domain dimerization normally helps 
stabilize the active hexameric form of ClpX (Grimaud et al., 1998; Wojtyra et al., 2003), 
replacing this domain with FKBP12 probably resulted in weaker hexamerization. To stabilize the 
active enzyme, FKBP12 and the linker were fused to the N-terminus of a trimeric form of 
ClpX
ΔN
 in which the subunits were connected with a flexible linker (Figure 3.3A) (Martin et al., 
2005). Purified FKBP-linker-[ClpX
ΔN
]3 exhibited linear ATP-hydrolysis rates at concentrations 
ranging from 50 nM to 500 nM (Figure 3.3B), consistent with stable pseudo-hexamer formation 
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at low enzyme concentrations. As observed for wild-type ClpX6 (Kim et al., 2001; Kenniston et 
al., 2003), ATP hydrolysis by the linked FKBP-linker-[ClpX
ΔN
]3 enzyme was slightly repressed 
by ClpP binding and stimulated by addition of an unfolded substrate (Figure 3.3C). Importantly, 
FKBP-linker-[ClpX
ΔN





(Figure 3.3D). These steady-state kinetic parameters are similar to those reported for 
wild-type ClpXP (Kim et al., 2000), showing that the presence of the FKBP12 domain in the 
linked enzyme does not interfere with degradation of ssrA-tagged substrates. 
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]3 enzyme variants. (B) Dependence of ATP-hydrolysis rates on 
enzyme concentration. The rate of ATP hydrolysis by FKBP-linker-[ClpX
ΔN
]3 was a 





indicating that this protein forms a stable hexamer at low protein concentrations. ATP 
hydrolysis by the FKBP-linker-ClpX
ΔN
 enzyme, by contrast, was highly non linear in a 
fashion that suggested hexamer dissociation at concentrations below 100 nM. (C) The 
rate of ATP hydrolysis by FKBP-linker-[ClpX
ΔN
]3 (0.3 µM pseudo hexamer) was slowed 
by the presence of ClpP (0.9 µM) and enhanced by the presence of an unfolded substrate 
(1.4 µM), the carboxymethylated-titin-I27-VP15-ssrA protein (Kenniston et al., 2003). 
(D) Michaelis-Menten plot of the substrate dependence of the steady-state rate of 
degradation of the GFP-ssrA substrate by FKBP-linker-[ClpX
ΔN
]3 (100 nM pseudo 
hexamer) and ClpP14 (300 nM). The solid line is a non-linear least-squares fit of the 
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Next, we tested if the artificial SspB
core
-FRB adaptor could deliver substrates to FKBP-linker-
[ClpX
ΔN
]3 in a rapamycin-dependent fashion (Figure 3.4A). In the presence of this 
adaptor/enzyme pair, ClpP, and rapamycin, two different DAS+4-tagged substrates were 
degraded with KM values near 1 µM and Vmax values expected based on the resistance of these 
native proteins to ClpX unfolding (Figure 3.4B & 3.4C) (Kim et al., 2000; Kenniston et al., 
2003). In the absence of rapamycin, degradation of both substrates was extremely slow (Figure 





]3, and ClpP (data not shown). 
These experiments indicate that artificial tethering mediated by the FRB-rapamycin-FKBP12 
complex results in efficient adaptor-dependent degradation. We conclude that simple tethering of 
substrates to ClpX is sufficient to explain adaptor-mediated enhancement of degradation. 
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Figure 3.4. (A) Cartoon showing delivery of DAS+4 tagged substrate to FKBP-linker-[ClpX
ΔN
]3 
by the synthetic SspB
core
-FRB adaptor and rapamycin. (B) Substrate dependence of GFP-DAS+4 
degradation by FKBP-linker-[ClpX
ΔN
]3 (100 nM pseudo hexamer) and ClpP14 (300 nM) in the 
presence of SspB
core
-FRB (200 nM) and the presence (1 µM) or absence of rapamycin. The line 





). The line for the no-rapamycin data is a linear fit. (C) Michaelis-Menten plots for 
titin-I27-DAS+4 degradation by FKBP-linker-[ClpX
ΔN
]3 (100 nM pseudo hexamer) and ClpP14 
(300 nM) in the presence of SspB
core
-FRB (200 nM) and the presence (1 µM) or absence of 





The line for the no-rapamycin data is a linear fit. 
Rapamycin-dependent degradation 
Artificial tethering mediated by the FRB-rapamycin-FKBP12 interaction requires the interaction 
of three molecular components. To test the kinetics of assembly, we monitored the fluorescence 




]3, and ClpP 
(Figure 3.5A). When rapamycin was added, degradation reached an enhanced steady-state rate 
within the dead time of the experiment (approximately 20 s; Figure 3.5A). Thus, FRB-
rapamycin-FKBP12 binding and subsequent degradation occurs on the time scale of many 
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biological responses. We also tested the response of the system to rapamycin concentration and 
found that the degradation rate was unchanged at rapamycin concentrations above the enzyme 
concentration (Figure 3.5B). This result indicates that near stoichiometric quantities of the small 




-FRB saturate the system. Thus, 
the response of the system to rapamycin is rapid and sensitive. 
 
Figure 3.5. (A) Rapamycin addition results in rapid degradation. The GFP-DAS+4 
substrate (0.5 µM), SspB
core
-FRB (1 µM), FKBP-linker-[ClpX
ΔN
]3 (0.5 µM pseudo 
hexamer), and ClpP14 (1.5 µM) were preincubated and slow steady-state degradation was 
observed by loss of substrate fluorescence. At the time indicated by the arrow, rapamycin 
(2 µM) was added. Within the dead-time of the experiment (≈ 20 s), degradation of GFP-
DAS+4 reached a new and much faster steady-state rate. (B) Changing rapamycin 
concentration over the range shown had almost no effect on the steady-state rate of 
degradation of 
35
S-titin-I27-DAS+4 (10 µM) by FKBP-linker-[ClpX
ΔN
]3 (100 nM pseudo 
hexamer), ClpP14 (300 nM), and SspB
core
-FRB (200 nM). (C) Degradation of 
35
S-titin-
I27-DAS+4 (10 µM) by FKBP-linker-[ClpX
ΔN
]3 (200 nM pseudo hexamer) and ClpP14 
(600 nM) was assayed as a function of the SspB
core
-FRB adaptor concentration in the 
presence of rapamycin (1 µM). 
 
To evaluate the effects of adaptor concentration, we titrated increasing quantities of the SspB
core
-
FRB adaptor against fixed concentrations of FKBP-linker-[ClpX
ΔN
]3, ClpP, and rapamycin and 
assayed degradation of titin-I27-DAS+4. Degradation initially increased linearly and reached a 
maximal value at a ratio of one SspB
core
-FRB dimer for each FKBP-linker-[ClpX
ΔN
]3 pseudo-
hexamer. For the wild-type proteins, it is known that one substrate-bound SspB dimer binds to 
one ClpX hexamer (Wah et al., 2002). At high concentrations of the SspB
core
-FRB adaptor (10 
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µM), the degradation rate was reduced to approximately 25% of its maximal value (Figure 3.5C). 
Under these conditions, free adaptor molecules probably compete with ClpX-bound adaptors for 
substrate binding. 
Tethering-dependent delivery of a λO-tagged substrate 
The results presented so far show that alternative mechanisms of tethering can facilitate ClpXP 
proteolysis of substrates with C-terminal degradation tags. Degradation of proteins bearing the 
N-terminal λO tag normally requires the N-domain of ClpX (Singh et al., 2001), which is 
missing from the FKBP-linker-[ClpX
ΔN
]3 variant. To test the versatility of the artificial tethering 
system, we constructed and purified a substrate with an N-terminal λO tag (NH2-
TNTAKILNFGR; Flynn et al., 2003), followed by the titin-I27 domain, and then the FRB 
domain. This λO-titin-I27-FRB substrate contains no sequences from the SspB adaptor but can 
tether itself via rapamycin to the FKBP-linker-[ClpX
ΔN
]3 enzyme. 
The purified λO-titin-I27-FRB fusion protein was degraded by FKBP-linker-[ClpXΔN]3 and ClpP 
when rapamycin was present but not when it was absent (Figure 3.6A). As a control, we 
constructed an otherwise identical fusion protein in which the λO tag was replaced by the 
sequence MD6 (MDDDDDD) which we hypothesized would not be recognized by ClpX. No 
degradation of this protein was observed in the presence or absence of rapamycin (Figure 3.6A). 
We conclude that an N-terminal λO tag can serve as a degradation signal for substrates which 
can tether themselves to ClpX.  
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Figure 3.6. (A) Cartoon showing rapamycin-dependent degradation of a substrate with 
an N-terminal λO tag and C-terminal FRB domain by FKBP-linker-[ClpXΔN]3 and ClpP. 
The gel below the cartoon shows that variants of the titin-I27 protein with an N-terminal 
λO tag and C-terminal FRB domain were degraded in a rapamycin-dependent fashion in 
vitro as assayed by SDS-PAGE. Replacing the λO tag with a MD6 sequence blocked 
degradation. All reactions contained substrate (10 µM), FKBP-linker-[ClpX
ΔN
]3 (300 nM 
pseudo hexamer), and ClpP14 (900 nM). (B) Relative growth rates in M9 minimal 
medium of clpX
–
 E. coli strains expressing λO-DHFRII-FRB as a function of rapamycin 
(10 µM, when present), trimethoprim (100 µg/mL, when present), and a plasmid 
expressing FKBP-linker-[ClpX
ΔN
]3. (C) Western blotting shows intracellular degradation 
of λO-DHFRII-FRB after addition of rapamycin (10 µM) but not after a mock addition in 
clpX
–
 E. coli strains expressing FKBP-linker-[ClpX
ΔN
]3. Protein synthesis was not 
blocked in this experiment. The sample volume in each lane was adjusted to yield the 
same amount of total cellular protein. 
 
Rapamycin-dependent degradation in vivo 
For studies of degradation in E. coli, we constructed a substrate with an N-terminal λO-tag, 
followed by the DHFRII enzyme and the FRB domain (λO-DHFRII-FRB). This substrate was 
degraded in a rapamycin-dependent manner by FKBP-linker-[ClpX
ΔN
]3 and ClpP in vitro (data 
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not shown). Expression of DHFRII in E. coli results in resistance to trimethoprim, an antibiotic 
that inhibits the endogenous dihydrofolate reductase enzyme (Fleming et al., 1972; Pattishall et 
al., 1977; Smith et al., 1979; Stone and Smith, 1979; Krahn et al., 2007). When we expressed 
λO-DHFRII-FRB in a clpX- strain containing FKBP-linker-[ClpXΔN]3, the cells grew well in the 
presence of trimethoprim (Figure 3.6B). When rapamycin was added, however, these cells 
became trimethoprim sensitive and growth slowed substantially (Figure 3.6B). This result was 
not caused by rapamycin toxicity, as rapamycin did not affect growth in media lacking 
trimethoprim or in a strain without FKBP-linker-[ClpX
ΔN
]3 (Figure 3.6B). Thus, the FKBP-
linker-[ClpX
ΔN
]3 enzyme and ClpP appear to degrade λO-DHFRII-FRB in a rapamycin-
dependent fashion in vivo. To confirm this inference, we prepared cell lysates at different times 
after treatment with rapamycin or a mock-addition and subjected them to SDS-PAGE and 
Western blotting using an anti-DHFRII antibody. The steady-state level of λO-DHFRII-FRB was 
reduced rapidly upon addition of rapamycin (Figure 3.6C), even though protein synthesis was 
not blocked in this experiment. Hence, rapamycin-dependent tethering of FRB-fusion substrates 
to FKBP-linker-[ClpX
ΔN
]3 can successfully control degradation in the cell. 
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Discussion 
The results presented here demonstrate that tethering of a substrate to a AAA+ protease is 
sufficient for adaptor function. We found, for example, that the normal tethering function of the 
SspB adaptor protein could be transferred directly to a substrate by fusing the ClpX-binding 
peptide and tail of SspB to an otherwise poor substrate for the ClpXP protease. This result shows 
that the substrate binding domain of SspB is dispensable for adaptor function. Moreover, we 
were able to engineer a completely artificial tethering system, in which the N-domain of ClpX 
was replaced with the FKBP12 protein and the normal tail and ClpX-binding peptide of the SspB 
adaptor was replaced with the FRB domain. In the presence of rapamycin, a small bridging 
molecule, substrates bearing a weak degradation tag were degraded efficiently in the presence of 
this artificial adaptor and re-engineered enzyme. Finally, we established a synthetic rapamycin-
dependent system in which substrates bearing an N-terminal λO-degradation tag and the FRB 
domain were efficiently degraded by a FKBP-ClpX variant and ClpP. It is important to note that 
this substrate contained no parts from the SspB adaptor and ClpX lacked its N-domain, which is 
required for normal adaptor-mediated delivery of substrates to wild-type ClpX. Because the 
functions mediated by SspB and the ClpX N-domain can effectively be replaced by other 
tethering elements, it is possible that the wild-type adaptor system stimulates proteolysis simply 
by tethering substrates to ClpXP. 
Although tethering of substrates to ClpX appears to be sufficient for adaptor function, there 
clearly must also be other geometric and structural criteria that need to be met (McGinness et al., 
2007). For example, a potential substrate that is tethered too rigidly and therefore could not reach 
the translocation pore would presumably not be degraded efficiently. In the studies reported here, 
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we tried to account for this factor by engineering a flexible linker between the FKBP12 and 
ClpX portions of our synthetic enzyme. In some cases, however, it may also be necessary to 
design flexibility into the adaptor or substrate as well. 
Efficient ClpXP degradation mediated by the λO tag normally requires both a multimeric 
substrate and the N-domain of ClpX. For example, the tetrameric λO protein is degraded well by 
wild-type ClpXP but is not degraded efficiently by ClpX
ΔN
 and ClpP (Singh et al., 2001; 
Wojtyra et al., 2003). Moreover, KM for ClpXP degradation of a dimeric λO-tagged substrate 
was substantially lower than that for a monomeric λO-tagged protein (Farrell et al., 2007). 
Nevertheless, we found that a monomeric substrate, λO-titin-I27-FRB, was degraded efficiently 
by FKBP-linker-[ClpX
ΔN
]3 and ClpP. This result suggests that degradation of λO-tagged 
substrates does not require substrate multimerization or the ClpX N-domain if alternative 
mechanisms of tethering to ClpX are available. We propose that λO-tagged substrates normally 
require multimerization for efficient degradation, because one λO tag in a multimer tethers the 
substrate to ClpX via the N-domain, allowing a second λO tag to be engaged by the translocation 
channel of ClpX to initiate degradation. Indeed, this dual-function tag model is supported by 
reports that both the isolated N-domain of ClpX and ClpX
ΔN
 itself bind to the λO protein (Singh 
et al., 2001; Wojtyra et al., 2003). 
Multivalent recognition of degradation signals is likely to facilitate the targeted proteolysis of 
many substrates at low concentrations. For example, monomeric substrates might contain more 
than one type of degradation tag. Indeed, Flynn et al. reported that roughly 25% of identified 
cellular substrates for ClpXP contained more than one degradation motif (Flynn et al., 2003). For 
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multimeric substrates, the same sequence signal in two different subunits could be recognized by 
different parts of the protease as proposed above. We found, for example, that clpX
+
 strains 
containing λO-DHFRII-FRB were trimethoprim sensitive (data not shown), suggesting that wild-
type ClpXP can degrade this substrate. Because DHFRII is a tetramer, it is likely that a λO tag 
from one subunit tethers the substrate to the N-domain of ClpX, allowing the λO tag from a 
second subunit to be engaged by ClpX for degradation. Recent studies indicate that ClpX 
disassembly of the tetrameric MuA transposase also involves recognition of multiple classes of 
sequence elements (Abdelhakim et al., 2008). 
Furthermore, our results demonstrate that adaptor-mediated degradation can be placed under 
small-molecule control both in vitro and in vivo. In the cell, the kinetics of rapamycin uptake and 
the subsequent assembly of the FRB-rapamycin-FKBP12 complex are sufficiently rapid to 
ensure that degradation starts within minutes of addition of the small molecule. The system 
described here may not be optimal for many desired uses in controlling intracellular degradation. 
Nevertheless, our results suggest that it should be possible to design improved systems that 
combine small-molecule control, fast temporal responses, and the exquisite specificity of a 
genetically encoded degradation tag. We expect such systems to be useful in the study of protein 
products, including those encoded by essential genes, for which the phenotype of depletion on a 
short-time scale needs to be determined. In principle, such a system could be used with either N- 
or C-terminal tethering-dependent tags, greatly extending their applicability. 
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Abstract 
We have generated a series of variable-strength, constitutive, bacterial promoters that act 
predictably in different sequence contexts, span two orders of magnitude in strength, and contain 
convenient sites for cloning and the introduction of downstream open-reading frames. 
Importantly, their design insulates these promoters from the stimulatory or repressive effects of 
many 5´ or 3´ sequence elements. We show that different promoters from our library produce 
constant relative levels of two different proteins in multiple genetic contexts. This set of 
promoters should be a useful resource for the synthetic-biology community. 
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Introduction 
The introduction of novel genetic components and pathways into cells has proven useful in 
biotechnology and as a tool to study and improve our understanding of natural systems (Elowitz 
and Leibler, 2000; Ro et al., 2006; Atsumi and Liao, 2008; Stricker et al., 2008). For some 
applications, achieving the proper steady-state levels of each gene product can be critical in 
optimizing the function of an entire biosynthetic pathway, whereas, in other cases, assaying the 
consequences of altered expression levels is important for probing native gene function (Alper et 
al., 2005; Lutke-Eversloh and Stephanopoulos, 2008; Anthony et al., 2009). 
In principle, steady-state protein levels can be controlled by using libraries of variable-strength 
promoters to change transcription rates, by employing different ribosome-binding sites to alter 
translation efficiency, and by appending degradation tags to adjust rates of protein turnover 
(Alper et al., 2005; Wong et al., 2007; Salis et al., 2009). Often, the process of finely-tuning 
each of these parameters is laborious and relies on trial-and-error, a problem that has led some to 
utilize directed-evolution to guide the optimization process (Yokobayashi et al., 2002; You et al., 
2004; Basu et al., 2005). Others have begun to characterize individual genetic parts rigorously 
(for example, the transcriptional strength of a promoter) with the hope that such information 
might guide and expedite the refinement process (Endy, 2005; Canton et al., 2008; Kelly et al., 
2009). The success of reusing well-characterized components relies on a critical assumption that 
such devices are functionally composable, that is the properties of the device in one test context 
are predictive of those properties in a new context.  
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Building on the work of others, we sought to design a set of variable-strength constitutive 
bacterial promoters that are insulated from influences of genomic context. Although it may not 
be possible to insulate any biological component completely, a wealth of information is available 
that can be exploited to limit context-dependent behavior. Bacterial transcription can be 
decomposed into three phases; binding, initiation, and elongation. Extensive biochemical and 
structural studies have helped elucidate the promoter and polymerase components that control 
each of these steps (Browning and Busby, 2004). Bacterial RNA polymerase (RNAP) is a 
heterohexamer composed of a core polymerase (ßß´α2ω), which is competent for transcriptional 
elongation, and a σ subunit, which is utilized to define promoter specificity during binding and 
initiation but is dispensable for elongation. In the initial binding step, the σ subunit of the RNA 
polymerase holoenzyme (ßß´α2ω-σ) contacts two hexameric DNA sequences located 10 and 35 
base pairs 5´ of the transcription start site (named the -10 and -35 boxes, respectively) (deHaseth 
et al., 1998). At some promoters, additional contacts are formed between the α2 subunits and 
A,T-rich promoter sequences residing as many as 60 base pairs 5´ of the transcription-start site 
(known as an “UP” sequence). These contacts facilitate polymerase binding and can enhance 
promoter activity up to 300-fold in manner that depends upon the sequence distance from the 
core recognition elements (Estrem et al., 1998; Estrem et al., 1999; Ross et al., 2001). Once 
bound, the enzyme-promoter complex must isomerize from a “closed” complex in which the 
DNA is double stranded to an “open” complex in which base pairs from approximately positions 
–10 to +2 melt or separate into single strands (deHaseth et al., 1998). The conformational 
equilibrium between closed and open complexes depends, in part, on the sequence of the base 
pairs that melt (Pemberton et al., 2000). From the open complex, the polymerase can undergo a 
repetitive process, termed abortive transcription, in which it initiates transcription, releases a 
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short RNA transcript (<10 nt), and then returns to the site of initiation. This process continues in 
a stochastic fashion until the polymerase clears the promoter, releases the σ subunit, and 
continues the elongation phase of transcription (often referred to as promoter escape). The 
identity of the 20 nucleotides downstream of the transcription-start site (defined as +1 to +20) 
strongly influence the efficiency with which a bacterial polymerase escapes from the promoter 
and continues elongation (Chan and Gross, 2001; Hsu, 2008).  
To respond to external signals, transcription factors have evolved mechanisms to up-regulate or 
down-regulate each of the steps described above. For example, cyclic-AMP receptor protein 
(CRP) binds the promoter upstream of the -35 box, simultaneously making favorable contacts 
with the C-terminal domain of the polymerase α subunits (de Crombrugghe et al., 1984; Lawson 
et al., 2004). These contacts enhance polymerase binding and increase transcription at promoters 
where binding is rate limiting (Ebright, 1993). Promoters can also be regulated at the 
isomerization step of transcription. For example, the merR transcriptional repressor acts by 
inhibiting conversion of the closed to open complex (Rojo, 1999). Lastly, the efficiency of 
promoter escape can be regulated. At some promoters, for example, the phage φ29 protein p4 
binds tightly to the polymerase α subunit, which slows promoter escape and down-regulates 
productive transcription (Rojo, 1999). Interestingly, at promoters where polymerase binding is 
limiting, this same protein can activate transcription by enhancing binding (Mencia et al., 1996). 
Such non-uniform effects are particularly important when considering the design of synthetic 
variable-strength promoter libraries. 
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Many synthetic promoters have been generated and characterized, but they often show activities 
that vary with the genetic locus or gene transcribed (Jensen and Hammer, 1998; Alper et al., 
2005; Hammer et al., 2006; Anderson, 2009; Kelly et al., 2009; Martin et al., 2009). As 
discussed above, this context dependence is not surprising. For example, increased activity can 
arise from 5´ UP-sequence elements or as a consequence of read-through from upstream 
promoters (Estrem et al., 1998; Meng et al., 2001). One solution to the latter problem is to 
include a transcriptional terminator at the 5´ boundary of the synthetic promoter, but AT-rich 
terminators share some sequence similarity with UP elements and may themselves increase 
transcription of downstream genes. Promoter fusions to different genes may also affect 
transcription efficiency if the 5´ end of the mRNA contains a sequence that changes the rate of 
promoter escape. 
The strength of any minimal promoter, containing sequences from the -35 hexamer to the site of 
initiation, is likely to vary depending on neighboring sequences. As a consequence, we generated 
promoters in which adjoining upstream and downstream sequences, which potentially could alter 
transcription initiation and promoter escape, were included in the promoter cassette (Figure 4.1). 
These “insulated” promoter cassettes extend from position –105 to +55, a span which includes 
the majority of transcription-factor binding sites in natural bacterial promoters as well as most 
elements that affect transcription initiation and promoter escape (Mendoza-Vargas et al., 2009). 
We find that such promoters exhibit transcriptional activities that are significantly more 
predictable in varied genetic contexts. 
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Figure 4.1. Comparison of promoter organization. Schematic of an insulated promoter 
(A) and a minimal, uninsulated promoter (B). The promoter recognition region (PRR) 
containing the -10 and -35 RNAP binding determinants (green) is shown in blue, the 
transcription initiation site (+1) is represented by the red line. In the insulated promoter, 
the surrounding genetic context (orange) is separated from the PRR by insulation 
sequences (grey). Most elements known to effect transcription initiation and promoter 
escape are contained within the insulated promoter cassette boundaries. Because of its 
smaller size, the genetic context surrounding the minimal promoter is more likely to 
contain sequences that can effect transcription initiation, thereby increasing the 
possibility of context-dependent activity. 




Basic promoter design 
Our initial construct was based on E. coli rrnB P1, a strong σ70-dependent promoter with near 
consensus –10 (TATAAT) and –35 (TTtACg) elements. A 17-bp sequence 
(GGCATGCATAAGGCTCG) separates the -10 and -35 boxes, resulting in the optimal spacing 
for near-consensus promoters (Aoyama et al., 1983; Rossi et al., 1983; Paul et al., 2004). To 
provide insulation, we also defined the flanking sequences from position –105 to +55, using 
elements described in Materials and Methods. Our promoter design extends beyond the 
transcription initiation start site and thus creates a specific and invariant 5´ mRNA terminus. This 
feature was incorporated to improve the predictability of promoter strength, mRNA stability, and 
the site of transcriptional initiation, but it may preclude experiments in which this region of the 
transcript must be of a particular sequence (Win et al., 2009). We note however that the 
ribosome binding site and translation start codon reside downstream of this element, and thus the 
resulting protein product is not affected by the insulation sequence. It is also interesting to note 
that the vast majority of natural transcripts in E. coli are predicted to encode a 5´ untranslated 
region greater than 20 nucleotides in length (Mendoza-Vargas et al., 2009).  
We transformed cells with a plasmid vector bearing our first-generation insulated promoter 
(called proD) driving production of a GFP reporter gene (Bba_E0040, Registry of Standard 
Biological Parts, www.partsregistry.org) and measured GFP synthesis rates as a proxy for 
promoter strength. Briefly, cells were grown in culture tubes at 37 °C to mid-log phase, OD600 
was measured as a surrogate of cell number, and GFP fluorescence was determined. After an 
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additional 1.25 hours of growth, we again measured OD600 and GFP fluorescence. The GFP 




  (4.1) 
To determine the strength of proD relative to another promoter, we performed the same 
procedure using a minimal length, constitutive promoter (Bba_j23101: Registry of Standard 
Biological Parts), which has been previously characterized (Kelly et al., 2009). In this 
comparison, proD had greater activity than the reference promoter (Figure 4.2). 
 
Figure 4.2. Insulated promoters drive production of GFP. GFP synthesis rates per cell 
were measured for a control construct lacking GFP, a minimal promoter (j23101), or an 
insulated promoter (proD). 
Generation and characterization of an insulated promoter library 
Next, we generated a library by using degenerate oligonucleotides to randomize either the –35 or 
the –10 element of our insulated promoter in the plasmid vector and transformed E. coli cells. 
This library was enriched for active promoters using fluorescence activated cell sorting (data not 
shown). Measurements of GFP synthesis rates from individual colonies of the enriched pool 
were then used to identify 10 clones that exhibited varied GFP expression. Measurement of GFP 
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synthesis rates showed that this set of variants encoded promoter strengths spanning two orders 
of magnitude. To allow for comparison with previously characterized minimal promoters, we 
also measured the activity of a set of uninsulated promoters which spanned a similar range of 
activity (Bba_j23113, Bba_j23150, Bba_j23151 and Bba_j23101 from The Registry of Standard 
Biological Parts, www.partsregistry.org). As described in Kelly et al. (2009), relative measures 
of promoter activity can greatly reduce assay-to-assay variance. We determined relative 
promoter strength by normalizing the GFP synthesis rate of each promoter to that of a reference 
proD promoter, as shown in Equation 4.2. The sequence of each promoter variant as well as the 











From our set of ten insulated variants, we selected proD and three additional promoters (proA, 
proB, and proC), which spanned the activity range, for more detailed characterization (Figure 
4.3). These promoters were named in ascending order of activity.  
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Figure 4.3. Promoter strength of library members. The strength of each promoter was 
measured in triplicate in E. coli DH5α grown in minimal media using GFP as a reporter 
(Kelly et al., 2009). The GFP synthesis rate is reported on a log10 scale as a surrogate of 
promoter strength. Promoter strength measurements relative to proD are listed in Table 
4.1 in Materials and Methods. 
Characterization of promoter insulation 
The UP element from rrnB P1 was chosen to test the efficacy of the 5´ insulation. This 24-
nucleotide sequence (AGAAAATTATTTTAAATTTCCTCA) has been shown to activate 
transcription from some promoters (Meng et al., 2001). We inserted the UP element at the 5´ 
boundaries of the insulated promoter cassettes (proA, proB, proC, proD) and the noninsulated 
promoter cassettes (j23113, j23101, j23150, j23151). Using the GFP-reporter assay, we 
determined the relative strength of each promoter either with or without the UP element (Figure 
4.4). Introduction of the UP sequence slightly reduced transcription from each insulated 
promoter compared to the same promoter with no UP element, whereas it increased transcription 
from the uninsulated promoters in a highly variable manner (Figure 4.4 inset). 
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Figure 4.4. Effect of UP sequence on apparent promoter activity. The UP sequence 
was cloned upstream of either insulated (proA, proB, proC, proD) or uninsulated (j23113, 
j23150, j23151, j23101) promoters and promoter strength was measured using the GFP-
reporter assay. Promoter strength was normalized to the strength of proD resulting in 
relative promoter units (RPU). The inset shows relative strength of each promoter with 
the UP sequence normalized to the strength of the parental promoter. A value of 1 
indicates no change in promoter strength. The promoter j23113 was excluded from 
comparative analysis due to its weak promoter strength and relatively large colony-to-
colony variation. 
Next, we tested downstream insulation by inserting an anti sequence 
(ATCCGGAATCCTCTGGATCCTC) at the 3´ boundaries of insulated and uninsulated 
promoters (Figure 4.5). This portable sequence decreases the rate of promoter escape when 
present at positions +1 to +22 of many transcripts (Chan and Gross, 2001). For each set of 
promoters, this sequence was inserted using the available restriction sites downstream of the 
promoter element. This strategy resulted in the same scar between the promoter and the 
downstream sequence that would be present if the promoter were used to drive the production of 
a new transcript (see Materials and Methods for a description of scar sequences). The position of 
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the “anti” sequence was +47 to +69 for the insulated promoters and +7 to +31 for the uninsulated 
promoters. Again, relative GFP synthesis rates were measured as a surrogate for promoter 
activity. As shown in Figure 4.5, insertion of the anti sequence had almost no effect on the 
insulated promoters and had variable effects on the uninsulated promoters. The strongest 
promoter, j23101 was downregulated ~2-fold whereas the weaker promoter, j23150, showed no 
change. Interpreting activity differences between promoters with and without the anti sequence is 
difficult because the insertions alter the mRNA and thus could affect mRNA stability and 
translation efficiency in addition to promoter activity. We note, however, that for each set of 
insulated or uninsulated promoters, the mRNA transcribed is independent of the particular 
promoter assayed and thus is constant within that set. When normalized for relative promoter 
activity as shown in Figure 4.5, it is clear that the insulated promoters are resistant to the effects 
of inserting this sequence.  
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Figure 4.5. Effect of sequences inserted 3´ of the promoter. The “anti” sequence was 
cloned downstream of either insulated or uninsulated promoters and the promoter 
strength of each construct was measured using the GFP-reporter assay. For each promoter 
that could be robustly measured, the inset reports the ratio of promoter strength with the 
anti sequence to that without the insertion. 
Promoter activity when driving disparate open reading frames 
Is promoter strength predictable following fusion to different open-reading frames? To address 
this question, we fused the insulated and uninsulated promoters to sequences encoding two 
additional fluorescent reporters. The first was Gemini, which contains an N-terminal LacZα 
sequence and a C-terminal GFP domain (Martin et al., 2009). The second was dsRed, which is 
an engineered fluorescent protein with little homology to GFP (Campbell et al., 2002). Although 
it is difficult to directly compare expression levels of GFP with those of dsRed or Gemini in a 
meaningful way, the relative strengths of different promoters driving expression of each type of 
 Davis | 113 
 
protein should be predictable if there is sufficient insulation from the effects of the initially 
transcribed sequence.  
We first measured the synthesis rate of Gemini for each promoter (proA, proB, proC, proD, 
j23113, j23150, j23151, j23101) in a manner similar to that described for GFP. Gemini, could be 
readily assayed using fluorescence from its GFP domain. Importantly, the N-terminus of Gemini 
(LacZα) is different from that of GFP, and thus one might expect differences in transcription 
from uninsulated promoters. As reported previously, we observed a decrease in the absolute 
synthesis rates of Gemini relative to those of GFP (Martin et al., 2009). For each promoter, we 
calculated the relative promoter strength compared to proD driving the same open reading frame 
using to equation 4.2. Figure 4.6 plots the relative promoter strength (RPUproD) determined using 
GFP (x-axis) against that determined using Gemini (y-axis). Promoters not altered by the 
introduction of Gemini, approximately fall on the line y=x (red). Interestingly, the insulated 
promoters show a ~1:1 relationship between relative activity measured either by GFP or by 
Gemini. By contrast, the stronger uninsulated promoters (j23151, j23101) show diminished 
apparent relative activity when driving production of Gemini (Figure 4.6, right). We do not 
believe that the decreased activity of the uninsulated promoters occurs as a consequence of 
translation or Gemini folding becoming rate limiting, because the absolute activity of even the 
strongest uninsulated promoter is weaker than that of the strongest insulated promoter (proD). 
The fact that neither proC nor proD show diminished activity when driving Gemini production 
argues that transcription from the strongest uninsulated promoters becomes limiting in this assay. 
Again, the uninsulated promoters show greater context-dependent activity. 
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Figure 4.6. Aparent promoter activities driving production of GFP versus Gemini. 
Promoter strength was measured for a set of insulated (left) or uninsulated (right) 
promoters driving the production of GFP (x-axis) or Gemini (y-axis). For each open 
reading frame, aparent synthesis rates were determined by measuring florescence as 
shown in Equation 4.1. To allow comparison between open reading frames, each 
synthesis rate was normalized to that of proD driving production of the same open 
reading frame (Equation 4.2). 
We next measured the synthesis rate of dsRed for proA, proB, proC, proD, j23113, j23150, 
j23151, and j23101 promoters in a manner similar to that described for Gemini (see Materials 
and Methods for details). For each promoter driving production of each open reading frame, we 
calculated promoter strength relative to j23101 driving production of the same open reading 
frame. As described above, this analysis allows for comparison between promoter strength 
determined using either GFP or dsRED. For promoters with weak activity, we observed a 1:1 
correspondence between apparent promoter strength measured using GFP and dsRed. For the 
strongest promoter tested, proD, we saw decreased relative activity when driving production of 
dsRed (Figure 4.7). As described previously, this could result from altered transcription 
indicating the insulation is insufficient or could arise because a process other than transcription 
becomes limiting for this elevated level of dsRed production. Interestingly, for all of the 
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uninsulated promoters tested, the relative promoter strength was maintained when driving 
production of dsRed. 
 
 
Figure 4.7. Aparent promoter activity when driving production of the protein 
dsRed. Promoter strength was measured for a set of either insulated (left) or uninsulated 
(right) promoters each driving the production of either GFP (x-axis) or dsRed (y-axis). 
For each open reading frame, aparent synthesis rates were determined by measuring 
florescence as shown in Equation 4.1. To aid in comparison between open reading 
frames, each synthesis rate was normalized to that of j23101 driving production of the 
same open reading frame. 
Promoter activity from a chromosomal locus 
In the experiments described so far, the promoters were carried on the medium copy number 
plasmid, pSB3C5, which bears a p15A origin of replication (Shetty et al., 2008). To further 
investigate the efficacy and predictability of these promoters, we moved the insulated proA, 
proB, proC, proD promoters, the uninsulated j23113, j23150, j23151, j23101 promoters, and a 
nonfluorescent control cassette to a chromosomal locus. The promoter-RBS-GFP-terminator 
construct was fused to a kanamycin resistance marker using PCR and the entire cassette was site-
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specifically recombined at the chromosomal tonB locus using recombineering techniques (see 
Materials and Methods) (Datta et al., 2006). 
Promoter activities from the tonB locus were measured using the fluorescent signal from the 
encoded GFP. Figure 4.8A shows the synthesis rates for each promoter. As expected, the 
absolute activity of each promoter was decreased when placed on the chromosome, presumably a 
result of decreased copy number. To allow for comparison of promoter strength between these 
two loci, the synthesis rate was converted to relative promoter units by normalization to the 
synthesis rate of proD (Equation 4.2). As described previously, this normalization masks the 
effects of copy number (Kelly et al., 2009). For each promoter, Figure 4.8B shows the relative 
promoter strength measured from the plasmid vs. the relative promoter strength measured from 
the chromosome. Interestingly, both sets of promoters exhibited an approximately 1:1 
correspondence in relative promoter activity at the chromosomal versus plasmid loci. 
  




Figure 4.8. Promoter activity from the chromosomal tonB locus. Promoters driving 
the expression of GFP were recombined onto the chromosome downstream of the tonB 
locus and the activity of the promoter was measured using fluorescence from the GFP 
gene. (A) GFP synthesis rate per cell from the tonB locus (c) or from the plasmid 
pSB3C5 (p). (B) Plots correlating the relative promoter activity either from the plasmid, 
pSB3C5 or the chromosome (at the tonB locus) for the insulated promoters (left) or the 
uninsulted promoters (right). 
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Discussion 
We have generated a library of constitutive bacterial promoters whose activity spans two orders 
of magnitude. These promoters contain sequences extending beyond the core polymerase binding 
region in both the 5´ and 3´ direction. By testing these promoters in a variety of sequence 
contexts, both chromosomal and plasmid-based, we have demonstrated that their activity is 
highly predictable with minimal effects from the surround genetic context. As such, the 
promoter’s activity measured in one context should be predictive of their function in a new 
context. Such functional composition should facilitate the engineering of biological systems. 
Our promoters are 160 bp in length, substantially larger than the minimal 51 bp promoters we 
have used for comparison. Although our promoters were less affected by the stimulatory and 
repressive effects of many sequence elements, it should be noted that some long-range regulation 
by transcription-factors may still affect these promoters. Given that such regulation is probably 
unavoidable with any amount of insulation, we compromised on a promoter size that shows 
improved context-independent behavior but remained small enough to be easily incorporated 
into genetic pathways. 
To decrease the possibility of the initially transcribed sequence altering promoter activity, our 
promoters include insulation extending beyond the transcriptional start site. This design results in 
several desirable features. First, unlike a minimal promoter, the transcription initiation site is 
clearly defined and invariant for the library irrespective of the downstream gene. Second, the 
defined 5´ untranslated sequence may facilitate the measurement and prediction of mRNA 
degradation rates for transcripts generated by these promoters. Lastly, because some prediction 
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algorithms for the strength of ribosome binding sites make use of surrounding sequence 
information, the invariant 5´ termini could improve the prediction of translational initiation rates 
(Salis et al., 2009).  
Although the 5´ termini encoded by our promoters has no effect on the resulting protein product, 
it will prohibit some applications. For example, natural and synthetic riboregulators located in 
the 5´ untranslated region allow for small-molecule control of translation (Winkler et al., 2002; 
Suess et al., 2004). The initially transcribed sequence generated by our promoters may be 
incompatible with such devices. For most applications, however, this 5´ sequence should pose no 
problem, as it affects neither the ribosome binding site nor the resultant protein product. 
We find that our insulated promoters are not perturbed by the introduction of stimulatory UP 
sequences 5´ of the promoter, or repressive “anti” sequences 3´ of the promoter. The UP 
sequence likely has no effect on these promoters because the extended insulation sequence 
precludes the polymerase from simultaneously forming favorable contacts with the core 
promoter and the UP sequence. By contrast, we observe strong activation of the weak minimal 
promoters by the UP sequence, suggesting that this sequence improves polymerase recruitment. 
For the strongest minimal promoter, the UP element had no effect and thus some process after 
polymerase recruitment is probably rate limiting. Such non-uniform effects for the minimal 
promoters limits their predictably in different sequence contexts. 
The anti sequence also affects the minimal promoters non-uniformly, down regulating the 
strongest promoter 2-fold but not affecting other promoters. For these unaffected promoters, a 
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process other than promoter escape (e.g. polymerase binding) is likely to be rate limiting. 
Interestingly, none of the insulated promoters are affected by the anti sequence, which causes 
transcriptional repression in a σ70-dependent fashion (Chan and Gross, 2001). It seems likely that 
the insulated promoters are unaffected, because the σ subunit dissociates from the core 
polymerase before encountering the anti sequence. 
In one instance, we found that the insulated promoters predictably drive production of a different 
gene product (Gemini), whereas the minimal promoters did not. Again, it appears that for the 
strongest uninsulated promoters, the initially transcribed sequence strongly affects promoter 
activity. The fact that even the strongest insulated promoter was not affected implies that 
transcription is rate limiting for production of GFP and Gemini. However, for the strongest 
insulated promoter driving dsRed production, we observed decreased apparent promoter activity. 
In this instance, translation or chaperone-dependent folding may have become limiting for 
protein synthesis. In such cases, one can no longer assume that protein production will depend 
linearly on promoter activity and instead, a more complicated transfer function to correlate 
promoter activity to protein production will have to be determined. When a process other than 
transcription becomes rate-limiting for production, no amount of insulation will mitigate non-
linear effects. 
Achieving proper steady-state protein levels can be accomplished using libraries of constitutive 
promoters as described here, or by using promoters whose activity can be titrated using a small-
molecule inducer (Lee and Keasling, 2005; Canton et al., 2008). Inducible systems are 
particularly appealing for applications in which only one gene product must be regulated and for 
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those systems in which it is advantageous to regulate gene activity dynamically (e.g. induction 
and repression of essential or toxic genes). The use of insulation sequences to decrease context-
dependent promoter activity could easily be extended to regulated promoters. 
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Materials and Methods 
Promoter sequences 
The sequences for the promoters used in this work are listed below. The scar sequences 
generated by standard BioBrick assemblies are in lowercase font, and the expected start site is 
underlined. For each promoter set (insulted or minimal), only the -35 and -10 hexamers (shown 
in large, bold font) vary between library members (Table 4.1). 





j23101 (minimal promoter) 
ttctagagTTTACAGCTAGCTCAGTCCTAGGTATAATGCTAGCtactagag 
 







proA tttacg taggct 0.030 
proB tttacg taatat 0.119 
proC tttacg tatgat 0.278 
proD tttacg tataat 1.000 
pro1 tttacg gtatct 0.009 
pro2 gcggtg tataat 0.017 
pro3 tttacg gaggat 0.017 
pro4 tttacg gatgat 0.033 
pro5 tttacg taggat 0.050 
pro6 tttacg taaaat 0.193 
j23113 ctgatg gattat 0.005 
j23150 tttacg tattat 0.077 
j23151 ttgatg acaatg 0.192 
j23101 tttaca tattat 0.345 
  
 Davis | 123 
 
Plasmids and strains 
Experiments with plasmid-borne reporters were performed in E. coli strain DH5α (F-, λ-, 
φ80lacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, 
thi-1, gyrA96, relA1), whereas experiments with chromosomally encoded reporters were 
performed in E. coli strain W3110 (F
-
, λ-, IN(rrnD-rrnE), rph-1). With the exception of assays 
for promoter function on the chromosome, all experiments utilized plasmid pSB3C5 and the 
construct of interest was cloned via standard procedures between the BioBrick cloning sites 
(Shetty et al., 2008). Each construct contained the Bba_B0032 ribosome binding site and the 
Bba_B0015 transcriptional terminator. The sequences for the fluorescent reporter proteins, GFP 
(Bba_E0040), dsRed (Bba_E1010), Gemini (Bba_E0051), the ribosome binding site 
(Bba_B0032) and the terminator (Bba_B0015) can be found at the Registry of Standard 
Biological Parts (www.partsregistry.org). 
Plasmid constructs contained the following elements: promoter-TACTAGAG-B0032-TACTAG-
ORF(dsRed, GFP, Gemini)-TACTAGAG-B0015, where the ORF was exchanged using standard 
PCR-based techniques. For chromosomal insertions, test constructs were fused to a kanamycin 
resistance marker (Bba_P1003, Registry of Standard Biological Parts, www.partsregistry.org) 
using SOEing PCR (Horton et al., 1990). PCR products were recombined onto the chromosome 
using the λ-red recombination system, encoded on the plasmid vector pSIM5, as described 
previously (Datta et al., 2006). After verification of successful cassette insertion by sequencing, 
pSIM5 was cured from the strain. For the tonB locus, the SOEing primers used are as follows 
(with homology to the locus listed in bold). 














The UP sequence (GAGAAAATTATTTTAAATTTCCTC) was introduced upstream of the 
promoter constructs using standard techniques resulting in a BioBrick scar (ACTAGA) between 
the UP sequence and the promoter. The anti sequence (ATCCGGAATCCTCTGGATCCTC) was 
introduced in a similar fashion resulting in constructs of the form: promoter-TACTAGAG-anti-
B0032-TACTAG-GFP-TACTAGAG-B0015. 
Two strains were used to control for cellular auto-fluorescence. DH5α transformed with pSB3C5 
was used as a negative control for experiments using plasmid-based constructs. For experiments 
testing promoter function from the tonB locus, the kanamycin resistance marker with no reporter 
construct was recombined downstream of the tonB locus using primers tonB-BioBrickPrefix-
fwd, P1003-tonB-rev. 
Promoter activity assays 
All GFP, dsRed, and Gemini based assays were performed and analyzed as described (Kelly et 
al., 2009) with the minor modifications listed below. Individual test colonies along with a 
negative control strain were picked in triplicate and grown overnight in 5 cm culture tubes in LB 
broth supplemented with 35 µg/mL chloramphenicol (for experiments using pSB3C5) or 10 
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µg/mL kanamycin (for experiments using chromosomal insertions). Cultures were then diluted 
100-fold into M9 media (M9 salts, 1 mM thiamine hydrochloride, 0.2% casamino acids, 2 mM 
MgSO4, 0.1 mM CaCl2, 0.4% glycerol) supplemented with appropriate antibiotics and grown at 
37 °C for four hours. Cultures were aliquoted (150 µL) into a 96-well plate (Greiner Bio-One) in 
which OD (600 nm) and fluorescence (GFP, Gemini: excitation 467 nm, emission 511 nm; 
dsRed: excitation 560 nm, emission 590 nm) were read using a SpectraMax M5 fluorescence 
plate reader (Molecular Devices). Cultures were allowed to continue growing in tubes for an 
additional 1.25 hours at 37 °C at which time OD600 and fluorescence were read again. For each 
sample, the change in fluorescence signal between the two readings was divided by the average 
OD600. This measure of promoter activity (per cell synthesis rate) was corrected for background 
auto-fluorescence by subtracting the per cell synthesis rate of the negative control. The corrected 
synthesis rate was then normalized to the average synthesis rate of the reference promoter, proD, 
resulting in relative promoter units (RPUD) (Kelly et al., 2009). The average synthesis rate of the 
minimal promoter, j23101, was used to normalize promoter activity in experiments using dsRed 
as proD displayed diminished activity with this open reading frame. Errors bars shown in all 
figures represent the standard deviation of triplicate measurements. 
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Abstract 
Targeted degradation provides an effective method to study the function of protein products and 
has applications in biotechnology. One promising approach to control intracellular degradation 
uses adaptor proteins to specifically target substrates bearing genetically encoded degradation 
tags. We have developed a degradation system using an engineered split adaptor in which 
assembly and thus adaptor function is dependent on rapamycin, a small-molecule. This 
degradation system does not require modification of endogenous proteases, functions robustly 
over a wide range of adaptor concentrations, and does not require new synthesis of adaptor or 
protease molecules to induce degradation. In addition, we identify new C-terminal degradation 
tags that exhibit varied levels of rapamycin-dependent and rapamycin-independent degradation 
by the ClpXP protease. Together, these reagents should prove useful in controlling protein 
degradation in bacteria. 
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Introduction 
Targeted proteolysis provides one mechanism to control intracellular protein levels in a dynamic 
fashion and has applications in basic science and biological engineering (Banaszynski et al., 
2006; McGinness et al., 2006; Griffith and Grossman, 2008; Moore et al., 2008; Davis et al., 
2009; Taxis et al., 2009). Indeed, the perturbation of protein stability has proven critical in the 
generation of synthetic cellular circuits (Elowitz and Leibler, 2000; Wong et al., 2007; Stricker 
et al., 2008). Controlled degradation could also be applied to metabolic engineering. For 
example, after growing cells to a critical density, essential enzymes catalyzing off-pathway 
reactions could be targeted for degradation, directing metabolite flux toward the desired product 
more efficiently. Targeted degradation has also been utilized to investigate loss of function 
phenotypes (Griffith and Grossman, 2008), providing an alternative and often complementary 
mechanism to transcriptional knockdowns. A degradation approach is particularly valuable when 
pre-existing proteins are inherently long-lived, as terminating the synthesis of such molecules 
results in relatively slow elimination of the gene product (Guzman et al., 1995; Rappleye and 
Roth, 1997; Fire et al., 1998; Ji et al., 2001; Knight and Shokat, 2007). In these cases, proteins 
are diluted via cell growth and division, often requiring many cell cycles to reach levels that are 
low enough to eliminate function. During this time period, cells may up-regulate compensatory 
pathways or acquire suppressor mutations, often obscuring the phenotype of the perturbation.  
When combined with temporal control, targeted proteolysis can be used to investigate essential 
proteins under control of their native transcriptional and translational control elements. 
Temperature-sensitive (ts) alleles share many of the advantages of targeted proteolysis, but tight 
ts-alleles are difficult to isolate for many gene products. Furthermore, a temperature shift can 
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result in unintended changes in cellular physiology, complicating interpretation. In yeast, for 
example, shifting the temperature form 25 to 37 °C alters the expression of nearly 1000 genes, 
half of which have unknown function (Causton et al., 2001). Small-molecule 
inhibitors/activators allow perturbations of native gene function with rapid temporal control 
under many environmental conditions (Stockwell, 2000). Unfortunately, the identification of 
highly specific, cell-permeable inhibitors is not trivial, and conclusively ruling out “off-target” 
effects is a substantial challenge. 
In Escherchia coli and most other bacteria, processive intracellular proteolysis is mediated by a 
group of energy-dependent AAA+ proteases, including ClpXP (Baker and Sauer, 2006). The 
ClpXP enzyme degrades substrates via a multi-step process, which begins with the recognition of 
short peptide sequences (referred to as degradation tags or degrons), which are exposed in the 
native protein substrate (Flynn et al., 2003; Sauer et al., 2004). Once bound, processive cycles of 
ATP hydrolysis in ClpX drive translocation of the degradation tag through a narrow axial pore 
(Sousa et al., 2000; Kenniston et al., 2003; Glynn et al., 2009). Successive pulling events 
eventually result in global substrate unfolding, allowing translocation of the denatured 
polypeptide into the lumen of ClpP, where it is cleaved into short peptide fragments (Joshi et al., 
2004; Kenniston et al., 2004). ClpX can unfold proteins with a wide range of thermodynamic 
stabilities and appears to have little sequence specificity in terms of substrate translocation 
(Kenniston et al., 2005; Barkow et al., 2009). Thus, substrate selectivity is determined by the 
efficiency of the initial binding event, which can be modulated by accessory factors called 
adaptors. For example, the SspB adaptor improves ClpXP degradation of ssrA-tagged substrates 
by binding to the protease and to a portion of the ssrA tag (AANDENYALAA), thereby 
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increasing the effective concentration of the substrate relative to the enzyme (Levchenko et al., 
2000; Wah et al., 2003; Bolon et al., 2004a; McGinness et al., 2007). Indeed, using synthetic 
degradation components, we found that tethering alone is sufficient for efficient substrate 
delivery by SspB (Davis et al., 2009). 
Adaptor proteins have proven useful in engineering controlled degradation systems. For 
example, McGinness et al. (2006) showed that ClpXP degradation became almost entirely 
dependent on SspB when the C-terminal residues of the ssrA tag were mutated from LAA to 
DAS. Importantly, model substrates bearing DAS tags were selectively degraded in cells when 
transcription of the adaptor from a lac promotor was induced using IPTG (McGinness et al., 
2006; Wilson et al., 2007; Griffith and Grossman, 2008). Combining a genetically encoded 
degradation tag and small-molecule inducer has many of the advantages of classical genetics and 
pharmacology and can be applied to almost any protein target with temporal control provided by 
the presence or absence of the small molecule.  
In the work reported here, we have engineered and characterized a new targeted degradation 
system in which the assembly and thus activity of a split adaptor is controlled by the small-
molecule rapamycin. Experiments with purified components in vitro and with model substrates 
in E. coli show that ClpXP degradation of appropriately tagged proteins can be efficiently 
controlled in a rapamycin-dependent manner without the need for new protein synthesis. This 
system is simple, generally applicable, and requires few genomic modifications. Moreover, it 
should be relatively straightforward to port to other ClpXP-containing bacteria such as 
Caulobacter crescentus and Bacillus subtilis (Chien et al., 2007b; Griffith and Grossman, 2008). 
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Results 
Rapamycin-dependent control of adaptor function in vitro 
For initial studies, we used wild-type ClpXP protease, substrates bearing a DAS+4 ssrA tag 
(AANDENYSENYADAS; McGinness et al., 2006), and split the functionally important portions 
of SspB into two components. The first adaptor part consisted of the SspB core domain 
(SspB
CORE
), which binds the ssrA tag, fused to an FRB domain (Figure 5.1, SspB
CORE
-FRB). The 
second part contained the FKBP12 protein fused to the SspB ClpX-binding tail (Figure 5.1 
FKBP12-SspB
XB
). Addition of rapamycin mediates dimerization of FRB and FKB12 (Chen et 




-FRB constructs exist as physically separate and 
therefore nonfunctional components in absence of rapamycin but should assemble into a 
potentially functional adaptor in the presence of rapamycin (Figure 5.1). 
 
Figure 5.1. Schematic of the split adaptor. The SspB core domain (residues 1-113) was 
split from the ClpX-binding tail (SspB
XB
, residues 139-156). SspB
CORE
 was fused to FRB 
and FKBP12 was fused to SspB
XB
. Addition of rapamycin reconstitutes a complete 
adaptor. 
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To test for rapamycin-dependent degradation, we incubated 0.3 µM ClpX, 0.9 µM ClpP, 5 µM 
FKBP12-SspB
XB
, 5 µM SspB
CORE
-FRB and an ATP regenerating system at 30 °C and initiated 
the reaction by addition of 2 µM GFP-DAS+4 substrate in the presence or absence of rapamycin 





(Figure 5.2A). No degradation was detected in the absence of rapamycin. To assay assembly 
kinetics of the degradation complex, we preincubated substrate, ClpX, ClpP, and the adapter 
components and monitored the degradation of GFP-DAS+4 before and after addition of 
rapamycin (Figure 5.2B). A steady-state rate of degradation was reached within the dead-time of 
the experiment (~20 s), demonstrating that formation of the multi-component degradation 
complex is rapid. 
 
Figure 5.2. Rapamycin-dependent degradation. (A) Incubation of GFP-DAS+4 (2 
µM), ClpX
 




-FRB (5 µM), 





degradation was observed in the absence of rapamycin. (B) Addition of rapamycin 
resulted in rapid assembly of the degradation complex. GFP-DAS+4 (2 µM), ClpX
WT 




-FRB (5 µM) were 
preincubated at 30 °C. Rapamycin (8 µM) was added at the time indicated by the arrow. 
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Next, we varied the concentration of each adaptor component and assayed degradation. First, we 
titrated equal quantities of the two adaptor components against fixed concentrations of protease 
and substrate. In this experiment, degradation increased in a hyperbolic fashion with an apparent 
binding constant of 0.51 µM (Figure 5.3A), consistent with the previously reported affinity 
between SspB and ClpX (Bolon et al., 2004b). We also determined the efficiency of substrate 
degradation in experiments in which the protease, substrate, and SspB
CORE
-FRB (5 µM) 
concentrations were fixed and the concentration of FKBP12-SspB
XB
 was varied (Figure 5.3B). 
Again, degradation increased in a roughly hyperbolic fashion. By contrast, when the 
concentration of FKBP12-SspB
XB
 was fixed and SspB
CORE
-FRB was varied, degradation 
increased initially and then was inhibited at high concentrations of SspB
CORE
-FRB (Figure 5.3C). 
This inhibition probably results from substrate competition between free SspB
CORE
-FRB and the 
limited number of active delivery complexes (SspB
CORE
-FRB•rapamycin•FKBP12-SspBXB). 
Finally, we measured the rapamycin and substrate dependence of ClpXP degradation in the 
presence of 5 µM FKBP12-SspB
XB
 and 5 µM SspB
CORE
-FRB (Figure 5.3D). Rapamycin 
strongly enhanced degradation, even at high substrate concentrations. Indeed, in the presence of 





DAS+4 degradation demonstrated that the split adaptor delivers substrates to ClpXP efficiently, 
even at relatively low substrate concentrations. Taken together, these results indicate that most 
enzyme and adaptor concentration regimes result in robust rapamycin-dependent degradation.  
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Figure 5.3. Dependence of GFP-DAS+4 degradation on adaptor or substrate concentration. 





-FRB. The solid line is a hyperbolic fit with an apparent binding constant of 0.51 µM. 
(B) Degradation in the presence of a fixed concentration of SspB
CORE
-FRB (5 µM) and 
increasing FKBP12-SspB
XB
. The solid line is a hyperbolic fit. (C) Degradation with a fixed 
concentration of FKBP12-SspB
XB
 (5 µM) and increasing concentrations of SspB
CORE
-FRB. Data 
were fit to the equation, 𝑟𝑎𝑡𝑒 =  
𝑘1 𝑆𝑠𝑝𝐵
𝐶𝑂𝑅𝐸 −𝐹𝑅𝐵 
(𝐾𝑎+  𝑆𝑠𝑝𝐵𝐶𝑂𝑅𝐸 −𝐹𝑅𝐵 + 
 𝑆𝑠𝑝𝐵 𝐶𝑂𝑅𝐸 −𝐹𝑅𝐵  
2
𝐾𝑏
  (D) Substrate dependence 
of degradation in the presence of SspB
CORE
-FRB (5 µM) and FKBP12-SspB
XB
 (5 µM). Fitting 




. In all panels, the concentrations of ClpX6
 
and ClpP14 were 0.3 and 0.9 µM, respectively. In 
panels A-C and the “plus rapamycin” experiment of panel D, the rapamcyin concentration was 
12 µM. In panels A-C, the GFP-DAS+4 concentration was 2 µM. 
Controlled degradation of a transcriptional repressor 
Given the promising results in vitro, we developed an assay for rapamycin-dependent 
degradation in vivo. To prevent uncontrolled substrate delivery and degradation, the sspB gene 
was deleted from the chromosome of E. coli strain W3110. Next, we introduced a DAS+4 tag at 
the C-terminus of the lacI transcriptional repressor, using a scarless λ-red based recombination 
technique (see Materials and Methods). This strain was transformed with a plasmid (pJD427) 
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We expected LacI-DAS+4 to repress lacZ transcription and thus production of β-galactasidase in 
the absence of rapamycin (Figure 5.4A), with addition of rapamcycin resulting in LacI-DAS+4 
degradation and thus lacZ induction, which could be measured by RT-qPCR or by Miller assays 
for β-galactasidase activity (Miller, 1972; VanGuilder et al., 2008; Clarkson et al., 2010). 
LacI-DAS+4 exhibited rapamycin-dependent degradation in vitro (Figure 5.4B). To assay for 
degradation in vivo, we grew strain JD704 (W3110 lacI-DAS+4, sspB
-
, pJD427) in M9 media at 
37 °C to mid-log phase and added 10 µM rapamycin, 5 mM IPTG as a positive control for 
induction, or an equal volume of DMSO (the solvent for rapamycin and IPTG). At different 
times, samples were taken and β-galactosidase activity was assayed and normalized to OD600. 
Addition of either rapamycin or IPTG led to increased β-galactosidase activity (Figure 5.4C). By 
contrast, addition of DMSO had no effect. Importantly, otherwise identical strains lacking the 
LacI degradation tag showed no rapamycin response (Figure 5.4C). Rapamycin-dependent 
induction of lacZ mRNA levels was also observed by RT-qPCR, confirming a direct effect on 
transcription (Fig 5.4D). Compared with IPTG induction, rapamycin induction showed a lag and 
somewhat slower kinetics (Figure 5.4C, D). This lag may result from slow diffusion of the drug 
into the cell or from relatively slow ClpXP-mediated degradation. We note, however, that 
rapamycin-dependent induction still occurred on the time scale of many biological processes. 
Compared to a strain containing wild-type LacI, the strain bearing LacI-DAS+4 exhibited 
increased β-galactasidase activity, even in the absence of rapamycin (Figure 5.4C). In principle, 
this derepression could arise for several reasons. For example, LacI-DAS+4 may be degraded in 
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the absence of adaptor-mediated tethering in vivo, either by ClpXP or another cellular protease. 
Alternatively, the C-terminal DAS+4 tag, either alone or bound to SspB
CORE
-FRB might reduce 
the ability of LacI to repress transcription. Finally, introduction of the DAS+4 tag might disrupt 
the lac operon at the DNA level. To help determine the contribution of each of these alternatives, 
we added rapamycin or a mock control (DMSO), waited 1 h, and assayed β-galactasidase in 
strains containing wild-type LacI, LacI-DAS+4, or LacI-LDD+4, a tag that prevents ClpXP 
degradation (McGinness et al., 2006) (Figure 5.4E). To control for adaptor effects, strains were 
also grown in the presence or absence of pJD427. In the absence of rapamycin and adaptor, 
introduction of the DAS+4 and LDD+4 tags led to small increases in β-galactasidase levels, with 
a somewhat larger effect for DAS+4. With adaptor but no rapamycin, the β-galactasidase 
activities of LDD+4 and DAS+4 strains increased, suggesting that additional derepression may 
arise from binding of the SspB
CORE
-FRB adaptor component to the tag. Finally, in presence of 
rapamycin plus adaptor, β-galactasidase levels increased substantially in the lacI-DAS+4 strain 
but did not increase in the lacI-LDD+4 strain. This result confirms that LacI-LDD+4 is not 
degraded by ClpXP. 
 
  




Figure 5.4. Degradation of LacI-DAS+4. (A) Assay strains contained an sspB deletion 
and a DAS+4 tag at the C-terminus of LacI, which represses transcription of lacZ. 
Production of the split-adaptor components is mediated by plasmid-borne constitutive 
promoters. (B) Time course of degradation of LacI-DAS+4 (5 µM) by FKBP12-
(ClpX
ΔN
)3 (0.3 µM), ClpP (0.9 µM), SspB
CORE
-FRB (0.6 µM), and 1 µM rapamycin. (C) 
β-galactosidase activities were measured in strains containing LacI-DAS+4 following 
addition of rapamycin (10 µM), IPTG (5 mM), or DMSO. An isogenic LacI strain 
showed no response to rapamycin. (D) Concentrations of lacZ mRNA were measured by 
RT-qPCR and normalized to total RNA following addition of rapamycin (10 µM), IPTG 
(5 mM), or DMSO. (E) β-galactosidase activities were assayed 1 h after rapamycin or 
DMSO addition in strains containing LacI, LacI-DAS+4, or LacI-LDD+4 with or without 
the plasmid encoding the split-adaptor components. 
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Identification of tags that show minimal degradation without rapamycin 
In an attempt to identify ssrA-tag variants that showed minimal degradation in the absence of 
rapamcyin, randomization and recombination methods were used to alter the three C-terminal 
residues of the tagged LacI protein. This procedure inserted a kanamycin-resistance marker 
downstream of the lacI gene in the chromosome. For comparison, otherwise isogenic strains 
bearing DAS+4 and LDD+4 tags were also constructed. We screened 92 clones from the 
randomized library in the presence of the split-adaptor components (see Fig. 5.S3 for selected 
results, Supplementary Materials). Based on these results, we focused on two clones, with C-
terminal sequences RCN and KHG, that exhibited β-galactosidase activity equivalent to the 
LDD+4 strain without rapamcyin but increased activity upon addition of rapamycin (Figure 5.5). 
Interestingly, neither of these tag sequences resembles those found in good ClpXP substrates. 
Moreover, in both cases, addition of rapamycin resulted in lower β-galactosidase levels than 
observed in the isogenic DAS+4 strain (Figure 5.5). These tags may be useful in cases where the 
limited rapamycin-independent degradation observed for the DAS+4 tag inhibits function. 
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Figure 5.5. New degradation tags. β-galactosidase activities normalized to cell density 
were assayed in strains containing LacI variants with RCN, KHG, DAS, or LDD at the C-
terminus before or 90 min after addition of DMSO or rapamycin. 
Use of an orthogonal adaptor 
The experiments described above were performed in sspB-null strains to prevent uncontrolled 
delivery of DAS+4 substrates to ClpXP. To extend the potential applicability of the split-adaptor 
system, we investigated whether altering the adaptor and degradation tag would allow 
rapamycin-dependent degradation without needing to remove E. coli SspB. Previous studies 
revealed that the C. crescentus ssrA tag was bound well by the cognate C. crescentus SspB but 
contained a sequence change known to dramatically weaken binding by E. coli SspB (Flynn et 
al., 2001; Chien et al., 2007a; Griffith and Grossman, 2008). Moreover, substrates fused to a C. 
crescentus ssrA tag were degraded E. coli ClpXP. In initial experiments, we found that a protein 
consisting of residues 1-125 of C. crescentus SspB fused to FRB was actually a tethering-
dependent substrate for ClpXP degradation but removal of the first 10 residues eliminated this 
proteolytic susceptibility (Figure 5.6A).  
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Using the stabilized C. crescentus fusion protein (ccSspBΔ10-FRB) and FKBP12-SspBXB, 
ClpXP degraded GFP bearing a ccDAS+4 tag (ADNDNFAEESENYADAS) in a rapamcyin-
dependent fashion (Fig 5.6B). Importantly, no degradation of this substrate was observed when 
E. coli SspB
 
was substituted for the split-adaptor components (Fig 5.6B). These results suggest 
that use of the ccDAS+4 tag and appropriate split-adaptor components should allow rapamycin-
dependent degradation in sspB
+
 E. coli strains. 
 
 
Figure 5.6. Degradation assays using C. crescentus SspB-FRB fusions. (A) A fusion 
protein consisting of residues 1-125 of C. crescentus SspB and FRB (4 µM) was 
degraded in a rapamycin-dependent fashion by FKBP12-(ClpX
ΔN
)3 (0.3 µM) and ClpP 
(0.9 µM) as assayed by SDS-PAGE. Removing the 10 N-terminal residues of this fusion 
protein eliminated detectable degradation. (B) GFP-ccDAS+4 (2 µM) was degraded in a 
rapamycin-dependent reaction by ClpX (0.3 µM), ClpP (0.9 µM), ccSspBΔ10-FRB (5 
µM), and FKBP12-SspB
XB 
(5 µM). No degradation of GFP-ccDAS+4 was observed 
when E. coli SspB (5 µM) was substituted for the split-adaptor components. 




Adaptor proteins must be capable of binding substrates and also tethering the bound substrate to 
a protease (Fig. 5.7A). In the wild-type SspB adaptor, these functions reside in a core substrate-
binding domain and an unstructured C-terminal tail, respectively (Wah et al., 2003; Bolon et al., 
2004a; Bolon et al., 2004b; McGinness et al., 2007). The results presented here show that these 
adaptor functions can reside in separate fusion proteins, with adaptor assembly and function 
depending on the presence of rapamycin, which mediates dimerization of the FRB and FKBP12 
domains of the split-adaptor components (Fig. 5.7B). This split-adaptor system allows 
rapamycin-dependent degradation of appropriately tagged substrates by the wild-type ClpXP 
protease both in vitro and in vivo. 
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Figure 5.7. Substrate-delivery strategies. (A) SspB-mediated delivery of a DAS+4 
tagged substrate to wild-type ClpXP. (B) Rapamycin-dependent delivery of a DAS+4 





FRB. (C) Rapamycin-dependent delivery of a λO-substrate-FRB molecule to FKBP12-
(ClpX
ΔN
)3/ClpP. (D) Rapamycin-dependent SspB
CORE
-FRB delivery of a substrate to 
FKBP12-(ClpX
ΔN
)3/ClpP. Tagged substrates are colored blue. Rapamycin is depicted as a 
red star. The substrate-binding domain of SspB is shown as an orange oval. The ClpX-
binding tail of SspB is shown as an orange circle. FRB is shown as a black oval. FKBP12 
is shown as a larger gray oval. The N-domain of ClpX is shown as an open hexagon. 
In previous studies, we investigated different strategies for rapamycin-controlled degradation 
(Davis et al., 2009). In one system (Figure 5.7C), substrates bearing a weak N-terminal degron 
were fused to FRB, and FKBP12 was fused to three covalently linked subunits of ClpX lacking 
the N-domain (FKBP12-(ClpX
ΔN
)3). This system requires modifications of both termini of the 
substrate and also relies on a highly engineered variant of ClpXP. A second system (Fig. 5.7D), 
used the same FKBP12-(ClpX
ΔN
)3 enzyme and depended on a SspB
CORE
-FRB fusion protein to 
deliver DAS+4 tagged substrates in a rapamycin-dependent fashion. Use of FKBP12-(ClpX
ΔN
)3 
 Davis | 148 
 
systems in vivo was complicated by the requirement to use clpX
–
 strains to avoid subunit mixing 
and difficulties in maintaining functional FKBP12-(ClpX
ΔN
)3 genes in recA
+
 cells (Figure 5.S1, 
Supplemental Material). Moreover, use of monomeric FKPB12-ClpX
ΔN
, which can be 
maintained in recA
+
 cells, required nearly perfect stoichiometry between the protease and the 
SspB
CORE
-FRB adaptor for efficient substrate degradation (Figure 5.S2, Supplemental Material). 
Our split-adaptor system retains the advantages of small-molecule control but utilizes the wild-
type endogenous ClpXP protease. This feature eliminates problems associated with using the 
FKBP12-(ClpX
ΔN
)3 enzyme for targeted intracellular degradation and also allows normal ClpXP 
degradation of natural substrates that require the ClpX N-domain for recognition, degradation, 
and homeostasis. ClpXP is present is many bacteria, and E. coli SspB has been shown to deliver 
substrates to ClpX homologs from C. crescentus and B. subtilis (Chien et al., 2007a; Griffith and 
Grossman, 2008). Porting the split-adaptor system to these or other bacterial species may be as 
simple as introducing a plasmid driving roughly comparable production of the two adaptor 
components and adding an appropriate degradation tag to the protein target of interest. We found 
that a split-adaptor system using some parts of C. crescentus SspB and modified C. crescentus 
degradation tags worked well in vitro, in a manner that was not affected by the presence of E. 
coli SspB. This ability to interchange modular components should prove useful in optimizing 
split-adaptor systems with altered degradation-tag specificity. 
We have shown that modification of the wild-type LacI repressor by addition of a C-terminal 
DAS+4 tag allows rapamcyin-dependent degradation and induction of -galactosidase 
expression. The kinetics of -galactosidase induction using rapamycin were slower than those 
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observed using IPTG, a small molecule that binds directly to LacI repressor and reduces its 
affinity for operator DNA ~1000-fold (Lewis et al., 1996; Falcon and Matthews, 2000; Wilson et 
al., 2007). Rapamycin may enter cells more slowly than IPTG, or the rate of rapamycin-mediated 
induction may be limited by other factors, such as the rate of repressor dissociation from the 
operator or the rate of ClpXP degradation. Importantly, however, similar final levels of -
galactosidase expression were observed for both small-molecule inducers. Other transcription 
factors may also be potential targets for rapamycin-dependent induction. For example, we found 
that modification of the tetracycline repressor (derived from transposon Tn10) with a C-terminal 
DAS+4 tag resulted in rapamycin-dependent ClpXP degradation in vitro (unpublished 
observations). 
The addition of any sequence, whether or not it mediates conditional degradation, has the 
potential to perturb normal protein function. For example, compared to wild-type lacI strains, we 
observed higher levels of basal β-galactasidase synthesis in strains in which the DAS+4 tag was 
appended to the C-terminus of LacI. Control experiments showed that some of this effect was 
caused by adaptor-independent degradation, some by degradation-independent binding of one of 
the split-adaptor components to the tag, and some by simple addition of a C-terminal extension. 
By screening a library of tag mutants, we identified sequences that exhibited reduced basal β-
galactasidase expression but still allowed rapamycin-dependent degradation, albeit to a lesser 
extent than observed for the DAS+4 tagged protein. 
Targeted degradation that relies on rapamycin-dependent assembly of split adaptors has many 
potential applications. Because this system does not require synthesis of new adaptor proteins 
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(McGinness et al., 2006; Griffith and Grossman, 2008), degradation could be initiated at the 
same time as inhibition of transcription or translation, allowing for faster clearance of  target 
proteins from the cell. Our system could also be used to target ribosomal proteins for 
degradation. Indeed, Moore et al. (2008) demonstrated that ClpXP could forcefully extract a 
ribosomal protein from an intact 50S particle in vitro. Split-adaptor degradation systems might 
allow similar experiments in vivo, helping to elucidate the physiological function of essential 
genes required for translation. 
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Materials and Methods 
Plasmids and strains 
GFP variants used in this study contained the sequence H6-IDDLG at the N-terminus in addition 
to the mutations S2R, S65G, S72A, and M78R. The sequences of the DAS+4, LDD+4, and 
ccDAS+4 tags were AANDENYSENYADAS, AANDENYSENYALDD, and 
ADNDNFAEESENYADAS, respectively. 
LacI degradation experiments were performed in E. coli strain W3110 sspB
–
 with the 
degradation tag (DAS+4 or LDD+4) introduced at the C-terminus of lacI as described below. 
Strains also contained pJD427, a pSB3C5-derived (www.partsregistry.org) plasmid, which 





 from the proB and proC promoters, respectively (Chapter 4 describes these promoters). 
For each split-adaptor gene, transcription was terminated using the Bba_B0011 element and 
translation was initiated using the Bba_B0032 ribosome-binding site (for descriptions of these 
sequences, see www.partsregistry.org). 
A library of degradation-tag variants fused to lacI was generated by amplifying lacI-DAS+4 
from a plasmid (pJD263) using degenerate primers to randomize the three C-terminal amino 
acids (see Table 5.1). This product was then cut with EcoRI and SpeI restriction enzymes and 
ligated in a 3-part reaction to a kanamycin marker, Bba_P1003 (www.partsregistry.org) and the 
vector pSB3C5. Transformation of E. coli ER2566 (New England Biolabs) with the ligation 
product resulted in ~6,000 clones. Sequencing of 10 clones from the library revealed a unique in-
frame C-terminal tag. Mini-prepped plasmid from the pooled library (~6,000 elements) was used 
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as a template in PCR to amplify lacI-XXX+4 fused to the kanamycin-resistance marker. The 
primers used in this reaction encoded 40 nucleotides of homology to sequences immediately 3´ 
of the lacI stop codon (see Table 5.1). Purified dsDNA from the PCR reaction was 
electroporated into W3110 sspB
–, which had been prepared for λ-red-mediated recombineering 
as described previously (Datta et al., 2006). After allowing cells to recover for 12 h at 30 °C, 
successful recombinants were selected by addition of kanamycin. Recombinants were pooled, 
grown at 37 °C to cure the pSIM5 recombineering plasmid, and transformed with pJD427, the 





were also recombined onto the chromosome and were used for the experiments described in 
Figure 5.4E. 
  





































Table 5.1. Recombineering primers. Residues underlined are used to form duplexes 
with the target sequence. Residues in upper-case font are homologous to a locus on the E. 
coli chromosome. Residues m were synthesized with a mixture of A and C at that 
position; positions with n were synthesized with a mixture of all bases. 
 
Scarless λ-red mediated chromosomal manipulation 
The λ-red-mediated recombineering machinery, which is encoded on the plasmid vector pSIM5, 
was used to integrate degradation tags onto the chromosome and to knock-out sspB (Datta et al., 
2006). As described in Chapter 1, scarless genomic manipulation was achieved by first 
introducing a cassette encoding both a selectable and counter-selectable marker. Successful 
recombinants were identified using the selectable marker, the entire cassette was then targeted 
for replacement, and recombinants were identified using the second counter-selectable marker. 
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Unlike previous methods, which relied on SacB or I-SceI for counter selection, we utilized a 
mutant variant of E. coli phenylalanine tRNA synthatase (mPheS), which incorporates ρ-
chlorophenylalanine (ρ-Cl-Phe) into cellular tRNA and proteins (Kast, 1994; Lalioti and Heath, 
2001; Cox et al., 2007; Griffith et al., 2009). Importantly, expression of mPheS results in cell 
death only in the presence of ρ-Cl-Phe. 
Our targeting cassette contained a kanamycin-resistance marker (Bba_P1003), with production 
of mPheS driven by a constitutive promoter, (Bba_J23116), and ribosome-binding site, 
(Bba_B0032; www.partsregistry.org). This cassette was PCR amplified from plasmid pJD141, 
using primers with 20 bp of homology to the cassette and 40 bp of homology to target either the 
sspB ORF (primers sspB-a, sspB-b, Table 5.1) or the 3´ terminus of lacI (primers lacI-a, lacI-b, 
Table 5.1). Plasmid DNA was removed by restriction digestion with DpnI, followed by gel 
purification of the PCR product.  
After induction of the λ-red recombination proteins by heat shock for 15 min at 42 °C, PCR 
products (100 ng) were electroporated into cells, which were then allowed to recover for 6 h at 
30 °C, before plating on LB/kanamycin (20 µg/mL) at 30 °C. Successful recombinants exhibited 
resistance to 20 µg/mL kanamycin and sensitivity to 16 mM ρ-Cl-Phe and were verified by 
colony-PCR. dsDNA cassettes bearing the desired insertion sequence (flanked by the same 40 bp 
overhangs described above) were prepared by PCR using primers sspB-ko-1, sspB-ko-2 
(generating sspB
–
) or lacI-DAS-1, lacI-DAS-2 (resulting in lacI-DAS+4). Cassettes were 
electroporated into cells prepared for recombination, and were allowed to recover at 30 °C for 6 
h before plating on YEG-agar/16 mM ρ-Cl-Phe at 30 °C (YEG-agar consists of 0.5% yeast 
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extract, 1% NaCl, 0.4% glucose, 1.5 % agar). Successful replacement of the mPheS-kan
R
 
cassette was verified by PCR amplification and sequencing of the region of interest. pSIM5 was 
cured from the cells via serial dilution and growth at 30 °C under non-selective conditions.  
Most ρ-Cl-Phe resistant colonies contained the insertion of interest. Often, sequencing revealed 
that the encoded mPheS no longer carried the mutation required for incorporation of ρ-Cl-Phe. 
These revertants were only observed after induction of the λ-red recombination system and 
probably result from recombination between the endogenous wild-type copy of Phe and the 
mPheS mutant. 
Protein purification 
ClpX, ClpP, SspB, GFP-DAS+4, and GFP-ccDAS+4 were expressed and purified as described 
(McGinness et al., 2006; Davis et al., 2009; Shin et al., 2009). FKBP12-SspB
XB
 (which contains 
a N-terminal thrombin-cleavable His6 tag) was expressed from a pET28 vector in E. coli BLR 
(F
–




), λ(DE3), recA–). Cells were grown at room temperature 
grown in 1.5xYT broth (1.3 % tryptone, 0.75 % yeast extract, and 0.75 % NaCl, [pH 7.0]) to 
OD600 0.7, induced with 1 mM IPTG, and harvested by centrifugation 4 h after induction. Cell 
pellets were resuspended in LB1 buffer (20 mM Hepes [pH 8.0], 400 mM NaCl, 100 mM KCl, 
20 mM imidazole, 10% glycerol, and 10 mM 2-mercaptoethanol) and lysed by addition of 1 
mg/mL lysozyme followed by sonication. Benzonase was added to lysates for 30 min prior to 
centrifugation at 8000 rpm in a Sorvall SA800 rotor. The supernatant was applied to a Ni2+-NTA 
affinity column, washed with 50 mL of LB1 buffer, and eluted with LB1 buffer supplemented 
with 190 mM imidazole. Fractions containing FKBP12-SspB
XB
 were pooled and 
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chromatographed on a Sephacryl S-100 gel filtration column in GF-1 buffer (50 mM Tris-HCl 
[pH 7.6], 1 mM dithiothreitol, 300 mM NaCl, 0.1 mM EDTA, and 10% glycerol). Fractions were 
analyzed by SDS-PAGE, concentrated to 1 mL, and incubated with thrombin overnight at room 
temperature. Cleaved FKBP12-SspB
XB
 was purified away from thrombin using a S100 gel-
filtration column. Analysis by SDS-PAGE confirmed complete cleavage. FKBP12-SspB
XB
 was 
concentrated and stored at -80 °C. 
SspB
CORE
-FRB, ccSspB-FRB, and truncated variants contained internal His6 tags separating the 
two domains and were expressed from a pACYC-derived vector in E. coli BLR as described for 
FKBP12-SspB
XB
. Harvested cells were resuspended in LB2 buffer (100 mM NaH2PO4 [pH 8.0], 
10 mM Tris-HCl, 6 M GuHCl, 300 mM NaCl and 10 mM imidazole) and stored at -80 °C prior 
to purification. Cells were lysed by rapidly thawing the cell pellet, followed by centrifugation as 
described above. The supernatant was applied to a Ni2+-NTA affinity column, washed with 50 mL 
LB2 buffer, and eluted with LB2 buffer supplemented with 240 mM imidazole. After overnight 
dialysis against GF2 buffer (20 mM Tris-HCl [pH 8.0], 10% glycerol, 25 mM NaCl, 25 mM 
KCl, 1 mM dithiothreitol), soluble protein was chromatographed on a Sephacryl S100 gel-
filtration column. Fractions were analyzed by SDS-PAGE, concentrated, and stored at -80 °C. 
LacI-DAS+4 containing a cleavable His6 tag was purified by Ni
2+
-NTA affinity chromatography, 
tag cleavage, and gel-filtration chromatography as described above. 
β-galactosidase activity assays 
To measure β-galactosidase activity, strains were grown in 1 mL of supplemented M9 media 
(M9 salts, 1 mM thiamine hydrochloride, 0.2% casamino acids, 2 mM MgSO4, 0.1 mM CaCl2, 
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0.4% glycerol, and 35 µg/mL chloramphenicol when appropriate) at 37 °C in aerated culture 
vials. At mid-log phase, the OD600 was measured, an aliquot (20 µL) was taken for a Miller 
assay, and the cells were treated either with rapamycin (10 µM), IPTG (5 mM), or an equal 
volume of DMSO (the solvent for both IPTG and rapamycin). The final DMSO concentration in 
each sample was 0.5%. Growth of this strain was unaffected by DMSO concentrations up to 4% 
(data not shown). At different times after treatment, OD600 was measured (150 µL) in a 
SpectraMax plate reader (Molecular Devices) and samples (20 µL) were quenched by adding 80 
µL Z-lysis buffer (B-PERII (Pierce) supplemented with 200 µg/mL spectinomycin and 1 mM 
PMSF). A 1 mL volume of Z-assay buffer (66 mM Na2PO4 [pH 7.4], 6 mM KCl, 700 µM 
MgCl2, 1 mM DTT, and 0.67 mg/mL o-nitrophenyl β-d-galactoside) was then added to each 
sample, before aliquoting samples (150 µL) into a 96-well plate and measuring absorbance at 
420 nm as a function of time using a SpectraMax plate reader (Molecular Devices). Sample 
OD600 was corrected for path-length using the equation,  
    𝑂𝐷600 =  𝑂𝐷600𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 − 0.04 ∗ 3.39.  
For each sample and each timepoint, β-galactosidase activity was reported as  
     β-galactivity = 10,000 ∗
∆𝐴420
∆𝑡𝑖𝑚𝑒   𝑚𝑖𝑛𝑠  
𝑂𝐷600
. 
To facilitate screening the library of C-terminal degradation tags, a high-throughput form of this 
assay was developed. Cultures were grown overnight in LB/chloramphenicol (35 µg/mL) in 96-
deep-well plates (Greiner Bio-One), diluted 100-fold into M9 media (600 uL), and grown at 37 
°C with aeration for 4 h in deep-well plates. 150 µL of each sample was used to measure OD600 
in a 96-well plate, and 10 µL of culture was added to 40 µL of Z-lysis buffer. 200 µL Z-assay 
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buffer was added to each sample and the change in absorbance as a function of time was 
measured using a plate reader as described above. 
qPCR 
Strains were grown at 37 °C in culture tubes in 5 mL of M9 broth to an OD600 of 0.2. At this 
time, 750 µL was removed, cells were harvested by centrifugation, the broth was aspirated, and 
the pellet was flash-frozen in liquid nitrogen. The remaining culture was treated with rapamycin 
(10 µM), IPTG (5 mM) or DMSO and, at each timepoint, 750 µL was removed and treated as 
described above. Cell pellets were thawed at room temperature for 10 min in 100 uL 
TE/readylyse (Qiagen). The cell lysate was kept on ice as 350 µL buffer RLT (Qiagen) was 
added to each sample. After vortexing, 250 µL of 95% ethanol was added and mixed, before the 
entire sample was applied to an RNAeasy purification column (Qiagen). A standard purification 
protocol was followed, and RNA was eluted in 30 µL DEPC-treated H2O. Reverse transcription 
was performed at 42 °C for 1 h using random hexameric primers (Invitrogen) and Superscript II 
reverse transcriptase (Invitrogen). After quenching the reaction at 85 °C, RNA was removed by 
incubation RNaseH (NEB) at 37 °C for 1 h. The reaction was treated using a PCR Cleanup Kit 
(Qiagen) and total cDNA was determined spectrophotometrically. qPCR was performed on a 
Roche LightCycler 480 using sybrGreen reaction mix (Roche). For each sample, primers specific 
to either lacZ or FRB were used. Data were normalized to total cDNA for each sample. In each 
instance, measured FRB mRNA levels were constant as expected. 
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Degradation assays 
All degradation assays in vitro were performed in PD buffer (25 mM Hepes KOH [pH 7.6], 5 
mM MgCl2, 10% glycerol, and 200 mM KCl) at 30 °C. GFP fluorescence was monitored by 
exciting with 467 nm light and measuring emission at 511 nm using either a SpectraMax M5 96-
well fluorescence plate reader (Molecular Devices) or spectrofluorometer (Photon Technology 
International). Each degradation reaction contained an ATP-regeneration mix, consisting of 4 
mM ATP, 16 mM creatine phosphate, and 0.32 mg/mL creatine kinase (Shin et al., 2009). 
Degradation reactions of LacI-DAS+4 in vitro were quenched by boiling in GB buffer (50 mM 
Tris-HCl [pH 6.8], 75 mM dithiothreitol, 35 mM 2-mercaptoethanol, 0.003% bromphenol blue, 
0.015% sodium dodecyl sulfate, 8 % glycerol) and resolved by SDS-PAGE. 
When present, error bars represent the standard deviation of triplicate measurements. 
  











)3–based degradation system (Figure 5.7D) in E. coli proved 
difficult. First, a plasmid (pJD151) bearing the chimeric protease, FKBP12-(ClpX
ΔN
)3 was 
introduced into the cells. As shown in Figure 5.S1, this construct readily recombined in a recA-
dependent fashion even in the absence of selection for the recombination event. The plasmid 
instability likely results from homologous recombination between the three 1.4 kilobase ClpX
ΔN 
direct repeats that make up the FKPB12-ClpX
ΔN
3 trimer (Morag et al., 1999; Martin et al., 
2005). Such recombination would likely decrease the time-scale over which the degradation 
system was functional and could be limiting for many applications. 
 
Figure 5.S1. Plasmid recombination of FKBP12-ClpX
ΔN
3. A plasmid bearing 
FKBP12-(ClpX
ΔN
)3 was transformed into E. coli DH5α. A single colony was picked and 
used to inoculate a culture that was grown to saturation. From this culture, the plasmid 






 E. coli W3110. Single 
colonies were picked, cultures were grown to saturation, and plasmids were purified. 
Each plasmid (45 ng) was digested with XbaI, PstI to remove the FKBP12-(ClpX
ΔN
)3 
insert, and the products of this reaction were resolved by electrophoresis on a 0.9% 
agarose gel. The bands marked in black correspond to the expected migration of the 
vector and insert. The bands marked in red are probably recombination products, as they 





 is inhibited by high concentrations of the adaptor, SspB
CORE
-FRB 
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To mitigate the effects of these direct repeats, we attempted to further characterize a monomeric 
version of the chimeric protease, FKBP12-ClpX
ΔN 
(Figure 5.7D). Previously, we had observed 
defects in protease hexamerization however, these defects could be overcome by using 
sufficiently high enzyme concentrations (Davis et al., 2009). Substrates bearing the DAS+4 tag 
were degraded by 0.5 µM FKBP12-ClpX
ΔN
, 1.5 µM ClpP, and 3 µM SspB
CORE
-FRB in a 
rapamycin-dependent fashion (data not shown). To assay the effect SspB
CORE
-FRB on 
degradation, we fixed the concentration of FKBP12-ClpX
ΔN
 at 0.5 µM, ClpP at 1.5 µM, GFP-
DAS+4 at 2 µM, rapamycin at 10 µM, and titrated SspB
CORE
-FRB from 0 µM to 8 µM, 
measuring the rate of GFP-DAS+4 degradation at each concentration. We observed limited 
substrate degradation at low concentrations of adapter and pronounced inhibition of degradation 
at high concentrations of adaptor (Figure 5.S2). Inhibition by excess adaptor may result from the 
inability of the protease to exchange substrate-free adaptors for those bound to substrate due to 
the extreme stability of the rapamycin-induced complex. 
 
Figure 5.S2. GFP-DAS+4 degradation rate as a function of SspB
CORE
-FRB 
concentration. Degradation of 2 µM GFP-DAS+4 by 0.5 µM FKBP12-ClpX
ΔN
 and 1.5 
µM ClpP is strongly dependent on the relative concentration of the adaptor to the 





 (6 adaptors per hexameric unfoldase). 
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Characterization of a library of mutated ssrA degradation tags 
We screened 92 mutants from our library of lacI C-terminal degradation tags. Clones were 
picked, grown overnight in LB/chloramphenicol/kanamycin, diluted into M9 broth, and grown 
for 4 h before measuring β-galactosidase activity. After addition of rapamycin (10 µM) and 
growth for 1 h, β-galactosidase activity was measured again. For a subset of clones, we PCR 
amplified the C-terminus of lacI and sequenced this product. 
 
 
Figure 5.S3. A library of C-terminal degradation tags. β-galactosidase activity before 
and after addition of rapamcyin is plotted for 50/92 clones assayed. With the exception of 
the untagged control, DAS, and LDD, clones are sorted based on their level of activity in 
the absence of rapamycin. For the subset of clones sequenced (all had in-frame, error-free 
ssrA+4 tags), the three C- terminal amino acids are listed. Some clones show constitutive 
β-galactosidase activity and may result from inactivation of the repressor or introduction 
of a degradation tag recognized in the absence of SspB (either by ClpXP or another 
cellular protease). 
We observed a distribution of uninduced β-galactosidase activity indicating either differential 
repression or degradation of these clones. Interestingly, some variants (e.g., RGG, RCN, KHG 
and HHL) displayed β-galactosidase activity similar that of a LDD tagged clone. Two strains 
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(RCN and KHG) could be induced by rapamcyin and were characterized further as described in 
Results. Although we have focused on the identification of tethering-dependent tags for ClpXP, 
this assay allows for a large number of clones to be screened in parallel and could prove valuable 
for the identification of C-terminal degradation tags for any cellular protease. If a protease were 
placed under the control of an inducible promoter, β-galactosidase activity could be used to 
identify protease-specific degrons.  




Plasmid pJD151 encodes FKBP12-(ClpX
ΔN
)3 under the control of the constitutive Bba_J23101 
promoter (www.partsregistry.org) and was maintained in strain E. coli DH5α (F-, λ-, 
φ80lacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, 
thi-1, gyrA96, relA1). Assays for intergenic recombination of this construct were performed in 
E. coli W3110 (F
-
, λ-, IN(rrnD-rrnE), rph-1, sspB–) with sspB removed from the chromosome as 
described in Methods. In one strain, recA was also knocked out by P1-phage-mediated 
transduction of a recA::kan cassette from an engineered recA+ donor strain (a gift of Dr. Sean 
Moore, University of Central Florida). The kanamycin resistance marker was excised using Flp 





 were expressed and purified as described (Davis et al., 2009). 
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The experiments shown in Figure A.S1 demonstrate that the biotinylated single-chain ClpX 
enzyme (ClpX
SC
) used for single-molecule studies has essentially the same activity as wild-type 
ClpX in directing ClpP degradation of a GFP-ssrA substrate. 
 
 
Figure A.S1. Activities of biotinylated ClpX
SC
 (0.3 µM hexamer; open circles) and wild-
type ClpX (0.3 µM hexamer; closed squares) in supporting ClpP (0.9 µM) degradation of 
GFP-ssrA (2.5 µM) as monitored by loss of GFP fluorescence. Reactions were performed 




/ClpP stalls after degrading most of the titin
V15P
-ssrA portion of the Cy3-GFP-titin
V15P
-
ssrA substrate in the presence of ATPS/Mg2+, but immobilized complexes of the enzyme and 
partially degraded substrate remain stably associated after chelation of Mg
2+
 by EDTA (Figure 
A.S2, left) and after replacing ATPS with ATP in the presence of EDTA (Figure A.S2, right). 
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/ClpP under pre-assembly conditions. (Left) Spots per field of view 
in the presence of 2 mM ATPS and 50 mM EDTA. (Right) Spots per field of view after 
exchange into 1 mM ATP and 6 mM EDTA. 
 
In the continual presence of ATPS/Mg2+, the fluorescence of immobilized stalled complexes is 
lost by photobleaching with a time constant of ≈330 s (Figure A.S3A). If immobilized complexes 
are washed with buffer with Mg
2+
 but no ATPS, most spots disappear in an exponential process 
with a time constant of ≈12 s (Figure A.S3B), suggesting that the enzyme-substrate complex is 
unstable without nucleoside triphosphate. 
 
Figure A.S3. Fraction spots remaining in control single-molecule experiments. (A) 
Photobleaching of enzyme-bound Cy3-GFP-titin
V15P
-ssrA was assayed in the presence of 
ATPS/Mg2+ (circles). The line is a single-exponential fit with a time constant of 330 s. 
(B) Fraction of Cy3-labeled substrate remaining after washing with buffer with Mg
2+
 but 
no ATPS (circles). The line is a double-exponential fit with time constants of 13.7 s for 
the fast phase (amplitude 71%) and 330 s (amplitude 29%) for the slow phase. 
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In single-molecule assays of Cy3-GFP-titinV15P-ssrA degradation by immobilized 
ClpX
SC
/ClpP, reducing the ATP concentration from 1 to 0.1 mM slowed the reaction (Figure 
A.S4A). The reaction was also slowed when degradation was performed in the presence of a 
mixture of 1 mM ATP and 0.25 mM ATPS (Figure A.S4B).  
 
Figure S4. Nucleotide dependence of single-molecule degradation of Cy3-GFP-titinV15P-ssrA. 
(A) Open circles show assays performed with 0.1 mM ATP. Filed circles show assays performed 
with 1 mM ATP (taken from Figure A.3B). (B) Open circles show assays performed with 1 mM 
ATP plus 0.25 mM ATPS. Filed circles show assays performed with 1 mM ATP (taken from 
Figure A.3B). 
 
The substrates used in our single-molecule experiments were modified by addition of a cysteine, 
at the second amino acid, to allow N-terminal labeling with Cy3 dye. The experiments shown 
below (Figure A.S5) show that a substrate lacking cysteine 2 is labeled at only 6% of the 
efficiency of an otherwise identical substrate with cysteine 2. The low degree of fluorescent 
labeling of the substrate without cysteine 2 is probably caused by labeling of two cysteines in the 
titin
V15P
 portion of the substrate, which are buried in the native molecule but become accessible 
upon transient unfolding. This portion of the substrate is removed by degradation by 
ClpX
SC
/ClpP in the presence of ATPS and would not be present in the stalled complexes that 
represent the starting material for our experiments. 
 
  





-ssrA substrates with (+) or without (-) cysteine at position 
2 (Cys2) were labeled with Cy3 (+) or in a mock reaction (-) and were analyzed by SDS-
PAGE and staining with Coomassie Blue (left panel) or by fluorography after excitation 
of Cy3 (right panel). The substrate without Cys2 was labeled at 6% of the level of the 
substrate with Cys2. 
 
As shown in the kinetic traces below (Figure A.S6), Cy3-labeled substrate-enzyme complexes 
disappeared in a single kinetic step as a consequence either of completion of degradation or of 
photobleaching. 
 
Figure A.S6. Kinetic traces of intensities of single Cy3-labeled substrate-enzyme 
complexes spots show that fluorescence is lost permanently in a single step.  
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In experiments monitoring GFP fluorescence, we reduced excitation power to extend the 
fluorophore lifetime and signal-to-noise was somewhat poorer than for the Cy3 experiments 
(Figure A.S6 and A.S7). Moreover, instances of GFP blinking were observed (marked by arrows 
in Figure A.S7A). The MATLAB code used for data analysis only counted degradation or 
photobleaching events that lead to permanent spot disappearance (Figure A.S7B). 
 
Figure S7. Kinetic traces of intensities of single GFP-substrate•enzyme complexes. (A) 
The transient decreases marked by arrows were considered to be blinking and were not 
counted as degradation or photobleaching events. (B) The permanent loss of GFP 
fluorescence at ≈73 s was counted as a degradation or photobleaching event. 
 
Table A.S1 summarizes the time constants for different steps in the degradation of individual 
substrates. These values provide good fits of the experimental data and are generally consistent 
for single-molecule and solution experiments. 
 
Table A.S1. Time constants for individual steps in degradation reactions. 
 
  Time constants (s)  
Substrate Experiment Den1 Trans1 Den2 Trans2 Term Overall 
Cy3-GFP-titin
V15P
-ssrA Preengaged single-molecule 19 6.2   29.6 55 
Cy3-CFP-GFP-titin
V15P
-ssrA Preengaged single-molecule 19 6.2 19 6.2 29.6 80 
Cy3-titin-GFP-titin
V15P
-ssrA Preengaged single-molecule 19 6.2 347 3.1 29.6 405 
GFP-titin
V15P
-ssrA Preengaged solution 25      
CFP-GFP-titin
CM
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Supplementary Methods 
Protein expression and purification 
The single-chain ClpX
SC
 variant contained an N-terminal FLAG tag, six repeats of E. coli ClpX-
ΔN (residues 61–423) connected by flexible linkers (Martin et al., 2005), a BirA-acceptor 
peptide (HAAGGLNDIFEAQKIEWHEDT; ref. Chen et al., 2005), and a C-terminal H6 tag. 
ClpX
SC
 was expressed from a pACYC-derived vector in E. coli strain ERL (ER2566 with a 
chromosomal λ-lysozyme gene; a gift from S. Moore, University of Central Florida, Orlando, 








modified to encode an N-terminal Met-Cys sequence (the methionine is removed post 
translationally). These substrates were expressed from pACYC vectors in E. coli strain BLR 
(BL21 recA
– λ(DE3)). The BirA enzyme contained a C-terminal H6 tag and was expressed in 
strain BLR from a pET22 vector (a gift from J. Damon, M.I.T.). E. coli ClpP-H6 was expressed 
in strain BL21 clpP
- λ(DE3). 
 
Enzymes and substrates were expressed from IPTG-inducible T7 promoters. Cells were grown to 
OD600 0.7 at 37 °C in 1-2 L of 1.5xYT broth, chilled to 18 °C, and expression was induced with 
1 mM IPTG. Cells were harvested 4 h later, resuspended in 15 mL of LB1 buffer [20 mM Hepes 
(pH 7.6), 400 mM NaCl, 100 mM KCl, 20 mM imidazole, 10% glycerol, and 10 mM 2-
mercaptoethanol] per liter of culture, and frozen at -80 °C until purification. For proteins 
expressed in strain BLR, cells were subjected to two freeze/thaw cycles before addition of 1 mM 
PMSF, 0.1 mg/mL lysozyme, and 250 units of benzonase nuclease. After 30 min at 4 °C, lysates 
were centrifuged at 8,000 rpm in a Sorvall SA600 rotor for 40 min, and the supernatant was 
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decanted and saved. For proteins expressed in strain ERL, frozen cells were thawed, 10 µL/mL 
chloroform was added, and the mixture was vortexed briefly prior to PMSF/benzonase addition 
and centrifugation. BirA was purified by applying the lysate supernatant to a 1 mL Ni
2+
-NTA 
affinity column, washing with 20 vol of LB1, and eluting with 8 aliquots of 0.5 mL EB1 buffer 
[20 mM Hepes (pH 7.6), 400 mM NaCl, 100 mM KCl, 200 mM imidazole, 10% glycerol, 10 
mM 2-mercaptoethanol]. BirA fractions were applied to a Superdex S200 gel-filtration column 
(Amersham-Pharmacia) equilibrated with GF1 buffer [50 mM Tris-HCl (pH 7.6), 1 mM DTT, 
300 mM NaCl, 0.1 mM EDTA, and 10% glycerol]. Fractions containing BirA were identified by 
SDS-PAGE, concentrated, and stored frozen at -80 °C. ClpX
SC
 and substrates were purified by 
Ni
2+
-NTA affinity and size-exclusion chromatography (Martin et al., 2008; Davis et al., 2009). 
After the affinity-chromatography step, ClpXSC was biotinylated as described (Chen et al., 2005). 





-ssrA, proteins were carboxymethylated for 1 h at room 
temperature in 3 M GuHCl by using a 10-fold molar excess of iodoacetic acid and exchanged 




Equations used for fitting 
ClpXP degradation of the preengaged Cy3-GFP-titin
V15P
-ssrA substrate was modeled to include 
an unfolding step (k1), a translocation step (k2), and a termination step (k3). In the model shown 
below, the starting enzyme-substrate complex (A1a) and the intermediate species (A2a and A3a) are 
fluorescent, but the final substrate-free species A4a is not. We assumed that fluorescence could 
also be lost by conversion of species A1a, A2a, or A3a to a photobleached state (B) with rate 
constant k (i.e., we assume that each subpopulation photobleaches at the same rate). 
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The relative populations of species A1a, A2a, and A3a are given by the equations: 
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The equation used for fitting was: 
1 1 2 3 2Total number of spots = ( ) exp( )A a A a A aD P P P D kt       
 
where D1 is the amplitude of the degradation/photobleaching pathway and D2 is the amplitude of 
a subset of spots that are lost only by photobleaching. 
 
ClpXP degradation of the pre-engaged Cy3-CFP-GFP-titin
V15P
-ssrA substrate was modeled to 
include a GFP unfolding step (k1), a GFP translocation step (k2), a CFP unfolding step (k1), a 
CFP translocation step (k2), a termination step (k3), and photobleaching steps as described above. 
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The relative populations of species A1b, A2b, A3b, A4b, and A5b are given by the equations: 
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The equation used for fitting was: 
3 1 2 3 4 5 4Total number of spots = ( ) exp( )A b A b A b A b A bD P P P P P D kt       
 
where D3 is the amplitude of the degradation/photobleaching pathway and D4 is the amplitude of 
a subset of spots lost only by photobleaching. 
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Single-Molecule FRET Assays for the Study of the AAA
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This work was initiated by Dr. Andreas Martin who built the first (non-sortase linked) versions 
of the ClpX
ΔN
 trimers and showed nucleotide-dependent florescence resonance energy transfer in 
bulk assays. The single molecule assays have been carried out in collaboration with Matt Lang’s 
lab. Yongdae Shin developed the dual-view TIRF microscope assay as well as the computational 
tools to analyze the data. 
  





 protein machines are present in all kingdoms of life and are vital for a range of cellular 
functions, including vesicular transport, protein secretion, microtubule motor function, and the 
maintenance of protein homeostasis via chaperone and proteolytic activities (Baker and Sauer, 
2006; White and Lauring, 2007). These seemingly disparate actions are all dependent the ability 
of AAA
+
 enzymes to convert the energy of ATP binding and hydrolysis into mechanical work. 
Pronounced sequence conservation and structural homology between members of this large 
family suggest the possibility of a common, underlying mechanism for the entire class 
(Erzberger and Berger, 2006).  
E. coli ClpXP is a AAA
+
 unfoldase, disassembly machine, and protease consisting of either one 
or two ring-shaped ClpX homohexamers that cap the ends of the tetradecameric peptidase, ClpP 
(Figure 1.2). The unfoldase, ClpX, oligomerizes into a ring containing a narrow axial pore that 
serves as a binding site for the degradation tags of substrates. Biochemical studies revealed that 
successive rounds of ATP hydrolysis drive conformational changes in ClpX that result in the 
application of a pulling force to bound proteins and eventually lead to global denaturation of the 
substrate. In an ATP-hydrolysis-dependent reaction, the unfolded polypeptide is translocated 
through the axial pore of ClpX to sequestered degradation chamber of ClpP, where it is cleaved 
and the released as short peptides (Sauer et al., 2004). Because the ClpP active sites can only be 
accessed via translocation by ClpX, the system achieves a high level of substrate specificity 
(Joshi et al., 2004).  
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Biochemical and structural studies indicate that ClpX is a highly asymmetric machine that 
undergoes large conformational changes. Indeed, Hersch et al. (2005) found that ClpX hexamers 
bind a maximum of four nucleotides in solution, implying that two or more distinct classes of 
subunits must exist at any given time (Hersch et al., 2005). Moreover, recent crystallographic 
studies show that even in the absence of ATP, ClpX is asymmetric with at least two classes of 
subunits (Glynn et al., 2009). Interestingly, Glynn et al. (2009) observed large conformational 
changes upon addition of nucleotide, hinting at a mechanism to couple the energy of ATP 
binding to mechanical work. 
We are interested in developing techniques to directly observe nucleotide-dependent 
conformational changes in ClpX with the ultimate goal of answering the following questions. 
How many distinct states exist in the ATP-hydrolysis cycle? Which transitions are rate-limiting? 
Does the rate-limiting step for the cycle change in the presence of substrate? Does the protease 
operate in different modes during substrate unfolding and translocation? Do individual ClpX 
subunits act independently, or is ATP hydrolysis in one subunit sufficient to drive 
conformational changes in distal subunits? Is there a preferred order of subunit firing? 
In collaboration with the Lang Lab (MIT, Biological Engineering), we have begun developing a 
fluorescence resonance energy transfer (FRET) based assay with single-molecule resolution. In 
bulk studies, the conformational state observed is averaged over the entire population, thus 
obscuring unsynchronized molecular motions. By contrast, these single-molecule experiments 
will allow us to inspect an isolated engine as it progresses through its reaction cycle.  
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Results and Discussion 
The subunits in a ClpX
ΔN
 ring can be connected with flexible linkers by genetically encoding 
linked dimers, trimers, or the entire hexamer as a single polypeptide (Martin et al., 2005). This 
technology allows for the generation of homogenous populations of molecules, each containing 
mutations in one or more specific subunits of the hexamer. These engineered enzymes 
recapitulate many activities of wild-type ClpX and have been used extensively to address ClpX 
structure-function questions (Martin et al., 2005; Martin et al., 2007; Martin et al., 2008a; Martin 
et al., 2008b). Popp et al. (2007) have described another method of linking proteins using the 
Sortase A enzyme from Staphylococcus aureus (Popp et al., 2007). This transpeptidase 
recognizes a short peptide sequence (LPXTG) and cleaves the peptide bond between the 
threonine and the glycine thereby forming a stable acyl-enzyme intermediate between the active 
site cysteine of sortase and the newly generated C-terminus of the substrate. This acyl-enzyme 
intermediate can be resolved by addition of a peptide bearing an N-terminal poly-glycine repeat, 
resulting in release of the enzyme and formation of a native peptide bond linking the substrate 
and the peptide (Antos et al., 2009). 
We utilized sortase-mediated protein ligation to fuse fluorescently-labeled ClpX
ΔN
 trimers 
(Figure B.1A). This linkage resulted in a ClpX
ΔN
 single-chain hexamer bearing two different 
fluorescent labels (Figure B.1B). First, we generated a single-chain trimer bearing a single-
reactive cysteine at position 169 in the first subunit (Materials and Methods, Table B.1). At the 
C-terminus, we appended a linker fused to a sortase recognition site (Figure B.1A, trimer A). We 
then built a second single-chain trimer encoding a reactive cysteine at position 153 in the first 
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subunit, a biotinylation acceptor peptide at the C-terminus, and the sortase resolution sequence, 
GGGG, at the N-terminus (Figure B.1A, trimer B). We expressed and purified these trimers and 
used Alexa488-maleimide to label C169 of trimer A and Alexa647-maleimide to label C153 of 
trimer B. As shown in Figure B.1C, ~50% of the trimers could be covalently linked via the sortase 
reaction resulting in a species that chromatographs on a gel-filtration column similarly to single-
chain ClpX. The reactants and products of the sortase reaction are roughly isoenergetic and thus 
incomplete conversion observed is expected (M. Popp, personal communication). 
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Figure B.1. Sortase linking of ClpX
ΔN
 trimers to form a single-chain hexamer. (A) 
Schematic of single-chain ClpX
ΔN
 trimers. The terminal subunit of trimer A contains a 
sortase recognition sequence. The N-terminal subunit of trimer B contains a sortase 
resolution sequence and the C-terminal subunit encodes a biotin acceptor peptide. Each 
trimer contains a single-reactive cysteine allowing modification using maleimide-
conjugated dyes. (B) Linked hexamer after labeling, biotinylation, and sortase-mediated 
linkage. (C) Elution profile from a Superdex S200 gel-filtration column (bottom) of 
either single-chain ClpX
ΔN
6 or sortase-linked ClpX
ΔN
6. SDS-PAGE analysis (top) of 
trimer A mixed with trimer B (lane 2), trimer A and trimer B treated with sortase (lane 3) 
and fractions obtained after size-exclusion chromatography of the sortase-linked hexamer 
(lanes 4-9). 
In solution studies, we monitored the changes in fluorescence-resonance-energy transfer (FRET) 
between the two dyes as a function of nucleotide state. In the presence of ATPγS, a slowly-
hydrolyzed ATP analogue, ClpX adopted a “high-efficiency” transfer state, whereas it adopted a 
“low-efficiency” state in the absence of nucleotide or in the presence of ADP (Figure B.2A).  
When ATP was added, ClpX converted to the high-efficiency state and then converted back to 
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the low-efficiency state as a function of time (Figure B.2B). At the concentrations of ClpX 
utilized (1 µM of each trimer), most molecules should be hexameric even in absence of 
nucleotide, but it is difficult to distinguish if the observed FRET changes result from 
conformational movements within a hexamer or because ATP facilitates formation of hexamers 
from contaminating, unlinked, trimeric precursors.  
 
Figure B.2. Solution assays for nucleotide-dependent changes in FRET efficiency. 
(A) Sortase-linked ClpX
ΔN
6 was mixed with ADP (4 mM) or ATPγS (4 mM). 
Fluorophores were excited with 495 nm light and emission was measured at 700 nm. (B) 
2 mM ATP was added to sortase-linked ClpX
ΔN
6 at the time indicated. At subsequent 
times, fluorescence emission was measured. Because these experiments were performed 
on different days with different enzyme stocks, the fluorescence units are not comparable. 
In the assays described above, changes in energy-transfer efficiency are averaged over the entire 
population of molecules. To improve resolution of the dynamic conformational states adopted by 
individual molecules, we attached ClpX hexamers to a microscope slide via a biotin-streptavidin 
linkage as described previously (Shin et al., 2009). Using a dual-view microscope developed by 
Yongdae Shin, we excited the donor florophore (Cy3) and simultaneously observed emission 
from both the donor fluorophore and the acceptor fluorophore (Alexa647). Very few FRET-
paired ClpX
ΔN
6 molecules were observed, presumably because of inefficient labeling at these 
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positions combined with incomplete sortase linkage (data not shown). For those rare molecules 
labeled with both fluorophores, however, we observe time-dependent changes in FRET 
efficiency in the presence of ADP, ATP, or ATPγS (representative traces shown in Figure B.3). 
Critically, the donor and acceptor emission intensity are anti-correlated and each dye photo-
bleaches in a single event indicating that the observed fluorescence emission is a direct result of 
single-molecule FRET. 
 
Figure B.3. Single-molecule FRET in sortase-linked ClpX
ΔN
6. Donor fluorescence 
emission (green) is anti-correlated with acceptor fluorescence (red) resulting in a constant 
total emission (black). FRET efficiency (blue) is calculated using the ratio of acceptor 
and donor fluorescence.  
 
It is difficult to distinguish if the FRET changes we observe result from nucleotide binding and 
hydrolysis or from nucleotide-independent interconversion of conformational states. 
Interestingly, the rate of fluctuation and the time-averaged occupancy of different FRET states 
appear to vary depending on the nucleotide present implying that some fraction of the changes 
we observe do depend on nucleotide. Because ClpX is an allosteric machine, ATP/ATPγS 
binding, hydrolysis or ADP dissociation in any subunit could theoretically give rise to the FRET 
changes we observe. In future studies, the use of mutant subunits defective in either nucleotide 
binding or hydrolysis might greatly simplify interpretation. 
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The single-molecule methods we have developed allow for the observation of rapid 
conformational changes at a level of resolution previously unattainable. By moving the 
fluorophores to different positions in ClpX, these techniques could be extended to the 
investigation of rigid-body motions in ClpX, the movements of various pore loops relative to a 
AAA+ domain, or the movements between identical amino acid positions in adjacent or non-
adjacent subunits. Using a single label on ClpX, one might also monitor interaction with a 
labeled substrate or potentially with the peptidase, ClpP. 
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Methods 
Plasmids and strains 
ClpX
ΔN
3 expression plasmids derived from pACYC were constructed with unique restriction 
sites between subunits, purification tags and sortase recognition sites allowing for facile 
manipulation of the individual components (Table B.1). Linked ClpX
ΔN
 trimers were expressed 
from a derivative of E. coli strain ER2566 (JD456) bearing a chromosomally-encoded phage 
lysozyme gene fused to a kanamycin selection marker (a gift of Sean Moore, University of 
Central Florida). 
Protein expression, purification, biotinylation and labeling with fluorescent probes 
Linked ClpX
ΔN
 trimer expression strains were grown at 37 °C in three liters of 1.5xYT broth (1.3 
% tryptone, 0.75 % yeast extract, and 0.75 % NaCl, [pH 7.0]) to OD 0.5 and induced with 1 mM 
IPTG at room temperature. Four hours post-induction, cells were harvested by centrifugation, 
resuspended in 30 mL of degassed LB1 buffer (20 mM Hepes [pH 7.6], 400 mM NaCl, 100 mM 
KCl, 20 mM imidazole, 10% glycerol, and 10 mM 2-mercaptoethanol) and stored at -80 °C. 
After thawing at room temperature, 10 µL/mL chloroform was added to initiate lysis, and 1 mM 
PMSF was added to inhibit proteolysis. Cells were incubated with agitation at 4 °C for 30 min 
before adding 250 Units of benzonase and incubating an additional 30 min at 4 °C. The lysate 
was centrifuged at 8000 rpm in a Sorvall SA600 rotor for 40 min, and the supernatant was 
decanted and incubated for 5 min with 1 mL Ni
2+
-NTA resin, which had been equilibrated with 
LB1 buffer. After washing with 15 column volumes (CV) of degassed LB1 buffer, resin was 
incubated with 5 CV of LB1 supplemented with 2 mM TCEP for 20 min. The resin was then 
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washed with 10 CV of LB2 buffer (20 mM Hepes [pH 7.6], 400 mM NaCl, 100 mM KCl, 20 
mM imidazole, 10% glycerol) before incubation with 2 CV of LB2 buffer supplemented with 
100 µM maleimide-conjugated fluorophore (Cy3, Alexa-488, or Alexa-647), for 2 hours. The 
labeling reaction was quenched by washing the resin with 20 CV of LB1 buffer, before elution 
with 3 CV of LB1 buffer supplemented with 240 mM imidazole. Eluate was incubated for 6 
hours at room temperature with 0.1 µM BirA, 1 mM biotin and 4 mM ATP in BB1 buffer (50 
mM bicine [pH 8.3], 5 mM magnesium acetate) resulting in quantitative biotinylation (data not 
shown). The sample was then spin-concentrated and chromatographed on a Superdex S-200 gel 
filtration column equilibrated in GF1 buffer (50 mM Tris-HCl [pH 7.6], 1 mM dithiothreitol, 300 
mM NaCl, 0.1 mM EDTA, and 10% glycerol). Fractions containing ClpX
ΔN
3 were spin-
concentrated and stored at -80 °C. 
Sortase A from Staphylococcus aureus encoded on a plasmid bearing an IPTG-inducible T7 
promoter (A generous gift of M. Popp, MIT) was overexpressed from strain JD530 (E. coli BL21 
recA-) and purified as described in Popp et al. (2007). BirA was expressed from strain JD490 (E. 
coli BL21 recA
-
) and purified as described in Shin et al. (2009).  
Sortase linkage 
Sortase A (1 µM) was incubated overnight at room temperature with stoichiometric 
amounts (15 µM) of GGGG-ClpXΔN3–bioAP-His6 and ClpX
ΔN
3–LPETGG-His6 in SB buffer 
(100 mM Tris-HCl [pH 7.6], 1 mM dithiothreitol, 450 mM NaCl,10 mM CaCl2, 0.1 mM EDTA, 
and 10% glycerol). Chromatography on a Superdex S-200 gel-filtration column resulted in clean 
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chromatography on a monoQ 5/50 G column (Amersham Pharmacia) failed to resolve linked-






Plasmid rs-1 subunit 1 rs-2 subunit 2 rs-3 subunit 3 rs-4 subunit 4 rs-5 subunit 5 rs-6 
pJD313 NcoI His6 NdeI ClpXΔN C169S Y153C KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SpeI - HinDIII 
pJD314 NcoI His6 NdeI ClpXΔN C169S R200C KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SpeI - HinDIII 
pJD315 NcoI FLAG NdeI-SpeI ClpXΔN KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SphI bioAP-His6-* HinDIII 
            pJD356 NdeI ClpXΔN KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SpeI LPETGG-His6-* HinDIII 
  pJD338 NdeI ClpXΔN C169S Y153C KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SpeI LPETGG-His6-* HinDIII 
  pJD339 NdeI ClpXΔN C169S R200C KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SpeI LPETGG-His6-* HinDIII 
  pJD337 NcoI GGGG NdeI ClpXΔN KpnI ClpXΔN C169S  BamHI ClpXΔN C169S  SphI bioAP-His6-* HinDIII 
Table B.1. Description of ClpX expression plasmids. Each ClpXΔN subunits encodes residues 61-424 of E. coli ClpX fused to a C-terminal 
linker (ASGAGGSEGGGSEGGTSGAT). Stop codons (*) are lacking form pJD313 and pJD314, allowing for restriction digestion (NdeI and 
SpeI) and ligation into pJD315 generating a single-chain hexamer. The protein product of pJD337 can be linked to that of pJD356, pJD338 or 
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The engineering of many-component, synthetic biological systems is being made easier by the 
development of collections of reusable, standard biological parts. However, the complexity of 
biology makes it difficult to predict the extent to which such efforts will succeed. As a first 
practical example, the Registry of Standard Biological Parts started at MIT now maintains and 
distributes thousands of BioBrick™ standard biological parts. However, BioBrick parts are only 
standardized in terms of how individual parts are physically assembled into multi-component 
systems, and most parts remain uncharacterized. Standardized tools, techniques, and units of 
measurement are needed to facilitate the characterization and reuse of parts by independent 
researchers across many laboratories. 
Results 
We found that the absolute activity of BioBrick promoters varies across experimental conditions 
and measurement instruments. We choose one promoter (BBa_J23101) to serve as an in vivo 
reference standard for promoter activity. We demonstrated that, by measuring the activity of 
promoters relative to BBa_J23101, we could reduce variation in reported promoter activity due 
to differences in test conditions and measurement instruments by ~50%. We defined a Relative 
Promoter Unit (RPU) in order to report promoter characterization data in compatible units and 
developed a measurement kit so that researchers might more easily adopt RPU as a standard unit 
for reporting promoter activity. We distributed a set of test promoters to multiple labs and found 
good agreement in the reported relative activities of promoters so measured. We also 
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characterized the relative activities of a reference collection of BioBrick promoters in order to 
further support adoption of RPU-based measurement standards. 
Conclusion 
Relative activity measurements based on an in vivo reference standard enables improved 
measurement of promoter activity given variation in measurement conditions and instruments. 
These improvements are sufficient to begin to support the measurement of promoter activities 
across many laboratories. Additional in vivo reference standards for other types of biological 
functions would seem likely to have similar utility, and could thus improve research on the 
design, production, and reuse of standard biological parts. 
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Background 
The engineering of many-component, synthetic biological systems is being made easier by the 
development of collections of reusable, standard biological parts (Arkin, 1999; Knight, 2002; 
Endy, 2003; Knight, 2003; Endy, 2005a; Voigt, 2006). Standardization of components has been 
instrumental in managing complexity in other engineering fields by helping engineers to reliably 
design and deploy systems comprised of combinations of parts (Texas-Instruments, 1988). 
However, it is an open question whether the overwhelming complexity of living systems will 
prevent biological engineers from fully achieving similar capabilities (below). To help answer 
this question, a Registry of Standard Biological Parts started at MIT now maintains and 
distributes thousands of BioBrick standard biological parts (www.partsregistry.org). BioBrick 
parts provide the first popular example of standard biological parts. However, BioBrick parts are 
currently only standardized in terms of how individual parts are assembled into multi-component 
systems (that is, "physical composition") (Knight, 2003; Canton et al., 2008). 
The utility of so-called standard biological parts would increase if the behavior of parts, both in 
isolation and in combination, were more predictable (that is, "functional composition") (Canton 
et al., 2008). Prediction of behavior, in turn, depends on the initial designs and refinement of the 
parts themselves, the characterization of part functions, and the representation of part functions 
via abstract models (Guido et al., 2006; Ajo-Franklin et al., 2007; Rosenfeld et al., 2007). 
Today, most BioBrick parts are directly derived from natural DNA sequences with only slight 
modifications to support at least one physical assembly standard, and many parts remain to be 
characterized. For example, fewer than 50 out of over 500 transcriptional promoters now 
available via the Registry have been characterized. Making matters worse, for the 50 
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characterized promoters, the methods of characterization are disparate and the resulting data 
incomparable. Shared and standardized approaches are needed in order to begin to address the 
challenge of characterizing promoters (and other types of standard biological parts) across a 
distributed community of biological engineers. 
Making reliable and comparable in vivo measurements of biological parts has proven 
challenging. For example, five different efforts to measure the abundances of proteins in the 
yeast pheromone mating response system, one of the best characterized eukaryotic signaling 
systems, produced reports for the numbers per cell (abundances) of key system proteins that vary 
over a factor of ~12 (Ty Thompson, MIT, unpublished observation). Such examples suggest that 
measurement of the state or activity of biological systems, whether natural or engineered, may be 
unlike past engineering experiences, in that the minor differences in experimental conditions 
(relative to what can be readily controlled for, below) may cause large changes in the properties 
being measured. Even if conditions could be controlled for, it has proven challenging for 
researchers to develop and adopt standard approaches for characterizing biological parts. For 
example, an analysis of 80 published papers in which researchers used beta-galactosidase (β-gal) 
activity as a measure of gene expression found that at least six different protocols were used to 
measure enzyme activity (Serebriiskii and Golemis, 2000). In addition, nearly all activities were 
reported in "Miller units" even though in several cases there were differences in the substrates 
used to quantify enzymatic activity (CPRG or ONPG), the experimental conditions (pH and 
temperature for the assay), and even the absolute units of the Miller unit (nmol/min or μmol/min) 
(Miller, 1972). Differences in conditions such as using either CPRG or ONPG as a substrate for 
enzymatic assays lead to incompatible results (Eustice et al., 1991), and thus Miller units should 
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generally not be considered comparable unless they have been calibrated against a common 
reference standard (Serebriiskii and Golemis, 2000). 
The challenge of making reliable in vivo measurements of biological parts is further compounded 
by the need to measure many part properties indirectly via biological "measurement instruments" 
such as reporter proteins whose production can also be sensitive to experimental conditions. For 
example, β-gal activity can be used as an indirect measure of the behavior of a promoter, but the 
translation and activity of the β-gal protein is itself sensitive to experimental conditions such as 
temperature or choice of media. Since both the measurement instrument (β-gal) and the property 
being measured (promoter activity) are sensitive to measurement conditions (perhaps in differing 
ways) correcting for errors in measured promoter activity due to changes in conditions is more 
difficult. In theory such challenges could be addressed by strict adherence to standard 
measurement conditions. However, the adoption of standard measurement conditions in 
biological engineering is prevented by both practical constraints (as noted above) and also 
engineering constraints, such as culture or performance requirements that are specific to a 
particular biotechnology application. The overall situation is summed up nicely via the following 
quote: "There is no such thing as a standard (biological) component, because even a standard 
component works differently depending on the environment" (Pollack, 2006). 
Although the characterization of standard biological parts is challenging, lessons from the 
measurement of other types of physical objects are worth considering. For example, one 
approach to controlling for variation in the measured property of an object in response to 
changing experimental conditions is to collect data from which to develop a model that describes 
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the relationship between the measured property and experimental conditions. As a specific 
example, models based on empirically determined coefficients of thermal expansion for common 
building materials (for example, Oak = 54*10
-6
/K at 20°C; Stainless Steel = 17.3*10
-6
/K at 
20°C) are now sufficient to enable the reliable construction of structures across a range of 
environments. However, given the complexity of living matter, the relationships between the 
measured properties of biological parts and experimental conditions may be difficult to 
determine (at first). Thus, a second lesson worth considering is the measurement of relative (or 
ratio) properties rather than absolute characteristics. A relative measure is the ratio of the 
measurement of some aspect of the object being characterized in comparison to a standard 
reference object that is measured under the same conditions. For example, early methods for the 
diagnosis of osteoporosis made use of a measure of spinal cord deformity that was based on the 
ratio of various length measurements of vertebra within an individual patient (Barnett and 
Nordin, 1960). Doctors, by using a relative measurement for length, could account for variation 
in vertebra sizes between individuals of different body types or heights. As a second example, 
microarray experiments are frequently performed by co-hybridizing probes synthesized from 
both a reference and experimental RNA sample that have been labeled with different 
colors (Schena et al., 1995); gene expression levels are then reported as the ratio of the 
experimental and reference intensities on each array spot. Thus, measurements made in relation 
to defined reference standards may provide an important first approach in characterizing the in 
vivo activity of biological parts and, over time, could enable the collection of empirical data 
sufficient to support the development of models that describe the effect of varying conditions on 
part properties. 
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Here, we characterized the in vivo activity of BioBrick promoters in order to evaluate if 
measuring relative activities might provide a useful initial framework for measuring the activity 
of standard biological parts across varying conditions. We chose to characterize promoters as a 
first example since they are ubiquitous in engineered biological systems, relatively well-
understood, practically useful to biological engineers, and poorly characterized in the existing 
BioBrick collection (Weiss, 2001; Alper et al., 2005). We developed a system that allows 
indirect measurement of the activity of promoters via observation of the synthesis rate of Green 
Fluorescent Protein (GFP) encoded by mRNA transcribed from each promoter. Our system 
requires the use of a quantitative model that allows promoter activity to be estimated from 
observed rates of GFP synthesis (below). Using this approach we demonstrate that normalizing 
the apparent absolute activity of a promoter to a defined reference standard promoter can help 
account for variation in conditions that would otherwise lead to significant differences in 
reported measurements. 
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Results 
Definitions and models for absolute promoter activity 
Our first step in characterizing standard biological promoters was to choose the property or 
properties whose measure would best support the reuse of such parts by biological engineers. 
Since the primary use of promoters is to initiate transcription, we chose the rate of transcription 
initiation as the property to be measured. We next chose the promoter clearance rate as the 
specific property that best describes transcription initiation; we refer to this property as 
"promoter activity" throughout. In turn, we defined promoter activity as the number of RNA 
polymerase molecules that pass by (or clear) the final base pair of the promoter and continue 
along DNA as an elongation complex. We report promoter activity using the generic unit of 
"Polymerases Per Second," or PoPS, in place of the more traditional "promoter clearance rate" 
because reporting activity in PoPS allows promoters to be directly compared to other genetic 
parts whose functioning impacts elongating polymerases, such as transcription 
terminators (Endy, 2005b). Other properties of promoters such as the binding constant of RNA 
polymerase to the DNA encoding the promoter, or the secondary structure of the DNA were not 
considered; while such properties may be relevant to researchers who are studying or 
engineering new promoters, our focus here was to support researchers who are characterizing or 
reusing existing promoters. 
Directly measuring PoPS in vivo is challenging and, to our knowledge, has not yet been reported. 
However, by placing a promoter upstream of the coding sequence for green fluorescent protein 
(GFP) we could use the rate of GFP synthesis as an indirect measure of promoter activity. We 
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could then use a quantitative model to relate observed GFP synthesis rates to promoter activities 
reported as PoPS. 
We adopted a previously described ordinary differential equation (ODE) model of GFP 
expression from a constitutive promoter to relate GFP synthesis rates per cell to promoter 
activities (Leveau and Lindow, 2001; Canton et al., 2008). We evaluated this ODE model at 
steady-state (see supplemental information online, www.jbioleng.org/content/3/1/4/additional) in 
order to determine the rates of successful mRNA initiation events per DNA copy of each 
promoter (PoPS
SS
) given observed GFP synthesis rates per cell ( ss
cellS ): 







    (1) 
where γM  is the mRNA degradation rate, a is the GFP maturation rate, γI is the degradation rate 
of immature GFP, ρ is the translation rate of immature GFP from mRNA, and n is the number of 
copies of the promoter in the cell. 
Variability due to equipment and conditions 
We explored the sensitivity of our observable measure of promoter activity, GFP synthesis rates, 
to different measurement conditions and different measurement instruments. We estimated the 
per cell GFP synthesis rates of two promoters (BBa_J23101 and BBa_J23150) across seven 
different measurement conditions and instruments (Figure C.1A). We estimated GFP synthesis 
rate by reporting the change in arbitrary fluorescence units per absorbance over a 1-hour period 
in log phase growth (Methods). We varied the experimental conditions by changing the cell 
strain (TOP10 or W3110), carbon source (glucose or glycerol), and temperature (30C or 37C) 
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during growth. We found that the observed GFP synthesis rates were sensitive to the choice of 
strain (varying up to 2-fold) but insensitive to temperature and carbon source (within 
experimental error). We also varied the plasmid copy number and plasmid antibiotic resistance 
marker in order to explore how different genetic "measurement instruments" might impact the 
measured GFP synthesis rates. We found that GFP synthesis rates were sensitive to the plasmid 
copy number (varying up to 3-fold) and antibiotic resistance marker (varying up to 1.5-fold). 
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Figure C.1. Reference standards reduce variation in reported promoter activities 
under different measurement conditions. We measured the activity of 2 promoters, 
J23101 (white columns) and J23150 (grey columns) under seven different measurement 
conditions and measurement instruments. We varied the media, temperature, cell strain, 
and plasmid copy number of the promoter test construct. (A) To estimate the per cell GFP 
synthesis rate we reported the change in fluorescence over a 1 hour period in exponential 
phase divided by the average absorbance during this period. The coefficient of variation 
of the GFP synthesis rates across the seven measurement approaches was 49% for J23101 
and 39% for J23150. (B) We used the same data and divided the GFP synthesis rate of 
J23150 (grey bars) by that of J23101 (white bars) in order to calculate the relative 
promoter activity of J23150 in RPUs. The coefficient of variation of the relative promoter 
activity across the seven measurement approaches was only 17% suggesting that the 
relative promoter activity is less sensitive to conditions then absolute activity measured 
by per cell GFP synthesis rate. 
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Definition and models for relative promoter activities 
We noted that the activity of promoters (for example, J23101 and J23150) measured across 
different conditions or with different instruments was correlated (Figure C.1A). This correlation 
suggested that a measure of relative promoter activity might be less sensitive to varying 
experimental conditions or measurement instruments. To test this idea, we defined a new 
property – relative promoter activity – as the ratio of the absolute activity of a sample 
promoter, φ, relative to the absolute activity of a standard reference promoter, BBa_J23101, with 
both promoters measured under equivalent conditions and with the same measurement 
instrument. We reported relative promoter activities in a newly defined unit: Relative Promoter 
Units or RPUs. By our definition, a sample promoter with a relative activity of 1 RPU has 
activity equivalent to BBa_J23101. 
An important consequence of considering a relative unit of measurement for reporting promoter 
activities is that many of the difficult-to-measure model parameters (Equation 1) that might 
change with changing environmental conditions can be cancelled when calculating relative 
promoter activities: 





Thus, by substituting Eq. 1 into Eq. 2, we calculated promoter strengths in relative units of RPU 
and thereby eliminated many of the elementary parameters found in Eq. 1 via a cancellation of 
terms: 
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We then made four additional assumptions that further simplified Eq. 3. First, we assumed that 
GFP expressed from either the test promoter φ or the reference standard promoter has an 
equivalent maturation rate (aφ = aJ23101 = a; given that the two promoters are measured under the 
same culture conditions). Second, since both promoters are carried on the same backbone 
plasmid, we assumed that each promoter is at the same average copy number (nφ = nJ23101); while 
there are reported cases of promoter activity influencing the copy number of plasmids due to 
RNA polymerases transcribing through the plasmid origin of replication (Adams and Hatfield, 
1984), a transcription terminator (BBa_B0015) downstream of our test construct's GFP coding 
sequence as well as the transcription terminators flanking the BioBrick cloning site (Shetty et al., 
2008) should largely prevent differences in promoter activity from impacting plasmid copy 
number. Third, since the promoters tested here have been standardized to have identical 
transcription initiation sites (predicted) and identical sequences downstream of the initiation site 
(see supplemental information online) we expected that each promoter produces the same mRNA 
sequence (Hawley and McClure, 1983). Since the transcribed mRNAs are expected to be 
identical we assumed that their mRNA degradation rates are equivalent (γM, φ = γM, J23101) and that 
the translation rates of immature GFP from mRNA are also equivalent (ρφ = ρJ23101); while 
mRNA degradation is also a function of dilution due to cell growth, the dilution rate is negligible 
relative to typical rates of active mRNA degradation in E. coli (Bernstein et al., 2002). Finally, 
we assumed that immature GFP is stable so that protein degradation is negligible compared to 
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dilution due to cell growth (γI, φ = μφ and γI, J23101 = μJ23101, where μ is the cellular growth rate). 
Following the above assumptions, we simplified Eq. 3 to: 
















We further simplified Eq.4 by noting that: 








 1 (5) 
For example, we measured the growth rates of cells in our experiments to determine if the 
difference between the growth rates of cells containing the promoter test construct (μϕ) and cells 
containing the reference standard construct (μJ23101) is negligible compared to the maturation rate 
of GFP (that is, |μϕ - μJ23101| ≪ a). The cellular growth rates varied depending on the promoter 
being tested as well as on the experimental conditions: the fastest growth rate was observed in 
cells containing the BBa_J23113 promoter test construct grown in M9+glucose (μ = 0.9 hr-1), 
and the slowest growth rate was observed in cells containing the BBa_R0040 promoter test 
construct grown in M9+glycerol (μ = 0.5 hr-1). The maturation rate of the GFP variant used in the 
GFP reporter device (BBa_E0040) has been measured previously as a = 6.48 hr
-1
 (Canton et al., 
2008). Based on the worst-case assumption that cells containing the promoter test construct are 
the fastest growing cells (μϕ = 0.9 hr
-1
), and that cells containing the reference standard construct 
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Therefore, we assumed that the difference between the growth rates of cells containing the 
promoter test construct (μϕ) and cells containing the reference standard construct (μJ23101) is 
negligible compared to the maturation rate of GFP, allowing Eq. 4 to be combined with Eq. 5 
yielding: 










Taken together, by reporting promoter activity relative to a reference standard promoter 
(BBa_J23101) and choosing promoters with identical transcription initiation sites and identical 
sequences downstream of the initiation sites, researchers can quickly report measured relative 
promoter activities in compatible units without having to independently measure GFP maturation 
rates, mRNA degradation rates, protein production rates, or plasmid copy number for their 
specific experimental setup. We detail the precise numerical sensitivity of the quantitative model 
to each of the above assumptions in supplemental information available online. 
We converted GFP synthesis rates measured across 7 different conditions and instruments 
(Figure C.1A; Coefficient of variation (CV) of the measurements is 39.1%) to relative promoter 
activity in RPUs (Figure C.1B; CV of the measurements is 17.5%). We noted that the coefficient 
of variation in promoter activity was reduced by approximately half when converted to RPUs 
from GFP synthesis rates. This reduction in variation suggests that relative promoter activity 
might be a useful property for characterizing promoters. However, care should be taken to note 
that while relative promoter activities remain fairly constant across some range of conditions, 
absolute promoter activities vary widely across these same conditions. Stated differently, a 
promoter that has an equivalent relative activity across multiple conditions might not produce 
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equal absolute activity (as measured in PoPS) across the same conditions (please see 
Discussion). 
Laboratory-laboratory variation 
Our initial success in characterizing relative promoter activity across different conditions and 
measurement instruments suggested a practical test. Specifically, we sought to determine 
whether multiple laboratories could work together to characterize promoters. To do this, we 
distributed a "reference promoter set" comprised of four strains, each containing one promoter 
test construct (BBa_J23113, BBa_J23150, BBa_J23151, or BBa_J23102) to researchers in six 
independent laboratories. Each researcher then measured the activity of the four promoters 
following a five-step procedure: (1) three independent cultures were grown from single colonies 
for each of the four promoters, (2) cells were collected in exponential phase, (3) GFP 
concentration per cell was measured using a flow cytometer, (4) flow cytometer data was gated 
based on forward and side scatter and the negative control, and (5) the geometric mean of the per 
cell fluorescence in the population was reported for each culture (Methods). We made no efforts 
to standardize the equipment (flow cytometers) or equipment settings beyond asking researchers 
to use typical settings for measuring GFP and by providing each lab with an example plot to 
guide gating of the flow cytometry data based on forward scatter, side scatter, and 
fluorescence (Kelly, 2008). As expected, there were slight differences in how the protocol was 
conducted in each laboratory, such as different culture conditions (rollers or shakers) and growth 
time. Since the measurements were reported in common units of RPUs we are able to compare 
the results of the interlaboratory promoter activity measurements directly (Figure C.2). The mean 
promoter activity measured by each lab is relatively consistent across all laboratories with less 
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than a 2-fold range of activities (min-max) across all measured promoters (BBa_J23150: 0.14–
0.23 RPU; BBa_J23150: 0.38–0.61 RPU; BBa_J23103: 0.77–0.96 RPU). The activity of the 
weakest promoter, BBa_J23113, was equivalent to the negative control within error for all but 
one of the laboratories. These results suggest that relative promoter activity is an effective metric 
for making comparable measurements across multiple laboratories. Finally, we determined the 
coefficients of variation of the measured promoter activities across all labs to be 17.2%, 17.1%, 
and 8.5% for BBa_J23150, BBa_J23151, and BBa_J23101, respectively, setting a baseline for 
future improvements to the measurement kit and methods. 
  
Figure C.2. Reference standards and units allow independent labs to make sharable 
measurements. Each laboratory followed the same measurement procedure, measuring 
relative promoter activities based on GFP concentration measured via a flow cytometer. 
Measurements were taken in triplicate; the boxes show the highest and lowest measured 
relative promoter activities and the whiskers show the 95% confidence interval of the 
mean of the activities. The large range in the 95% confidence interval (extending beyond 
the highest and lowest measured activities) is partially a function of the small number of 
replicates (three) that were conducted by each laboratory. The activity of BBa_J23113 
was equivalent to the negative control within error for all but one of the laboratories. The 
measured activities of the other three promoters were fairly consistent across laboratories 
with less than a 2-fold range of activities measured for each promoter across all labs 
(BBa_J23150: 0.14 – 0.23; BBa_J23150: 0.38 – 0.606; BBa_J23103: 0.77 – 0.96).  
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Community-based measurement of promoter collections 
Given that many laboratories could coordinate their measurement of promoter activities, we 
sought to prepare tools that would facilitate the widespread adoption of relative promoter activity 
measurements. To do this we first measured the relative activities of a set of seven representative 
promoters obtained from the Registry of Standard Biological Parts (Figure 
C.3) (www.parstregistry.org). These promoters included members of a constitutive promoter 
library (BBa_J23100 – BBa_J23119, constructed by JC Anderson) as well as the commonly used 
Tet repressor (BBa_R0040) and Lac repressor (BBa_R0011) regulated promoters 9Lutz and 
Bujard, 1997). The regulated promoters were tested in the absence of their cognate repressor 
proteins. Such libraries of characterized promoters have been shown to be valuable to researchers 
for tuning biochemical networks to optimize the synthesis of products of interest (Alper et al., 
2005; Basu et al., 2005). We measured the relative promoter activities by calculating the steady-
state GFP synthesis rates (Methods) and converting these rates to RPUs. Nine independent clones 
were characterized across three separate experimental runs for each promoter tested. The 
promoters ranged in activity from 0.026 ± 0.003 to 1.45 ± 0.095 RPUs (uncertainties represent 
95% confidence interval of the mean). The GFP expression level from one promoter 
(BBa_J23113) was statistically equivalent within measurement error to the expression level of 
the negative control (TOP10). 
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Figure C.3. Promoter collections can be readily characterized via Relative Promoter 
Units (RPUs). The five promoters labeled J23### are from a constitutive promoter 
library and R0040 and R0011 are tet- and lac-repressible promoters, respectively. The 
activity of the promoters was measured in relative promoter units (RPUs). This collection 
of promoter may itself be useful for tuning gene expression in engineered systems. The 
error bars represent the 95% confidence interval of the mean based on nine replicates. 
 
To further support community-based standardized measurement of promoter activities, we 
developed a first generation measurement kit for characterizing the relative activity of BioBrick 
promoters in RPUs. Our overarching objective for the kits was to enable independent researchers 
to make comparable measurements of relative promoter activity in standard units. We developed 
instructions and a parts list for the promoter measurement kit (see supplemental information 
online). The promoter measurement kit contains measurement "instruments" such as a green 
fluorescent protein (GFP) reporter device (BBa_E0240) and backbone plasmid (pSB3K3), as 
well as a recommended E. coli strain (TOP10). The reference promoter (BBa_J23101) was 
inserted upstream of the GFP reporter device (BBa_E0240) and included in the kit as the 
reference standard construct (BBa_I20260). In order to measure the activity of a user-specified 
promoter, kit users assemble the user-specified promoter upstream of the GFP reporter device 
and insert this combined part into the backbone plasmid to form the promoter test construct. The 
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process for inserting a promoter upstream of the GFP reporter device is based on three-antibiotic 
BioBrick standard assembly (Shetty et al., 2008), and is outlined in the instructions included 
with the kit (see supplemental file online). 
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Discussion 
We found the absolute activity of promoters to vary under different experimental conditions and 
when using different measurement instruments. We chose a promoter (BBa_J23101) to serve as 
a reference standard and demonstrated that by measuring relative promoter activity (activity of a 
sample promoter divided by activity of the reference standard promoter BBa_J23101, measured 
under the same conditions) we could reduce reported variation in measured promoter activity 
across differing experimental conditions and equipment. We defined the Relative Promoter Unit 
(RPU) in order to enable researchers to report promoter characterization results in compatible 
units, and developed a measurement kit in order to more easily allow researchers to adopt an 
RPU-based measurement approach. We distributed a test set of 4 promoters to 7 independent 
labs and found good agreement in the measured relative promoter activities across the test set. 
Finally, we characterized the relative promoter activity of 7 BioBrick promoters in order to 
bootstrap a collection of promoters measured according to our initial RPU reference standard. 
Absolute and relative promoter activities 
The absolute activity of a promoter is defined by the number of elongating polymerases per 
second (PoPS) exiting the promoter. The same promoter under different environmental 
conditions can have widely varying absolute promoter activities (Figure C.1A). Moreover, it is 
challenging to relate an indirect measure of absolute promoter activity, such as per cell GFP 
synthesis rates, to PoPS since any variation across conditions in the functioning of the genetic 
measurement instrument may not be well correlated with variation in promoter activity across 
these same conditions. In contrast, the relative activity of a promoter is defined as the ratio of the 
absolute activity of the promoter to the absolute activity of a reference standard promoter 
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measured under the same conditions and with the same measurement instrument. We found that 
the relative activity of a promoter will remain fairly constant across a practical range of 
conditions (Figure C.1B). 
Relative promoter activity as reported in RPUs enables the ranking of the activities of promoters 
but does not, by itself, provide information about the absolute activity of the promoter under 
particular conditions. For example, if the relative activity of a sample promoter remains constant 
across several conditions, it is not necessarily the case that the promoter is producing equal 
numbers of mRNA transcripts in each condition, only that the promoter activity is remaining 
proportional to the reference standard across the conditions. Nonetheless, relative promoter 
activity is a valuable property to measure and report since promoters can be rank ordered by 
relative promoter activity even if they were characterized by different researchers or across 
different environments (see supplementary information online). Furthermore, if both the relative 
and absolute activities of a promoter are measured, then a conversion factor can be established 
that defines the relationship between relative and absolute promoter activity under specific 
measurement conditions. For example, the reference standard promoter J23101, which has a 
relative activity of 1 RPU, has an estimated absolute activity of ~0.03 PoPS under specific 
conditions (supplementary information online). Therefore, the promoter J23151, which has a 
relative activity of approximately 0.5 RPU under these same conditions, would be predicted to 
have an absolute activity of ~0.015 PoPS. As more absolute measurements are made, an 
expanded set of conversion factors (or functions) could be developed, allowing for improved 
estimates of absolute promoter activities across a wider range of measurement conditions. 
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Interlaboratory measurement of promoter activity 
Measurement of in vivo promoter activities across laboratories is challenging due to the 
sensitivity of results to both experimental conditions and measurement instruments (Figure C.1), 
as well as the lack of shared reference standards (Serebriiskii and Golemis, 2000). We 
demonstrated here that by using a relative promoter activity to characterize promoter strength 
based on a shared reference standard, seven independent laboratories could make comparable 
measurements of three promoters (Figure C.2). We expect that future improvements to the 
recommended measurement techniques and measurement kit components could further reduce 
the variation in measurements across laboratories, with the results reported here providing a 
practical baseline for judging proposed improvements. 
Measurement procedures 
The reference promoter BBa_J23101 and relative promoter activity measured in RPUs provide a 
shared platform for researchers to evaluate different measurement procedures. We deliberately 
have not advocated a single measurement procedure, and there should be many acceptable 
procedures for characterizing promoters in RPUs, just as units for length or mass are not tied to a 
single measurement approach. The choice of the best measurement procedure will be influenced 
by the particular group making the measurements. For example, laboratories without access to 
equipment for capturing high-throughput single-cell measurements of fluorescence might opt for 
a bulk fluorescence measurement using a fluorimeter. Other groups might prefer to obtain single-
cell measurements using quantitative microscopy or flow cytometry, or to capture a time-course 
of fluorescence measurements from a growing culture. As different measurement procedures are 
likely to have merits within different communities we expect that a number of procedures will be 
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established. As an example, for the community of undergraduate teams using the promoter 
measurement kit during the International Genetically Engineered Machines (iGEM) competition, 
we have suggested a measurement protocol that can be easily carried out by novice researchers 
and that only requires two absorbance and bulk fluorescence measurements (supplementary file 
online) iGEM, 2008. 
Engineering with characterized promoters 
We anticipate that both absolute and relative promoter measurements will be useful in 
engineering genetic networks, however it is unclear to what extent one approach might be 
preferred over the other (presuming both types of measurements could be readily obtained). For 
example, we can imagine an engineering design framework in which the absolute activities of 
promoters and other functional genetic elements are tracked explicitly, in order to support 
detailed modeling and analysis of issues such as the absolute "load" placed on a host cell via 
recombinant gene expression. Such an ability seems likely to become more important as many-
component engineered biological systems are attempted (dozens to hundreds of gene products), 
in which the absolute expression levels of individual genes must be well managed and might be 
kept low compared to the high-expression, protein production systems typically used today. 
However, we can also imagine a competing or complementary engineering framework, based on 
the idea that cells already provide self-adapting and robust environments within which the 
absolute activities of genetic elements such as promoters are finely regulated by overall 
environmental or culture conditions (Bremer and Dennis, Neidhart, F. C., 1996). In such a 
framework, relative measurements of promoter activities may be both easier to obtain and more 
relevant. Many natural biological systems already follow this model, and are robust to the 
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absolute properties of components so long as the relative relationships between subparts are 
maintained. For example, developmental body plans may vary in size with individual organisms 
having different overall sizes, however the ratio of the sizes of individual bones or organs to 
overall body mass is often tightly maintained (Huxley, 1932). 
Standard promoter definition 
The promoters tested here were practically standardized to have identical transcription initiation 
sites (predicted) and identical sequences downstream of the initiation site (supplemental 
information online). Thus, we expect that the mRNA expressed by each of the tested promoters 
is identical to the mRNA produced by the reference standard promoter, and that we can cancel 
the mRNA degradation rate and translation rate of immature GFP from mRNA terms in 
simplifying the model relating GFP synthesis rates to RPUs. This simplification allows the 
activity of promoters to be reported in comparable units (RPUs) without needing to directly 
measure mRNA levels. Going forward, an expanded definition for standard BioBrick promoters 
could be developed in order to ensure that all promoters share the same transcription start 
position and a fixed sequence downstream of the transcription start site (that is, 5' mRNA UTR). 
All promoters that adhered to such a standard could then be reliably measured using the kits 
described here, or via future kits based on gene expression reporters that adhered to any new 
standard, without the need for promoter-specific mRNA quantitation. 
Distribution, use, and improvement of standardized measurement kits 
Shared measurement tools and reference standards become more useful as they are broadly 
adopted. To facilitate such adoption, the Registry of Standard Biological Parts now includes our 
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promoter measurement kit and reference standard in the annual distribution of BioBrick parts. 
We also created a website in order to support the reporting and sharing of promoter activity 
measurements (www.partsregistry.org/measurement). This website contains instructions for use 
of the kit and summarizes previously characterized promoters. Finally, to enable discussion of 
proposed improvements to the kit and reference standard, and also the development of new kits 
and reference standards, we are supporting an open discussion of technical standards in synthetic 
biology (http://biobricks.org/standards). 
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Conclusion 
Standard tools, techniques, and units for measurement are needed for a distributed community of 
biological engineers to independently characterize and share biological parts. We have defined a 
shared unit for measuring relative promoter activity (Reference Promoter Units, RPUs) and 
demonstrated that relative promoter activity can address some of the challenges in measurement 
across labs due to varying experimental conditions and measurement instruments. We developed 
a first-generation measurement kit for BioBrick promoters, and are freely distributing the kit via 
the Registry of Standard Biological Parts. Having demonstrated the feasibility and ease of use of 
the kit, we hope to encourage a community of users to adopt and improve these measurement 
tools and reference standard in order to characterize promoters via a comparable and common 
unit, the RPU. We expect that the shared experiences of biological engineers using common 
measurement tools and standards will help to identify new engineering challenges in improving 
the reliability and reuse of standard biological parts. 
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Methods 
Strains and media 
All measurement experiments and cloning were performed in E. coli TOP10 (Invitrogen) or 
W3110. Supplemented M9 minimal medium (M9 salts, 1 mM thiamine hydrochloride, 0.2% 
casamino acids, 2 mM MgSO4, 0.1 mM CaCl2) was used for all measurement experiments with 
either glycerol (0.4%) or glucose (0.4%) added as a carbon source and kanamycin (20 μg/ml) 
antibiotic added where appropriate. All oligonucleotides were purchased from Invitrogen and 
DNA modifying enzymes were purchased from New England Biolabs. 
Promoter measurement kit contents 
Sequences for all BioBrick plasmids (denoted pSB***) and BioBrick parts (denoted BBa_####) 
are available through the Registry of Standard Biological Parts. pSB3K3 contains a p15A origin 
of replication (copy number 10–12) and the kanamycin resistance marker, pSB4T5 contains the 
pSC101 origin of replication (copy number ~5) and the tetracycline resistance marker, and 
pSB3C5 contains the p15A origin of replication and the chloramphenicol resistance marker. 
Physical copies of the plasmids and parts are also available from the Registry via the annual 
Registry parts distribution. The details of the promoter measurement kit contents are described in 
Supplementary Box 1 and Supplementary Table 1 (see supplementary information online). The 
sequences for the preparative primers used to amplify pSB3K3 to generate backbone plasmid 
are: TACTAGTAGCGGCCGCTGCAG (forward primer) and CTCTAGAAGCGGCCGCG 
AATTC (reverse primer). 
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Assembly of test constructs 
We built promoters by annealing synthesized oligonucleotides. The oligonucleotides were 
ordered with 5' phosphates and designed to leave an EcoRI overhang on the 5' end and a SpeI 
overhand on the 3' end so they could be used in subsequent ligation reactions without an 
intermediate restriction digest step. We inserted seven promoters: BBa_J23113, BBa_J23116, 
BBa_J23150, BBa_J23151, BBa_J23102, BBa_R0040, and BBa_R0011 into the promoter test 
construct and transformed into TOP10 according to the process outlined in Supplementary Box 1 
(see supplementary information online). We found the optimal concentration of DNA for each of 
the three components in the ligation reaction (pSB3K3, BBa_E0240 or BBa_I13401, and the test 
promoter) was approximately 10 ng per uL. More detailed protocols and troubleshooting can be 
found at www.partsregistry.org/measurement. In the process of construction we found mutations 
in two of the promoters that we attribute to errors in the synthesis of the oligonucleotides that 
were annealed to construct the promoters. The two promoters were functional so we included 
them as additional members of the collection (BBa_J23150 and BBa_J23151). The method of 
part assembly described here is based on the three-antibiotic BioBrick standard assembly 
method (Shetty et al., 2008). 
Assay of promoter collection 
The protocol described here will be referred to as the "original" protocol throughout the methods 
section and describes the measurement procedure used to characterize the set of seven promoters 
(Figure C.3). For each promoter construct three 17 mm test tubes containing 5 ml of pre-warmed 
(37 °C) supplemented M9 medium with kanamycin (20 μg/ml) were inoculated from single 
colonies of TOP10-DH5α containing the promoter test construct on the pSB3K3 vector 
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backbone. Cultures were grown in 17 mm test tubes for approximately 20 hrs at 37 °C with 
spinning at 70 rpm. We then diluted the cultures 1:100 into 5 ml of pre-warmed fresh media and 
the cultures were grown for approximately four hours under the previous conditions (17 mm 
tubes, 37 °C, spinning at 70 rpm). After four hours, we measured the OD600 of a 500 μl aliquot 
from each culture on a WPA Biowave Spectrophotometer. Based on this OD600 measurement, 
the cultures were diluted to the same OD600 (0.07) in 5 ml of pre-warmed fresh media and grown 
for one hour at 37 °C. We then transferred three 200 μl aliquots from each culture into a flat-
bottomed 96 well plate (Cellstar Uclear bottom, Greiner). We incubated the plate in a Wallac 
Victor3 multi-well fluorimeter (Perkin Elmer) at 37 °C and assayed with an automatically 
repeating protocol of absorbance measurements (600 nm absorbance filter, 0.1 second counting 
time through 5 mm of fluid), fluorescence measurements (485 nm excitation filter, 525 nm 
emission filter, 0.1 seconds, CW lamp energy 12901 units), and shaking (3 mm, linear, normal 
speed, 15 seconds). 
Background absorbance was determined by measuring wells containing only media. Background 
fluorescence was determined at different ODs from the fluorescence of TOP10 cells without a 
GFP expressing vector (Kalir et al., 2001). After background subtraction, time-series 
fluorescence (F) and absorbance (ABS) measurements were used to calculate the ratio of the rates 
of GFP synthesis for the promoter test construct and the reference standard construct. 
Measurements were taken from an approximately 30 min period in mid-exponential 














ABSdtdF   (9) 
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Since we are calculating a ratio of the GFP synthesis rates we do not need to determine each rate 
in absolute units of GFP per second per cell, rather we can use the background-subtracted 
fluorescence (F) that is proportional to the number of GFP molecules and the background-
subtracted absorbance (ABS) that is proportional to the number of cells in the culture to calculate 
the ratio of GFP synthesis rates (Ronen et al., 2002; Canton et al., 2008). 
Assay of different measurement conditions 
We measured the promoter activity of two promoters (BBa_J23101 and BBa_J23150) under 
seven different measurement procedures. The first of the seven procedures was identical to the 
"original" protocol described above for measuring the 7-member promoter collection except it 
was conducted at 30 °C in the strain W3110 with pSB3K3 as the vector backbone for the 
promoter test construct. The second procedure was identical to the original except it was 
conducted at 30 °C. The third procedure was identical to the original except that it was 
conducted at 30 °C and pSB4T5 was used as the vector backbone. The fourth procedure was 
identical to the original except that it was conducted at 30 °C and used pSB3C5 as the vector 
backbone. The fifth procedure was identical to the original. The sixth procedure was identical to 
the original except that instead of the second dilution into tubes followed by 1 hour of growth, 
the cells were diluted into 96 well plates and incubated for two hours before we started taking 
measurements. The seventh procedure was identical to the sixth except glucose was used instead 
of glycerol as the carbon source. 
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Assay of inter-laboratory variability 
We distributed a set of four promoters (BBa_J23113, BBa_J23150, BBa_J23151, and 
BBa_J23102) to six laboratories to take independent measurements of promoter activity. The 
protocol each lab conducted was identical to the original protocol described, except that the cells 
were harvested after the first 1:100 dilution and 4 hours of growth (there was no second dilution 
step). The cells were then spun down, resuspended in PBS, and the fluorescence per cell was 
measured using a flow cytometer. The measurement equipment used (cytometer model, laser, 
emission filter) varied between the laboratories (see supplementary information, Table 2). 
For all other experiments we measured RPUs from the GFP synthesis rates as described in 
Equation 9. However, for the inter-laboratory experiments we are unable to measure the GFP 
synthesis rates because these rates require a time series to calculate (dG/dt in Eq. 9) and we only 
requested a single time point, however we can use this single time point to find the background-
subtracted per cell fluorescence at steady-state ([F]). The flow cytometer measures fluorescence 
per cell directly, thus (F) is calculated by taking the geometric mean of the population 
fluorescence per cell. We related the per cell GFP concentration ([G]) to RPUs by using a model 

























  (10) 
μφ/μJ23101 is a correction term based on differences in growth rate. Changes in the growth rate 
effect per cell GFP accumulation since loss of GFP per cell is largely due to dilution. Since we 
are calculating a ratio of the per cell GFP concentrations we do not need to determine each rate 
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in absolute units of GFP molecules per cell, rather we can use the background-subtracted per cell 
fluorescence ([F]) that is proportional to the number of GFP molecules per cell to calculate the 
ratio of GFP concentrations. 
After background correction, the per cell fluorescence ([F]) was determined for each promoter 
and activities in RPUs were calculated using Eq. 10. We applied the growth rates measured 
previously (supplementary information online, table 3) across all laboratories when calculating 
RPUs, rather than requesting individual laboratories to measure growth rates. This 
approximation likely increased the variability in the promoter activity measurements across 
laboratories, as growth rates vary between laboratories due to differences in culture conditions 
and media. 
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